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Current therapies to repair damaged articular cartilage fail to consistently or fully restore the
biomechanical function of cartilage. Although cell-based clinical techniques have emerged for the
treatment of focal defects in articulating joints, these approaches typically lead to inferior tissue
formation when compared to native, healthy cartilage. Alternatively, subchondral microfracture is a
surgical procedure that aims to recruit endogenous mesenchymal stromal cells (MSCs) from the
underlying bone marrow to facilitate neocartilage formation in focal defects. Similarly, microfracture
typically results in the formation of repair cartilage incapable of withstanding the loading environment of
the articulating joint over time. New biomaterial-based strategies are therefore in significant demand to
improve cartilage tissue formation and maturation within focal defects.
Hyaluronic acid (HA) is a glycosaminoglycan that is found in native cartilage and that shows promise as a
biomaterial for cartilage tissue engineering due to its innate bioactivity and ability to form hydrogels,
water-swollen polymer networks that may be engineered to mimic the native extracellular matrix (ECM).
Moreover, hydrogels may be employed as materials for biofabrication, which involves the use of
automated additive manufacturing processes such as 3D printing to fabricate living, biological
constructs.
This dissertation describes the design and implementation of HA hydrogels for the biofabrication of
articular cartilage towards improving existing therapies for damaged cartilage. Multiple biofabrication
approaches, including extrusion bioprinting, melt-electrowriting, and digital light processing are
investigated to engineer scaffolds with rationally designed geometries, mechanical properties, porosities,
and biodegradability. Conserved across all these approaches is the use of thiol-ene based photochemistry
to control the formation and resultant material properties of HA hydrogels modified with norbornene
functional groups. Taken together, the employment of these biofabrication approaches for cartilage repair
has significantly informed the design and implementation of future therapies for articular cartilage
damage.
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ABSTRACT
BIOFABRICATION APPROACHES WITH HYALURONIC ACID HYDROGELS FOR
CARTILAGE REPAIR
Jonathan H. Galarraga
Jason A. Burdick

Current therapies to repair damaged articular cartilage fail to consistently or fully
restore the biomechanical function of cartilage. Although cell-based clinical techniques
have emerged for the treatment of focal defects in articulating joints, these approaches
typically lead to inferior tissue formation when compared to native, healthy cartilage.
Alternatively, subchondral microfracture is a surgical procedure that aims to recruit
endogenous mesenchymal stromal cells (MSCs) from the underlying bone marrow to
facilitate neocartilage formation in focal defects. Similarly, microfracture typically results
in the formation of repair cartilage incapable of withstanding the loading environment of
the articulating joint over time. New biomaterial-based strategies are therefore in
significant demand to improve cartilage tissue formation and maturation within focal
defects.
Hyaluronic acid (HA) is a glycosaminoglycan that is found in native cartilage and
that shows promise as a biomaterial for cartilage tissue engineering due to its innate
bioactivity and ability to form hydrogels, water-swollen polymer networks that may be
engineered to mimic the native extracellular matrix (ECM). Moreover, hydrogels may be
employed as materials for biofabrication, which involves the use of automated additive
manufacturing processes such as 3D printing to fabricate living, biological constructs.
vi

This dissertation describes the design and implementation of HA hydrogels for
the biofabrication of articular cartilage towards improving existing therapies for damaged
cartilage. Multiple biofabrication approaches, including extrusion bioprinting, meltelectrowriting, and digital light processing are investigated to engineer scaffolds with
rationally designed geometries, mechanical properties, porosities, and biodegradability.
Conserved across all these approaches is the use of thiol-ene based photochemistry to
control the formation and resultant material properties of HA hydrogels modified with
norbornene functional groups. Taken together, the employment of these biofabrication
approaches for cartilage repair has significantly informed the design and implementation
of future therapies for articular cartilage damage.
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CHAPTER 1: INTRODUCTION
1.1.

THE BURDEN OF CARTILAGE DAMAGE AND INJURY
Cartilage is a load bearing connective tissue that is found in articulating joints and

permits movement between bones with minimal friction. Cartilage is comprised of four
distinct zones: the superficial zone, middle zone, deep zone, and calcified zone.1,2 The
superficial zone exhibits densely packed collagen II fibrils, flattened elongated cells
(oriented by tangential shear stresses), relatively high cellularity, and a low compressive
modulus. The middle zone however contains round cells, higher compressive properties
and collagen fibers that are randomly arranged. Finally, the deep zone is characterized by
columns of ellipsoidal cells that are distributed between radially oriented collagen fibers,
while the calcified zone interfaces with underlying subchondral bone. In each of the
respective zones of cartilage, proteoglycans are contained within an entangled collagen
matrix. While the negatively charged sites found on aggrecan molecules result in swelling,
these proteoglycans are aggregated together due to the presence of the collagen matrix.
The repulsive forces between negatively charged proteoglycans and the osmotic swelling
that occurs within the matrix ultimately yield the impressive compressive properties of
cartilage.1,3 More generally, the stratified anisotropy of collagens in articular cartilage,
taken together with the variable ECM compositions throughout each zone, gives rise to
unique mechanical properties,4 such as tension-compression non-linearity,5 which impart
cartilage with its biomechanical function (Figure 1.1).6
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Figure 1.1: Overview of the distinct zones and extracellular matrix of articular cartilage.
A) Articular cartilage is composed of four distinct zones: the superficial, middle, deep, and
calcified zones. From the superficial zone to the deep zone of articular cartilage, the orientation
of both cells and collagen fiber transitions from parallel to the articulating surface to orthogonal.
In addition, relative differences in oxygen content (highest in the superficial zone), collagen
cross-links (i.e., lysylpyridinoline (LP), hydroxylysylpyridinoline (HP)), and compressive
modulus (highest in the deep zone) are observed throughout different zones.7 The calcified
zone is marked by the presence of hypertrophic chondrocytes, which undergo endochondral
ossification toward the formation of the underlying subchondral bone. B) The extracellular
matrix of articular cartilage is composed of collagen fibers (predominantly type II collagen) and
negatively charged proteoglycans (predominantly aggrecan), which are entangled together to
form a viscoelastic network that imparts resistance to compressive loading. Chondrocytes
embedded within the ECM interact with the surrounding environment via interactions between
fibronectin and integrin binding receptors and between hyaluronan (i.e., hyaluronic acid) and
CD44 surface receptors. Schematics adapted from 2.
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Articular cartilage degeneration is a pervasive problem that afflicts many people,
inhibiting quality of life and joint mobility in over 20 million Americans.8 Focal defects on
the articulating surface of joints typically form in patients due to trauma, sports injuries, or
daily activities associated with joint function.9 Unfortunately, native cartilage does not
possess any innate healing capacity,10 such that these defects may lead to the
progression of disease throughout the entire joint if left untreated. Furthermore, it is
understood that these focal defects may evolve towards pain and ultimately
osteoarthritis.11
To this end, a number of clinical approaches have been developed for
reconstructing chondral defects, such as microfracture (MFX), mosaicplasty, and matrixassisted chondrocyte implantation (MACI).12 Microfracture is a minimally invasive,
arthroscopic procedure that involves the formation of holes in underlying subchondral
bone via an awl to recruit mesenchymal stromal cells from bone marrow and elicit a
healing response.13 While microfracture may induce some cartilage repair in small defects
(< 2.5 cm2), it often leads to the formation of fibrocartilage,14 which exhibits inferior
mechanical properties when compared to native hyaline cartilage.13,15 Alternatively,
mosaicplasty may be employed to fill and repair large defects (>4 cm2) via transplantation
of autologous tissue from a non-weight bearing region.14 However, this technique often
results in donor site morbidity and poor transplant integration with adjacent tissue.16 MACI
has been employed clinically to deliver autologous chondrocytes within a collagen matrix
to promote the repair of cartilage, and has shown marked improvement over microfracture
for critical size defects (≥3 cm2);14,17 however, this procedure has yielded less than
satisfactory clinical results, as adequate repair in a subset of cartilage defect patients,
possibly due to insufficient matrix properties.17 With all of this considered, there remains
a significant clinical need for the development of new approaches that support the
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formation of functional cartilage and enhance the prospects for strategies such as MACI.
Specifically, approaches that utilize biomaterials and biofabrication techniques may
advance towards the clinical repair of cartilage focal defects, alleviating the burden of pain
and costs associated with cartilage degeneration.17
1.2

DESIGN OF HYDROGELS FOR CARTILAGE TISSUE ENGINEERING
One approach to cartilage repair involves the incorporation of cells within

hydrogels, water swollen polymer networks that mimic the native extracellular matrix, to
elicit neotissue formation.15 Although a range of materials have been investigated in this
approach, including natural collagen materials with the clinically-used MACI technique,
the quality of repair tissue formed in these materials is typically inferior to healthy
tissue.15 Additionally, it is a challenge to fabricate hydrogels that exhibit the necessary
mechanical properties for stabilization in defects while still supporting the viability and
function of cells.18
One important class of hydrogels in cartilage tissue engineering are those formed
from hyaluronic acid (HA). HA is a non-sulfated glycosaminoglycan found in native
cartilage that shows promise as a hydrogel for cartilage repair due to its inherent
bioactivity and amenability to facile chemical modification for hydrogel formation.19
Studies have shown that the presence of distinct physiochemical cues (e.g. network
mechanical properties, mesh size, signaling ligands) can appreciably influence ECM
formation and distribution by encapsulated cells.20–22 As one specific hydrogel example,
norbornene-modified HA (NorHA) has proven to be very amenable to tuning hydrogel
material properties and has potential in cartilage tissue engineering.
The field of additive manufacturing has also advanced in recent years to improve
techniques for the fabrication of cell-laden hydrogels into user-defined geometries,
including for cartilage tissue engineering.23 To understand the complex challenges and
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design criteria associated with the use of additive manufacturing for cartilage repair, it is
important to first consider recent progress and advancements within the field of
biofabrication for cartilage tissue engineering. The aim of this introduction is to outline
these advances to provide a general background for the new light-based biofabrication
techniques and hyaluronic acid-based scaffolds described in this dissertation.
1.3

STATE OF THE ART IN BIOFABRICATION FOR CARTILAGE REPAIR
Biofabrication generally involves the construction of complex biological products

from elementary units such as living cells, bioactive molecules, and biomaterials,24 and
has rapidly emerged as one of the leading technological platforms within the fields of
tissue engineering and regenerative medicine toward the automated manufacturing of
complex, functional tissues and organs.23–26 To build these structures, biofabrication
techniques require the implementation of multidisciplinary approaches, combining skills in
diverse fields such as cell biology and anatomy, mechanical engineering, and materials
science to assemble cells and engineered biomaterials into functional tissue
constructs23,24 or complex 3D in vitro tissue models for high throughput screening and
disease modeling.26
Toward recreating complex features within engineered tissues, a range of additive
manufacturing techniques have been adapted or developed in recent years, including
extrusion-based 3D printing, inkjet printing, lithography-based 3D printing (i.e.,
stereolithography (SLA), digital light processing (DLP), computed axial lithography (CAL),
continuous liquid interface printing (CLIP), two-photon printing (2PP)), laser induced
forward transfer (LIFT), and bioassembly.23,27–29 Across all of these approaches, the goal
is to organize cells and/or physicochemical cues in 3D to elicit desired cellular behaviors,
which may include cell proliferation, migration, differentiation, and tissue formation.
Bioprinting approaches specifically include instances where cells are directly processed
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and organized via 3D printing.30 In cartilage applications, typically chondrocytes,
mesenchymal stromal cells, chondroprogenitors, or co-culture of these cells are utilized,
such that chondrogenesis and/or ECM production can be mediated through both the
selected biofabrication method employed and the presentation of signaling cues. The
biofabrication method employed for cartilage tissue engineering often varies, as each
approach possesses their own respective advantages and limitations.
Bioprinting has rapidly evolved as a leading and widely adopted additive
manufacturing approach for the design and production of living cartilage tissue constructs.
By utilizing computer-aided design (CAD), bioprinting permits the automated formation of
living materials with desired architectures in a precise and reproducible manner.26
Specifically, the ability to 3D bioprint cells and materials into defined geometries allows
the fabrication of constructs that recapitulate the complex organization and
structure−function relationships found in native tissues. For example, bioprinting may be
leveraged to mimic the anisotropic mechanical properties and zonally stratified regions
found in native cartilage.31
1.3.1

Extrusion-Based Bioprinting and Biofabrication

1.3.1.1 Bioink Design and Implementation
Extrusion-based bioprinting methods have been widely employed in recent years
for the fabrication of cell-laden hydrogel constructs through the extrusion and subsequent
stabilization of bioinks. Bioinks are generally any biomaterial that can be processed via
3D printing that also incorporates living cells, cell aggregates/spheroids, organoids, or
microtissues.30 The simplicity, diversity and predictability of this printing technique has led
to its extensive popularity, with many commercial bioprinters now available. In comparison
to other printing approaches such as SLA, DLP, and CAL, extrusion-based bioprinting
functions at lower print speeds and resolutions;29 however, the major advantages of
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extrusion-based bioprinting include the wide range of printable bioinks, the use of
inexpensive equipment, and the minimal loss of the bioink during fabrication. As a result,
extrusion-based bioprinting has been the most common biofabrication approach
leveraged for cartilage tissue engineering to date.
Many researchers have modified conventional commercial 3D printers for
extrusion-based bioprinting or developed custom printing equipment to reduce the costs
required for bioprinting. On the other hand, due to the growing demand and development
of extrusion-based bioprinters, commercial systems have become widely available and
adopted by researchers in academia and industry, which has rapidly enhanced the print
quality and speed, as well as the ability to fabricate constructs with a wider range of
biomaterials.32
To successfully support conventional extrusion-based bioprinting, bioinks must be
designed with specific properties (Figure 1.2).29,33
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Figure 1.2: The traditional biofabrication window for extrusion printing of bioinks.
Generally, bioinks and biomaterial inks employed in extrusion printing must possess suitable
rheological properties so that they can readily flow upon application of shear stress, and in
tandem exhibit sufficient mechanical integrity to support the deposition of stable filaments in a
layer-by-layer manner. Viscous materials that yield hydrogels with higher polymer
concentrations, crosslink densities, and stiffness typically meet each of these respective
design criteria for ink printability (blue, upper right corner of schematic). However, hydrogels
with these properties often exhibit poor cytocompatibility, as they do not possess the mesh
sizes needed to support nutrient transport for encapsulated cells. Hydrogels desirable for cell
encapsulation and function typically exhibit lower polymer concentrations and crosslink
densities (yellow, lower left corner of schematic). To this end, conventional extrusion
bioprinting aims to balance ink properties to achieve optimal cellular microenvironments while
conserving ink printability and the shape fidelity of printed constructs (green, center of
diagram). The development of novel extrusion printing approaches (e.g., embedded 3D
printing) is focused on achieving optimal shape fidelity and hydrogel properties for cell culture
in parallel (upper left corner of schematic). Schematic adapted from 38.

For example, the viscosity of the bioink can be very important toward successful
processing with extrusion-based bioprinting.29 Specifically, extrusion printing requires that
biomaterial inks exhibit low enough viscosity so that they can traverse through a print head
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without clogging or generating cytotoxic shear forces if cells are included; however, inks
must also possess suitable mechanical integrity so that they can be deposited in a layerby-layer manner. Another important consideration is the influence that cells themselves
have on the overall bioink properties. Past studies have demonstrated that the
incorporation of cells at high densities (100x106 cells/mL) within collagen inks resulted in
increased ink viscosities and storage moduli initially, but decreased rates of gelation and
storage moduli post-gelation; however, printability can still be conserved at these high cell
densities.34
To ensure that encapsulated cells remain functional during the printing process,
strategies have been developed to mitigate the influence of shear stresses on cell viability
during bioink extrusion. Controlling properties such as ink viscosity (e.g. through material
formulation or temperature), printing pressure (or force for screw/piston-based extrusion),
nozzle geometry, and nozzle diameter improve the control over applied shear stresses
during the printing process.35,36 The development of fluid dynamic-based models have
further improved the ability to tune shear stresses generated during printing towards
ensuring cell viability throughout the printing process.35,37
To achieve the deposition of stable filaments during the extrusion process, the inks
employed must be rapidly crosslinked. Bioinks used in extrusion-based bioprinting may
be crosslinked with a range of different exogenous triggers including light, temperature,
and/or the presence of ions. For instance, co-axial extrusion setups have been leveraged
to print methacrylated-gelatin (GelMA), methacrylated-HA (MeHA), and chondroitin sulfate
amino ethyl methacrylate (CS-AEMA) as photosensitive inks for cartilage tissue
engineering, with ionically crosslinked alginate added to impart initial printability and
filament stability. Using this approach, constructs were printed with high viability of
embedded MSCs and features on the order ~100um.39 Interestingly, bioinks composed of
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alginate, gelatin, and chondroitin sulfate have also been employed to achieve optimal
ratios of COLII/COL I and COLII/COLX gene expression by encapsulated cells toward the
development of hyaline cartilage; however, ink formulations in the same study with higher
macromer concentrations resulted in more hypertrophic gene expression, likely due to the
increase in hydrogel crosslink density.39 Dual crosslinking of alginate has also been
achieved via modification with thiol and norbornene functional groups, such that the
alginate bioink could be initially crosslinked via ionic crosslinking and subsequently
stabilized via thiol-ene photocrosslinking.40 Additional discussion on the use of lightmediated crosslinking for extrusion bioprinting is included in Chapter 3.
In addition to the myriad of crosslinking chemistries employed for the stabilization
of bioinks, a range of different bioinks have been utilized and compared for extrusion
bioprinting including both natural biopolymers (e.g., gelatin methacryloyl (GelMA),
allylated gelatin (GelAGE)41, collagen, 42 chondroitin sulfate, 39 gellan gum, 43 silk fibroin,44
mannan,

45

fibrinogen,46 alginate,47 agarose,47 and hyaluronic acid48) and synthetic

polymers (e.g., PEGMA,

47

Pluronic block copolymer,49 allyl-functionalized poly(glycidol)s

(P(AGE-co-G))50). While synthetic materials typically possess well-defined material
properties and tunability, the inherent bioactivity, biodegradability, and biocompatibility of
natural materials make them excellent candidate materials for bioinks. In one
representative example, platelet-rich plasma was combined with photocrosslinkable
GelMA (which interacts with plasma via integrin receptors), to create a patient-specific
bioink that presents growth factors to chondrocytes.51
Decellularized ECM has also been leveraged to provide a local microenvironment
to encapsulated cells that is chondroinductive. For example, cartilage ECM particles have
previously been combined with gellan gum and alginate based inks in combination with
TGF-B3 to increase the matrix production of encapsulated cells (Figure 1.3a).52 Similarly,
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alginate bioinks containing MSCs have also been supplemented with decellularized
cartilage extracellular matrix to improve their chondrogenic potential, as evidenced by
increases in chondrogenic gene expression (i.e., SOX9, COLII, ACAN) when compared
to alginate alone controls.53 Since these gels also demonstrated differentiation consistent
with an endochondral pathway (marked by RUNX2 and COLX expression, as well as
mineralization), TGF-B3 was included within the ink to improve chondrogenesis toward a
hyaline-like phenotype. dECM is an excellent candidate bioink due to the innate
physicochemical cues retained within the ECM and its cytocompatibility.54 However,
variability in sourced ECM, taken together with the challenges posed by processing dECM,
storing dECM inks, and potentially scaling dECM manufacturing has led to the
implementation of alternative bioinks composed of natural polymers or ECM components.
To improve the overall control over ink properties, hybrid inks composed of both
natural and synthetic materials have been employed. For example, triblock copolymers of
PEG and methacrylated poly [N-(2- hydroxypropyl) methacrylamide mono/dilactate] were
previously utilized as thermally sensitive bioinks, permitting thermal self-assembly of
chondrocyte-laden gels to occur concurrently with photocrosslinking during the printing
process. Methacrylated-chondroitin sulfate and methacrylated-HA were then preferentially
incorporated into these inks to modulate resultant hydrogel mechanical properties and
degradation profiles.55
Shear-thinning and self-healing materials are commonly employed in extrusion
bioprinting since they exhibit viscous flow upon application of shear (i.e., during extrusion)
while also recovering their mechanical integrity with the removal of shear stress. Typically,
these types of inks incorporate either physically crosslinked polymers, reversible dynamiccovalent chemistries, or components that can physically interact with each other (e.g.,
Laponite nanosilicates,56 nanocellulose36,57) via ionic or intermolecular interactions. For
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instance, alginate-based inks have been supplemented with nanocellulose to permit viable
extrusion printing of chondrocytes.36,57
Similarly, nanocomposite bioinks containing nanoparticles (NPs) that exhibit
dynamic covalent or physical bonding with surrounding polymers are also utilized to
improve printability.44,58 In one instance, oxidized alginate along with gellan gum (physical
crosslinking is achieved with cooling post-printing) was mixed with amine presenting NPs,
such that reversible imine bonds could readily form, resulting in interpenetrating networks
(IPNs) composed of covalent alginate-NP networks and physically crosslinked gellan gum
networks. The inclusion of NPs improved the rheological properties for extrusion printing
(e.g., increase of yield stress from 14.5 Pa to 79 Pa with the inclusion of NPs) and
mechanical stability of inks when comparted to ionically crosslinked alginate alone, which
quickly undergoes dissolution. Chondrogenic culture of printed chondrocyte-laden
constructs and implantation in nude mice then led to neotissue formation in vitro and in
vivo, respectively.58
1.3.1.2 Multi-Material Extrusion-Based Printing
While composite ink formulations may improve overall ink printability or mechanical
properties, they do not always fully capture the range of physiochemical properties
presented within native tissues. Therefore, to further improve the complexity of scaffolds
for cartilage tissue engineering, multi-material printing techniques have been developed.
For example, the controlled deposition of GelMA/gellan gum and fugitive alginate inks
allowed for the formation of complex overhanging geometries that would otherwise not be
readily achieved, improving the ability to recapitulate anatomically relevant features.59
Similarly, collagen inks have been used to create constructs with gradients of cell
densities, mimicking the relative cellularity of the distinct cartilage zones. Interestingly,
printing of chondrocyte-laden gels with gradients of cell densities led to corresponding
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gradients in chondrogenic gene expression, as well as the formation of tissue that
exhibited gradients of ECM composition.42 Moreover, microfluidics have been leveraged
as a method to control the temporal deposition of different inks, permitting multi-material
printing.60 To this end, an extrusion printing setup with seven distinct printheads controlled
via pneumatic valves was designed to achieve continuous and rapid deposition of multiple
materials in parallel, such that multiple bioinks could be readily and precisely deposited in
parallel or in series with each other.61 Skylar-Scott and colleagues have also coupled
microfluidics with multiple print nozzles for high-frequency multi-material printing towards
the fabrication of complex, voxelated and heterogeneous structures.62 Generally, the
ability to combine multiple materials and cell populations in these approaches
demonstrates how continued advancements in both printer capabilities and bioink design
are enabling the fabrication of constructs that more faithfully emulate cartilage.
One of the limitations of most hydrogel bioinks is their relatively low mechanical
properties, which are significantly lower than those of native healthy cartilage. In response
to this, multi-material printing has enabled the fabrication of composites of hydrogels and
polycaprolactone (PCL) templates to improve construct mechanical properties (Figure
1.3b).63 Multihead dispensing systems (MHDS) have been employed for co-printing of
PCL and alginate hydrogels encapsulating chondrocytes and TGF-B. Importantly, these
composite systems demonstrated significance promise, with no adverse tissue responses
and the formation of neocartilage observed 4 weeks after subcutaneous implantation in
nude mice.64 Since co-printing PCL scaffolds with cell-laden gels is a common approach
for cartilage tissue engineering,50,53 the influence of PCL molecular weight, scaffold
porosity, filament size, filament spacing, and filament orientation on resultant mechanical
properties has been characterized.65
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In another study, cell-laden hybrid ECM gels (gelatin, fibrinogen, HA, glycerol)
were co-printed with reinforcing PCL in the presence of sacrificial gels (Pluronic F-127) for
stabilization, and the incorporation of negative internal features (i.e., microchannels)
permitted improved transport toward the fabrication of larger scale constructs (Figure
1.3c). For example, ear-shaped scaffolds with encapsulated chondrocytes were printed
and shown to form neocartilage after 5 weeks of chondrogenic culture in vitro and 2
months after subcutaneous implantation in athymic mice.46 Alginate bioinks for cartilage
bioprinting have similarly been reinforced via the inclusion of submicron polylactide fibers,
which increased hydrogel Young’s modulus three-fold.66
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Figure 1.3: Extrusion printing for the formation of cartilage. a) Representative examples
of extrusion 3D printing for the fabrication of gellan/alginate/ECM-based scaffolds with
anatomical geometries, including in the shape of (i-iv) a model ear, (vii-x) model menisci, (xi)
a model intervertebral disc, and (xii-xiii) a model nose. Schematics and images adapted from
52 b) (i) Schematic overview of co-printing of thermoplastic polymers and hydrogels (ii) to create
complex, multi-material constructs and (iii) to reinforce soft hydrogels. Schematics and images
adapted from 63. c) (i, left) Schematic of the multi-material extrusion printer employed to
fabricate PCL-reinforced hydrogels. A 3-axis stage controller enables the controlled deposition
of filaments onto an underlying stage, while a pneumatic pressure controller regulates the flow
of multiple inks from distinct cartridge modules. The entire system is enclosed within an acrylic
chamber containing a temperature regulator and humidifier to enable the extrusion of
thermoplastic PCL. (ii, right) A representative schematic detailing how PCL may be co-printed
with multiple bioinks (i.e., red and green filaments, containing distinct cell populations “A” and
“B”) to yield heterogeneous constructs. (ii) (From left to right) 3D CAD of a model ear, the print
path employed to deposit cell-laden filaments (red), PCL (green), and fugitive ink (i.e., Pluronic
F-127, blue) to support overhanging geometries, and representative images of the printing
process. (iii) (From left to right) Representative images of the printed ear before and after
removal of Pluronic F-127 via washing, and Safranin O staining of constructs with and without
microchannels after 5 weeks culture in chondrogenic medium in vitro. Schematics and images
adapted from 46. d) (i) Schematic and (ii) representative image of the handheld biopen device,
which permits (iii-iv) intraoperative extrusion bioprinting of cell-laden hydrogels within a focal
articular cartilage defect. Schematic and images adapted from 69 and 70.
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In a final representative example of PCL-hydrogel composites, MeHA was added
to thermally sensitive triblock copolymers (i.e., methacrylated poly[N-(2-hydroxypropyl)
methacrylamide mono/dilactate] (pHPMA- lac)/polyethylene glycol (PEG)) toward printing
chondrocyte-laden constructs with defined mechanical properties and internal
architectures. As previously discussed, these hydrogels were also mechanically
reinforced via co-printing with PCL. ECM formation by chondrocytes exhibited a dosedependent dependence on HA, with intermediate concentrations resulting in increased
glycosaminoglycan and collagen contents when compared to inks without HA, while too
much HA resulted in tissue more closely resembling fibrocartilage. Importantly, optimal
formulations identified in the performed in vitro studies were combined with PCL to yield
constructs with Young’s moduli similar to native cartilage (3.5-4.6 MPa).67
Toward translating extrusion printing into the clinic in a feasible manner, new
intraoperative approaches have been developed (Figure 1.3d). The biopen is a handheld
coaxial extrusion device that permits deposition of cultured cells and inks directly into
cartilage defect sites.68–70 When evaluated in a large ovine model of full-thickness cartilage
defects, MeHA/GelMA inks containing adipose-derived MSCs and printed with the biopen
facilitated the formation of repair cartilage. Interestingly, these constructs exhibited
superior gross and histological scoring over other investigated groups (empty defects,
constructs printed a priori, and defects treated with microfracture).69 The biopen has also
demonstrated the ability to fabricate human articular cartilage through the chondrogenesis
of human adipose derived MSCs.71
1.3.2

Incorporation of Fibrous Materials into 3D Printing
In addition to fused-deposition modeling (e.g., Figure 1.3b), PCL has also been

fabricated into microfiber networks via melt electrowriting, a biofabrication approach that
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permits the controlled deposition of micron-scale fibers in a layer-by-layer manner.72–74
These scaffolds can then be combined with cell-laden hydrogels to reinforce their
mechanical properties.75–77 Moreover, MEW may be readily combined with extrusion
bioprinting of MSCs, which may enable the fabrication of composites with more complex
fiber architectures (i.e., out-of-plane fibers if co-printed with fugitive inks), heterogeneously
patterned cell-laden hydrogels, or additional tissue phases (i.e., bioceramic inks for bone
tissue engineering) toward fabricating osteochondral implants.78,79 It is expected that with
the continued development of numerical and FE models, MEW architectures and
composite properties can be further modulated toward achieving target mechanical
properties that fully recapitulate each of the respective zones of cartilage. 80–82
Besides MEW, alternative fabrication approaches have been employed to create
nanofibrous scaffolds with architectures that mimic native ECM. For example, 3D printing
of PLLA was combined with thermally-induced phase separation to create filaments with
nanofibrous topography, which improved cell adhesion, protein adsorption, and MSC
chondrogenesis over smooth filament controls.83 PCL fiber scaffolds with microscale
features have also been woven into fibrous scaffolds using a custom-built weaving loom
that interlocks layers of fibers oriented in all three planes. These scaffolds were combined
with agarose gels containing encapsulated chondrocytes toward the formation of a cellladen implant with anisotropic features and mechanical properties (HA~0.14-0.2 MPa) that
approach native tissue levels (HA~0.1-2.0 MPa).84 Dual electrospinning of multiple fiber
populations has been leveraged to create microfiber scaffolds with dispersed nanofibers,
the inclusion of which improved GAG deposition by seeded hMSCs,85 while gas foaming
techniques have been employed to convert 2D electrospun fiber mats into 3D fiber
scaffolds suitable for 3D culture of chondrocytes.86 It is expected that combinations of

17

fibrous scaffolds or nanofibers with extrusion printing of bioinks may facilitate additional
control over printed cellular behaviors (Figure 1.4).87
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Figure 1.4: Incorporation of fibrous materials into 3D printing and biofabrication. a) (i)
Representative schematic of the hybrid co-printing approach that involves the incorporation of
melt-extruded PCL filaments within 3D printed bioinks. (ii) Printed lattice structure fabricated
via hybrid co-printing of PCL and ECM/alginate hydrogels. Schematic and image adapted from
53. b) (i) Multiscale bioprinting is achieved via the inclusion of fragmented electrospun
nanofibers within an HA-based bioink. The fiber-laden bioink may be readily processed via
embedded extrusion printing, such that shear forces generated during the extrusion process
align the incorporated fibers. (ii) After 7 days of culture, cells align along the direction of aligned
fibers within bioinks, demonstrating how these composite bioinks may be leveraged to direct
cell behavior. Schematic and image adapted from 37. c) (i) Schematic and (ii) representative
images of composite PCL-agarose hydrogel scaffolds fabricated via the 3D weaving of fibrous
PCL scaffolds using a custom-built weaving loom. Hydrogels containing encapsulated porcine
articular chondrocytes (green, calcein AM) were then infilled into PCL scaffolds via vacuumassisted infusion, but could be incorporated in future approaches using 3D printing. Schematic
and images adapted from 84. d) (i-iv) Melt electrowriting (MEW) of PCL scaffolds composed of
microscale fibers organized into scaffolds with various mesh geometries. (v-ix) Reinforcement
of soft hydrogels with fibrous PCL meshes of varied geometries and fabricated via MEW.
Images adapted from 76. e) Schematic overview of a co-printing approach that involves
concurrent melt electrowriting and extrusion bioprinting. Representative prints of MEW meshhydrogel composites containing (ii-iv) heterogeneously patterned bioinks and scaffolds with
the requisite porosity for 3D culture of encapsulated cells. Schematic and images adapted
from 78.
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1.3.3

Inkjet Bioprinting and Biofabrication

Inkjet printing involves the controlled deposition of inks of cells and/or materials
onto an underlying substrate in the form of droplets. In contrast to conventional extrusion
printing, continuous inkjet printing involves the continuous flow of droplets out of a
printhead. The inks employed are electrically conductive such that formed droplets can be
deposited in a desired location via application of an electric or magnetic field. Alternatively,
droplet-on demand inkjet printing involves the use of transient pressure pulses to form
droplets from the ink and to deposit them onto the substrate.88 In one approach, PEGDMA
hydrogels with human articular chondrocytes were processed via an inkjet printer, and the
transient presentation of growth factors FGF-2 and TGF-B1 improved both cell
proliferation and chondrogenic differentiation over time within printed gels (Figure 1.5a).89
One of the significant advantages of inkjet bioprinting is its amenability to multimaterial printing, which can be readily achieved by using varied ink cartridges. For
example, Daly and coworkers leveraged inkjet bioprinting to deposit cocultures of
chondrocytes and MSCs within microarrays of PCL (Figure 1.5b), as cocultures of MSCs
and chondrocytes have been previously shown to improve MSC chondrogenesis when
compared to culture of MSCs alone.90,91 Cell suspensions were patterned within PCL
templates to form spheroids that could then readily fuse and assemble into de novo
cartilage with zonally stratified properties.91 Importantly, these scaffolds could be
integrated with an underlying printed endochondral bone scaffold for applications in
osteochondral

tissue

engineering

(OCTE).

Alternatively,

a

hybrid

inkjet

printing/electrospinning system was previously developed such that PCL fibrous scaffolds
could be fabricated while fibrin-collagen gels containing chondrocytes were deposited in
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an alternating manner, permitting fabrication of 1 mm thick constructs that supported the
formation of neocartilage (Figure 1.5c).92

Figure 1.5 Inkjet bioprinting for the formation of articular cartilage. a) (i) Schematic
overview of the inkjet bioprinting of human articular chondrocytes within PEG-based
hydrogels. (ii) Representative image of a printed, chondrocyte-laden hydrogel. (iii) Safranin O
staining of printed constructs treated with the growth factors FGF-2 and TGF-B1 indicated
proteoglycan formation and neocartilage maturation over culture time. Schematic and images
adapted from 89. b) (i) Schematic on inkjet bioprinting process, which involves the deposition
of droplets containing cell suspensions of MSCs and chondrocytes (3:1 ratio coculture of
MSCs:chondrocytes) into pre-printed microchambers composed of PCL. (ii) Overview of
microchamber designs and the employed cell seeding process. After deposition into
microchambers, cell suspensions undergo condensation and spheroid formation. (iii)
Macroscopic images and Alcian Blue staining of constructs fabricated with varied
microchamber spacing (0.8 mm and 1.2 mm) and cell densities (20,000 cells/microchamber
and 40,000 cells/microchamber) after 4 weeks of culture in chondrogenic media. The intense
Alcian Blue staining indicates the presence of sulfated glycosaminoglycans (sGAG) in the
formed tissue. Schematics and images adapted from 91. c) (i) Electrospinning and inkjet
bioprinting were combined to fabricate 5-layered composite constructs composed of PCL and
chondrocyte-laden hydrogels composed of fibrin and collagen. (ii-iv) SEM images demonstrate
the presence of distinct (iii) PCL and (iv) hydrogel phases. Schematic and images adapted
from 92.

1.3.4

Lithography-Based Bioprinting and Biofabrication
Lithography-based techniques have been previously reported as one of the most

versatile 3D printing methods, providing the highest accuracy and precision to spatially
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pattern 3D constructs.93 This technology is dependent on photocrosslinking, as the
working principle is based on spatial control of light-exposure to solidify a liquid
photocrosslinkable resin. Using either a computer-controlled laser beam (projection
stereolithography, SLA)94 or a digital light projector (digital light processing, DLP),95 the
liquid resin can be photocrosslinked onto a computer-driven build stage or basement,
which moves stepwise in the z-direction (vertically) to allow fabrication of a 3D construct
in a layer-by-layer fashion.96,97Lithography-based 3D biofabrication technologies allow
significantly greater spatial resolutions to be achieved (25−50 μm),41,95,96as well as enable
the fabrication of free-form lattice and patterned structures that cannot be produced with
conventional extrusion-based 3D printing approaches.
SLA has progressed greatly in recent years, with numerous examples where cells
are included within resins (i.e., bioresin).98,99 For instance, PEGDA hydrogels were
constructed via SLA with encapsulated adipose-derived stem cells, which retained high
viabilities (>90%) through one week of culture.97 Similarly, methacrylated [poly-D,L-lactic
acid/polyethylene glycol/poly-D,L-lactic acid (PDLLA-PEG)] and MeHA hydrogels were
fabricated via SLA with encapsulated human adipose-derived stem cells, which underwent
chondrogenesis after culture for 28 days in the presence of TGF-B3.100 In another study,
mannan derived from yeast was methacrylated and printed via SLA, with cytocompatibility,
biocompatibility, and neocartilage formation (i.e., histological observation of collagen,
glycosaminoglycans) demonstrated in vivo in nude mice (Figure 1.6a).101 To this end,
since bioresins typically form improved neocartilage in the presence of growth factors,
composite resins have been developed to enable sustained delivery of factors to
encapsulated cells. Zhu and coworkers showed that GelMA (10%) could be combined with
PEGDA and TGF-B1 embedded nanospheres (fabricated via core-shell elecrtrospraying)
to yield a bioresin suitable for SLA-based 3D printing. Viable MSCs were readily printed
22

and increasing PEGDA concentrations improved the attainable print resolution (Figure
1.6b). The inclusion of nanospheres in formulations that supported optimal MSC viability
(10%/5% GelMA/PEGDA) increased chondrogenic gene expression and the formation of
nascent cartilage ECM.102
DLP has similarly supported the fabrication of cell-laden scaffolds through the
employment of natural, synthetic, and hybrid bioresins. In one approach, silk fibroin was
methacrylated via reaction with glycidyl methacrylate and printed via DLP with UVmediated photocrosslinking into model ear and trachea scaffolds. Importantly, printed
constructs demonstrated cytocompatibility with chondrocytes and the ability to support
nascent matrix formation after 4 weeks of culture in chondrogenic media.103 Alternatively,
PVA-Ma/Gel-MA

bioresins

have

been

processed

via

DLP

with

visible

light

photocrosslinking to bioprint articular cartilage derived progenitor cells toward the
formation of cartilage.95
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Figure 1.6: Stereolithography (SLA) and digital light processing (DLP) for the formation
of articular cartilage. a) (i) Representative images of an asterisk symbol composed of
modified-mannan hydrogel that was fabricated via SLA (ii-iii) with viable chondrocytes. (iv-vi)
CAD geometry, (v-vi) geometry slices at the top and bottom, respectively, and (vii, viii)
representative images of the printed asterisk symbol. Images adapted from 101. b) Schematic
of the stereolithography (SLA) approach used to 3D print PEG/gelatin-based hydrogels with
incorporated PLGA nanospheres for the delivery of TGF-B1 to encapsulated cells.
Representative images of (ii, iii) printed hydrogels (blue), (iv, v) nanospheres (red), and (vi, vii)
cells (green) within fabricated constructs. Schematic and images adapted from 102. c)
Schematic overview of how pneumatically controlled microfluidics may be combined with DLP
to achieve multi-material printing of heterogeneous constructs. Briefly, 365 nm light was
reflected by digital micromirror devices (DMDs) and projected through a lens onto a build plate,
which was in contact with a vat of photosensitive bioresin (i.e., PEGDA or GelMA) (ii)
Representative images of printed hydrogels fabricated with complex, heterogenous structures
using this multi-material DLP approach. Schematic and images adapted from 106.

While ongoing work within the field is focused on the continued development of
bioresins, past studies have demonstrated that DLP of synthetic polymers can be
combined with ECM molecules post-printing for cartilage tissue engineering. For example,
Shie and colleagues developed a slow degrading resin for DLP that is composed of a
water-soluble and photosensitive polyurethane. MSCs were seeded on these scaffolds,
and HA could then be incorporated into the resin to help facilitate MSC chondrogenesis.104
PCL-gelatin scaffolds have also been developed through an indirect 3D printing technique,
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which involves casting of the blended materials within a fugitive negative mold fabricated
via DLP. Once PCL/gelatin blends are crosslinked via glutaraldehyde, the mold composed
of an alkali-soluble photoresin can be removed via washing with NaOH solution, and the
scaffolds can be seeded with cells.105 It is expected that the ability to achieve multimaterial
printing via DLP through the employment of microfluidics will increase the prevalence of
approaches that leverage composite or hybrid materials (Figure 1.6c).106
To increase the overall throughput of lithography-based 3D printing, innovative
printing technologies have been developed. In continuous liquid interphase polymerization
(CLIP), an oxygen permeable window results in the formation of a dead zone in which
oxygen inhibition impedes free radical crosslinking; as a result, a liquid resin interface can
be maintained despite consistent irradiation with light. Thus, monolithic constructs can be
fabricated as the build plate continuously moves up in the z-direction, permitting the
fabrication of constructs at rates of hundreds of millimeters per hour. This is in stark
contrast to conventional SLA or DLP, which requires that resin flow under the build plate
and be replenished in between curing of each successive layer.107 However, one of the
disadvantages of CLIP is that it is limited to materials that undergo free radical
crosslinking; as will be discussed in Chapter 3, a range of other photochemistries are
becoming increasingly prevalent in light-based biofabrication.
In an alternative approach to improve print speed, volumetric bioprinting involves
the curing of photosensitive resins via tomographic light projection through a rotating 3D
volume (i.e., computed axial lithography, CAL).108,109 Through this novel technique,
complex geometries can be readily fabricated, including free-form and free-floating
architectures that cannot be formed via conventional layer-by-layer approaches. In
addition, volumetric printing permits the formation of centimeter-scale constructs in a rapid
manner (on the order of seconds), vastly improving on the print times associated with
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extrusion printing and SLA/DLP. Volumetric printing of GelMA supported the
encapsulation of viable cells (>85%) and the formation of menisci-shaped constructs that
were cultured for fibrocartilage formation that possessed extensive amounts of
glycosaminoglycans and type I collagen.108
1.3.5

Scaffold-Free Biofabrication and Bioassembly
In addition to bioprinting, bioassembly approaches exploit the ability of cell-

containing building units such as cell suspensions, spheroids/aggregates, organoids,
and/or microtissues to self-organize into functional tissue units. These include approaches
that facilitate the automated assembly of cell-containing building blocks such as
micromolding, microfluidics and 3D plotting.24 For example, micromolding via additive
manufacturing techniques such as inkjet printing and selective laser sintering has been
leveraged to scale the formation of spheroids for tissue engineering.110
Scaffold-free fabrication approaches have also been employed to engineer
cartilage in vitro, including with the kenzan 3D printing method.111-113 Briefly, cell spheroids
are deposited onto microneedle arrays in user-configured, three-dimensional shapes via
an automated handling system. Spheroids are then cultured on the microarray until
spheroid fusion and ECM production results in the formation of stable, self-standing tissue
constructs. For example, iPSC derived neural crest cells were formed into spheroids,
bioprinted via the kenzan method, and differentiated into neocartilage (Figure 1.7a,b).
Printed tissue constructs possessed high collagen contents, approaching native tissue
mechanical properties after 5 weeks of culture (0.88 MPa). Moreover, this approach allows
for the formation of large tissue constructs that mimic the articular surface of the femoral
condyles and the trochlea.112
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Figure 1.7: Scaffold-free fabrication approaches for articular cartilage formation. a) (i)
Schematic of the kenzan bioprinting method and (ii) representative images from the printing
process before (Day 0) and after (Day 1) spheroid fusion. Spheroids are first positioned onto
a microneedle array into a pattern of interest. Spheroids are then cultured within a bioreactor
until spheroid fusion occurs, which results in the formation of a stable, continuous tissue
construct that can be removed from the needle array. Schematic and images adapted from
113. b) (i) MSCs sourced from iPSC-derived neural crest cells (iNCCs) through MSC induction
(iNCMSCs) were bioprinted as individual spheroids (initially cultured for 10 days) or as ring
constructs and subsequently cultured for 21 days in chondrogenic media. Representative
images of Safranin O/Fast Green (SOFG), TUNEL, type I collagen, and type II collagen
staining for ring constructs indicate the elaboration of nascent matrix containing both
proteoglycans and collagens. However, elevated TUNEL staining around the holes created by
Kenzan needles suggests that appreciable cell damage is caused by the fixation of spheroids
on the needle arrays. Scale bars=500 m. (ii) CAD model and design (top) of a minipig distal
femoral condyle and trochlear groove (i.e., articular surface-shaped construct) and gross
images of the printed construct on two kenzan arrays immediately after printing (left) and 3
days after bioreactor culture (right). (iii) Gross image of the bioprinted articular surface-shaped
construct after removal form the kenzan needle array (day 15 of bioreactor culture). Images
adapted from 112. c) Schematic overview detailing the fabrication of bioinks from pre-formed
microtissues. Cell aggregation is promoted via microinjection of cells within fabricated tubular
alginate capsules. Thereafter, tissue strands are extracted and used (ii) for subsequent
processing via extrusion bioprinting. The fusion of individual tissue strands with culture gives
rise to the maturation of fabricated tissue constructs. Schematic and image adapted from 120.
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Spheroids hold promise as a clinical cell-based therapy for articular cartilage
regeneration,114 with ongoing work focused on exploring how MSCs and chondrocytes in
spheroid form can be utilized to improve ACI approaches. Lindberg and colleagues
demonstrated that human MSCs (hMSCs), human articular chondrocytes (hACs), and
mixtures of these cells can be processed as spheroids and precisely patterned within PCL
scaffolds to direct spheroid fusion, either with or without the presence of a biomaterial to
modulate the local microenvironment and presence of signaling factors at early timepoints.
Importantly, this platform system may enhance our ability to study cell-cell interactions
and differentiation capacity across length scales. For example preliminary studies
demonstrated that hMSCs are more migratory than hACs when processed as spheroids,
and mixed spheroid formulations (i.e., spheroids composed of both hMSCs and hACs)
resulted in improve neocartilage formation over the co-culture of discrete hMSC and hAC
spheroids.115
Several techniques have also been developed to improve the control over cellular
phenotypes during spheroid formation or the culture of cells in pellet form. In one instance,
globlet-shaped microwells were fabricated to improve the dynamic presentation of
signaling factors during spheroid culture toward improving differentiation of stem cells into
chondrocytes.116 Cellular pellets of MSCs can also be employed as modular building units
due to their ability to promote mesenchymal condensation, a process known to be involved
in cartilage development. However, challenges remain with regards to presenting a
homogenous microenvironment to formed pellets, since transport limitations arise in
conventional centrifugation or molding methods. To this end, Lee and coworkers
fabricated

a

perichondrium-inspired

permeable

nanofibrous

tube

(PINaT)

via

electrospinning nanofibrous PCL to permit oxygen exchange and growth factor
presentation to pellets, accelerating chondrogenic differentiation of iPSCs toward a
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hyaline-like phenotype. PINaT pellets exhibited improved formation of repair cartilage over
control pellets (formed in conical tubes) when evaluated in an osteochondral defect rat
model (i.e., increased Alcian blue, safranin O, and type II collagen staining).117
A range of other building units such as articular cartilage sheets, which are
fabricated via layering of decellularized cartilage matrix,118 and microtissues enable the
assembly of tissue constructs from mature and functional matrix components in lieu of
spheroids or cell pellets. For example, Mekhileri and coworkers developed an automated
bioassembly platform that permits controlled localization of microtissues or chondrocyteladen GelMA microspheres within a 3D plotted PEGT/PBT (poly(ethylene glycol)terephthalate- poly(butylene terephthalate) block copolymer) scaffold. Microtissues were
generated in 96-well plates, thereafter patterned within scaffolds, and cultured, resulting
in tissue fusion and long-term formation of ECM proteins consistent with hyaline
cartilage.119 In another scaffold-free approach, 8 cm-long tissue strands were
implemented as a bioink, exhibiting rapid fusion with the ability to readily self-assemble
into large tissue constructs. To create the inks, chondrocyte pellets were first formed,
followed by aggregation within alginate tubular capsules to form tissue strands composed
of aggregated cells. These strands were then extruded through a print head and cultured,
such that over time layers of strands fused together (Figure 1.7c).120
While these recent advances in bioassembly and scaffold-free biofabrication for
cartilage formation are promising, it is expected that the convergence of these
approaches with previously discussed biofabrication techniques will further improve our
ability to emulate native cartilage. For example, the ability to integrate building units such
as spheroids and microtissues, which may be assembled a priori, with bioprinting
techniques may enable the biomaterial-mediated assembly of tissue constructs
significantly larger than those formed by bioinks (i.e., cell suspensions) alone.
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1.3.6

Biofabrication for Osteochondral Tissue Engineering
In addition to articular cartilage engineering, the biofabrication approaches herein

discussed have also been leveraged for the fabrication of biphasic scaffolds toward
osteochondral defect repair,121,122 since scaffolds suitable for repairing both articular
cartilage and subchondral bone are required for osteochondral tissue engineering
(OCTE). For example, microfluidic extrusion print heads can be utilized to bioprint multiple
cell-laden hydrogels with varied populations of cells (i.e., MSCs and or chondrocytes),
biomaterials, and/or signaling factors to direct differential tissue formation throughout
target cartilage and bone zones (Figure 1.8a).123 Fused deposition modeling has also
been employed to create molds with stratified and graded pore distributions towards
mimicking the differences observed in full thickness osteochondral units.124 However, one
significant advantage of printing biphasic scaffolds for OCTE in lieu of alternative
fabrication approaches such as micromolding is the ability to create gradients of ink
components to recapitulate gradients of different cells or ECM found in the native
osteochondral unit. The inclusion of osteogenic factors such as β-tricalcium phosphate (βTCP) and hydroxyapatite within bioinks has also been exploited to form calcified cartilage
toward engineering the osteochondral interface, an important consideration to achieve
tissue integration in full-thickness cartilage defects.125,126
In one study the influence of type I collagen and HA on osteoblast and chondrocyte
proliferation, differentiation, and migration were explored, where it was found that each
cell type exhibited improved performance when cultured within gels that better mimicked
their native ECM (i.e., chondrocytes in HA, osteoblasts in type I collagen). PCL structures
were 3D printed with distinct cartilage and bone phases using these defined bioinks to
fabricate an osteochondral unit.127 Many other studies have adapted this generalizable
approach to incorporate chondrogenic and osteogenic signaling factors or varied cell
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populations within discrete zones of heterogeneous printed scaffold templates.128–130 For
example, Wang and coworkers fabricated biphasic scaffolds composed of a peptide/βtricalcium phosphate/poly(lactic-co-glycolic acid) bone phase and a poly(D,L-lactic acidco-trimethylene carbonate) cartilage phase via cryogenic 3D printing; the cartilage frame
of composites could then be readily infilled with bMSC-laden collagen I hydrogels to form
nascent cartilage (Figure 1.8b).131 PCL/PLGA scaffolds have also been fabricated via
extrusion printing for OCTE, with chondroitin sulphate and β-TCP included in the cartilage
and bone phases to induce the chondrogenesis or osteogenesis, respectively, of seeded
adipose-derived MSCs.132
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Figure 1.8: Biofabrication of biphasic, cell-laden scaffolds for the repair of full-thickness
osteochondral defects. a) (i) Multi-material extrusion bioprinting of human chondrocytes and
mesenchymal stromal cells within ECM-based bioinks was leveraged to fabricated graded
scaffolds. (ii) Distinct hyaline and calcified zones containing co-culture of cells or B-tricalcium
phosphate particles, respectively, were achieved towards engineering osteochondral tissue.
Schematic and images adapted from 123. b) (i) Schematic overview of the extrusion 3D printing
of an osteogenic peptide/β-tricalcium phosphate/poly(lactic-co-glycolic acid) subchondral
phase, a poly(D,L-lactic acid-co-trimethylene carbonate) cartilage frame, and MSC-laden
collagen hydrogel for the formation of biphasic scaffolds. (ii) Representative images of the
fabricated scaffold frames. Schematic and images adapted from 131. c) Cell-laden hydrogels
(i.e., HA-SH/P(AGE-co-G)) were casted on top of 3D printed PCL osteochondral scaffolds. To
engineer zonal constructs, the first layer of the scaffold’s chondral phase was seeded with
equine MSCs, while the second layer was seeded with chondroprogenitor cells (ACPCs).
Schematic adapted from 134.

Importantly, a number of biphasic scaffolds fabricated via 3D printing have been
evaluated in large animal models of osteochondral damage.130,133,134 Critchley and
colleagues investigated a range of fiber-reinforced hydrogel composites for their ability to
support MSC chondrogenesis in vitro and facilitate osteochondral repair in vivo.130 Fatpad derived stromal cells were co-cultured with chondrocytes to form neocartilage in the
top phase of biphasic scaffolds (with MSCs retained in the bone phase of the scaffold)
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prior to implantation. Scaffolds supported the formation of endochondral bone with
overlaying cartilage when implanted subcutaneously in rats, as well as the formation of
hyaline-like cartilage after 6 months implantation in caprine osteochondral defects.130
In a similar approach, PCL bone anchors were 3D printed with protruding,
reinforcing fibers to support a chondral phase composed of HA/poly(glycidol) hybrid
hydrogel (HA-SH/P(AGE-co-G)) and two distinct zones (Figure 1.8c).134 Articular cartilage
progenitor cells (ACPCs) were encapsulated in the top chondral part of the scaffold, while
MSCs were encapsulated below this top phase to mimic the native tidemark (i.e., the
cartilage-bone interface). Significant bone growth into the anchor was observed 6 months
after implantation in an equine model, while only limited cartilage formation occurred in
both zonal constructs and non-zonal controls. Although no differences were observed
histologically, zonal constructs resulted in repair cartilage with higher compressive moduli.
The authors speculate that inappropriate degradation rates and/or early loss of implanted
cells could be responsible for the lack of significant cartilage repair in this system.134
In an alternative approach to OCTE, composite scaffolds containing a PLGA/PLA
cartilage zone and a PLGA/TCP bone zone were fabricated via the TheriForm process to
create osteochondral implants with gradient porosities, mechanical properties, and
composition. Briefly, this microfabrication process selectively binds powder-based
materials together using a liquid binder to form three-dimensional constructs in a layer-bylayer manner. While chondrocytes preferentially attached to the top phase and formed
neocartilage over 6 weeks of in vitro culture, the bottom phase (E~200 MPa) approached
tensile properties that were comparable to native cancellous bone (E~700-1000 MPa).135
Selective laser sintering is a similar additive manufacturing technique that involves
the use of a laser to mediate the sintering or compaction of powdered materials in 3D
space to fabricate a construct. Hydroxyapatite and PCL microspheres were previously
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fabricated into multi-layered scaffolds via SLS (with gradients of hydroxyapatite
concentration increasing toward the bone phase) and evaluated in a rabbit model of
osteochondral defects.136 Implantation of these scaffolds into rabbit defects resulted in the
formation of repair articular cartilage due to the scaffolds ability to induce subchondral
bone regeneration.136 Similarly, SLS has been employed to fabricate PCL scaffolds with
pores of varied shapes and sizes, which could then be readily combined with chondrocyteseeded collagen gels.137
1.4

CONCLUSIONS
Articular cartilage is critical to the healthy function of joints, but when it is damaged

due to an acute or chronic injury, it unfortunately does not undergo self-repair.10 Surgical
interventions are therefore required to mediate the restoration of the damaged articular
surface; otherwise, cartilage defects that are left untreated may lead to the progression of
osteoarthrosis and/or other connective tissue injuries within the joint. While several
strategies are clinically employed to treat focal cartilage defects, including microfracture
and MACI, often these approaches yield repair tissue that does not fully capture the
mechanical properties of healthy cartilage.
To this end, there is a demand for the development of biomaterials that may help
facilitate improved neocartilage formation via the presentation of signaling cues to cells.
HA hydrogels are of special interest for cartilage tissue engineering since HA is involved
in a multitude of biological processes associated with tissue homeostasis, including but
not limited to cell signaling via interactions with cell-surface receptors and ECM molecules,
organization of the ECM, regulation of tissue hydration and solute transport within the
milieu of the ECM, morphogenesis, and wound healing.138 Moreover, the material
properties of HA hydrogels can be readily tuned so that they may be processed via the
additive manufacturing technologies herein discussed. Importantly, this enables the
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creation of advanced tissue engineering scaffolds that better recapitulate important
features of cartilage such as the anisotropic organization of ECM molecule, which
contributes to the impressive mechanical properties of cartilage.
The different biofabrication technologies and representative studies highlighted
throughout this chapter emphasize the general additive manufacturing approaches that
have been employed for the repair of cartilage to date. In addition, the implementation of
hydrogels for different biofabrication techniques is detailed to emphasize the importance
of hydrogel design on the manufacturing process of constructs, as well as their resultant
properties. However, several comprehensive reviews further describe the use of additive
manufacturing technologies for the repair of damaged cartilage. This dissertartion builds
upon these established paradigms through the continued development of new bioprinting
techniques, the rational design of implants for cartilage repair, and the characterization of
novel biomaterial inks.
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CHAPTER 2: RESEARCH OVERVIEW
2.1

SPECIFIC AIMS
The overall goal of this dissertation work was to develop light-based

biofabrication techniques to process hyaluronic acid (HA) hydrogels into useful
structures for the repair of cartilage tissue. The completion of these specific aims has
improved our understanding of how hydrogels can be designed in combination with
biofabrication techniques towards the translation of clinically-relevant constructs for
cartilage tissue engineering.

Specific Aim 1: Employ an in situ crosslinking bioprinting technique to fabricate
MSC-laden HA constructs for the formation of cartilage.
Hypothesis: Norbornene-modified HA (NorHA) hydrogels can be processed with in situ
crosslinking through control over the thiol-ene crosslinking kinetics and printing
parameters into structures with defined shapes that support mesenchymal stromal cell
(MSC) chondrogenesis and cartilage formation.

A limitation of current clinical approaches to cartilage repair is that they often
do not account for variabilities in defect size and shape, which can lead to repair
tissues that do not fully integrate with peripheral tissue.1 3D bioprinting enables the
fabrication of cell-laden hydrogels with patient-specific geometries and controlled
presentation of physicochemical cues, potentially improving prospects for defect filling
and repair tissue integration.2–5 A range of bioinks, or biomaterials that may be
processed with cells via automated biofabrication technologies,6 have been used to
create constructs with precisely defined architectures;2 however, many hydrogels do
not exhibit suitable rheological properties for extrusion-bioprinting.78–16 This limits the
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advancement of hydrogels for cartilage tissue engineering, as desirable materials exist
that cannot be processed using these biofabrication methods. 8–16
To address this, we previously developed a technique, termed in situ
crosslinking, where non-viscous and photocrosslinkable materials are cured with light
as they pass through a transparent capillary during printing.17 Here, we implemented
this in situ crosslinking method and visible light to print NorHA hydrogels (~6 kPa)
suitable for MSC chondrogenesis and tissue formation, where NorHA hydrogels are
crosslinked from non-viscous solutions and would not have been printable with
extrusion-bioprinting.17 NorHA hydrogels crosslink through a controlled thiol-ene
reaction and are largely based on HA, which has been shown to be a promising
component of hydrogels to support MSC chondrogenesis.18 Printing parameters were
varied and combined with an understanding of gelation behavior to fabricate printed
constructs. Once printed, MSC chondrogenesis and neocartilage formation within
MSC-laden constructs were investigated.

Specific Aim 2: Fabricate composites of soft hydrogels with supporting melt
electrowritten polycaprolactone and evaluate their potential for neocartilage
formation.
Hypothesis: NorHA hydrogels with lower crosslink densities will exhibit enhanced
matrix distribution and the formation of functional tissue properties when compared to
hydrogels with increased crosslinking. Moreover, loosely crosslinked hydrogels can be
mechanically reinforced with melt-electrowritten polycaprolactone meshes to improve
bulk construct properties while retaining their ability to support tissue formation.

Within the field of cartilage tissue engineering, hydrogels have been employed
to encapsulate MSCs and support their chondrogenesis and cartilage formation;
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however, there are many biochemical and biophysical properties that may influence
their success. For example, NorHA hydrogels are crosslinked in the presence of light
and a di-thiol crosslinker, which allows for easy tuning of crosslink density. To
investigate the influence of crosslink density on MSC chondrogenesis and tissue
formation, NorHA hydrogels were fabricated with moduli ranging from ~2-60 kPa and
cultured for up to 8 weeks. Bovine MSC chondrogenesis and cartilage tissue properties
(gene expression, mechanical properties, ECM distribution) were then assessed to
elucidate how the production and organization of extracellular matrix in NorHA
hydrogels varies as a function of crosslink density.
While NorHA hydrogels may support the chondrogenesis of encapsulated
MSCs and neocartilage formation, their low initial mechanics may restrict translation
into the clinic. The employment of additive manufacturing techniques may address this
concern and expand upon material combinations that meet the demands of in vivo
loading environments. Melt electrowriting is a biofabrication process that permits the
fabrication of polycaprolactone (PCL) meshes with unparalleled precision, such that
composites of PCL and NorHA hydrogels can be readily prepared. Hydrogels that
supported promising MSC chondrogenesis and neocartilage formation were reinforced
with PCL meshes fabricated via melt electrowriting to create composites with
enhanced initial mechanics. Composite constructs were then evaluated over 8 weeks
for cartilage tissue formation in vitro (gene expression, mechanical properties, ECM
distribution). Further, the ability of composites to integrate with cartilage was evaluated
with ex vivo chondral plugs via pushout testing, MicroCT analyses, and
histology/immunohistochemistry.

Specific Aim 3: Evaluate implantation of MEW-NorHA composites to facilitate
cartilage repair in a porcine model of articular cartilage damage.
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Hypothesis: MEW-NorHA composites will be readily secured within focal articular
cartilage defects through two different fixation methods (bioresorbable polylactic acid
(PLA) pins, fibrin glue) to support cartilage tissue repair.

Although in vitro cultures are important in the development of cartilage tissue
engineering approaches, ultimately it is important to assess implantable constructs in
cartilage defect models. A wide range of models have been developed to assess
tissue engineered cartilage, ranging from small animals (mouse, rat) to intermediatesized animals (rabbit) to large animals (porcine, goat). Each of these models are not
without their limitations related to clinically-relevant sizes, natural regeneration, or
difficulty in implementation. Despite their challenges, we chose a porcine model as a
first step to investigate our composites. Porcine models were used, as larger animal
models better recapitulate the loading environments of human joints and permit
treatment of clinically relevant defect sizes;19 further, porcine models are commonly
used in cartilage repair studies due to porcine cartilage thickness resembling human
cartilage and operative access.19,20
First, after validating the ability of composites containing bovine MSCs to
support neocartilage formation and integration with native tissue in an ex vivo model,
an in vitro culture study was performed to ensure that adult porcine MSCs across
multiple donors and encapsulated in composites also form neocartilage. Composites
were then implanted into 4-mm chondral defects formed in porcine models to assess
their ability to form functional repair tissue in vivo 12 weeks after implantation.
Outcomes included macroscopic and histologic analysis, mechanical testing, and
MicroCT.
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Specific Aim 4: Engineer hydrolytically degradable, thiol-ene step growth
hydrogels amenable to digital light processing (DLP) for cartilage repair
applications.
Hypothesis: Hydrogels composed of macromers with hydrolytically labile, pendant
norbornene groups can be fabricated into macroporous constructs via DLP and
engineered with user-defined degradability for future implementation in autologous
matrix-induced chondrogenesis (AMIC)-based therapies for cartilage damage.

Alternative approaches to cartilage repair involve the use of acellular scaffolds
to promote repair via presentation of signaling cues to endogenous cells. Specifically,
implantation of an acellular, porous scaffold into a cartilage defect combined with
microfracture allows for potential: (i) stabilization of the clot within the defect, (ii)
infiltration of MSCs into the implanted scaffold, and (iii) delivery of factors that can
stimulate chondrogenesis. Through AMIC-based approaches, these cells may then
promote the formation and organization of improved repair cartilage within the scaffold.
However, the success of this approach is predicated on the scaffold’s ability to degrade
as cells form and distribute nascent tissue throughout the scaffold, as well as the ability
of scaffolds to exhibit controlled porosity. The work in this Aim represents a step
towards improvement of this approach, although the work is limited to material
development and characterization.
Enzymatically degradable hydrogels have been previously explored for this
use, but these systems rely heavily on the dynamic in vivo environment, which may
exhibit variable enzyme concentrations prior to and after scaffold implantation,
resulting in unpredictable degradation behaviors. Thus, we implemented the design of
hydrolytically degradable hydrogels with user-defined degradation rates, such that the
hydrogel degradation behavior is more controlled and predictable. Carbic anhydride
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was reacted with HA to create a novel resin (NorHACA) that is suitable for DLP, and the
mechanical properties and degradability were investigated experimentally. A Monte
Carlo stochastic model was also developed using empirical hydrogel swelling
properties to characterize and predict the degradation behavior of NorHACA hydrogels,
including those with mixed degradable/non-degradable macromer formulations. Lastly,
proof-of-concept processing of NorHACA hydrogels was performed toward creating
resins with degradation rates that may match the rate of neocartilage formation in
future cartilage repair applications.
2.2

CHAPTER OUTLINE
Chapter 1 highlights the clinical demand that exists for innovations in articular

cartilage repair and the ways in which biofabrication approaches have been leveraged
towards improving repair cartilage for future therapies. Chapter 3 details how the
fundamentals of common photocrosslinking chemistries inform the design and
implementation of bioinks and biomaterials in light-based biofabrication techniques.
Thereafter, Chapter 4 discusses the work proposed in Specific Aim 1 on the use of in
situ crosslinking for the formation of large cartilage constructs with controlled shapes.
Chapter 5 focuses on work proposed throughout Specific Aim 2, which details the
influence of crosslink density on cartilage formation, the fabrication process and
characterization of MEW mesh-NorHA hydrogel composites, and the functional utility
of these composites in ex vivo models. Chapter 6 describes the evaluation of
composite implantation and their ability to repair cartilage in a porcine model of
cartilage damage. In Chapter 7, the synthesis and design of hydrolytically degradable
HA hydrogels described in Specific Aim 4 is detailed. In addition to their
characterization, this chapter also describes preliminary studies on how these
hydrogels may be tuned to yield variable degradation timescales and printing via DLP.
Finally, Chapter 8 discusses the conclusions, limitations, and future directions of this
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dissertation work, reviewing how these findings may inform future therapies for
cartilage repair.
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CHAPTER 3: FUNDAMENTALS OF PHOTOCROSSLINKING IN BIOPRINITNG
The following chapter is adapted from:
Lim, K.S.†, Galarraga, J.H.†, Cui, X, Lindberg, G.C. J, Burdick, J.A., Woodfield, T.B.F.
Chemical Reviews 2020 120 (19), 10662-10694.

3.1

INTRODUCTION

Despite significant research attention and developments in photocrosslinking approaches
and techniques in biofabrication for regenerative medicine and in vitro 3D tissue models,
in combination with a number of existing reviews focusing primarily only on polymerization
of hydrogels,1,2 there is limited information available that reviews the key fundamentals of
photocrosslinking and necessary compositional and processing criteria for the successful
design and implementation of photocrosslinked bioinks and bioresins. The aim of this
review is to provide a detailed overview of the various widely adopted 3D bioprinting
methods that utilize light (Figure 3.1).

Figure 3.1: Light-based bioprinting techniques. Schematic illustrating (top) extrusionbased bioprinting and (bottom) lithography-based bioprinting techniques that use light to
control the spatial organization of materials, cell-instructive factors, and cells towards the
engineering of tissues.

First,

an

overview

of

the

fundamental

mechanisms

associated

with

photocrosslinking reactions (e.g., free-radical chain polymerization, thiol-ene, redox) that
are used with light-based bioprinting techniques towards the processing of natural and
synthetic materials are discussed. The critical design criteria required for successful
bioink and bioresin development including: the selection of polymers, modification of
functional groups that permit photocrosslinking of these polymers, and optimal
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photoinitiator and light source selection, are then detailed. Thereafter, the specific bioink
or bioresin properties that must be achieved to ensure successful printability are
described. Significant progress will be made as these light-based techniques are further
advanced and this review – by introducing the relevant fundamentals in photochemistry
combined with a description of the unique bioink design criteria that must be implemented
for individual extrusion-based and lithography-based bioprinting technologies – motivates
future opportunities within the landscape of light-based bioprinting.
3.2

OVERVIEW OF PHOTOCROSSLINKING REACTIONS
Bioinks and bioresins used in both extrusion-based and lithography-based

bioprinting are most commonly fabricated as water-swollen polymer networks (i.e.,
hydrogels). Hydrogels are of interest, as they can be designed with a range of chemical,
mechanical, and biological properties and support the encapsulation of cells. These
networks can be fabricated through a number of techniques, such as enzymatic activity,3,4
redox reactions,5–7 or exogenous stimuli such as temperature or light.1 The application of
light-based methods for hydrogel formation is especially useful in additive manufacturing
and 3D printing due to the inherent spatiotemporal control over photocrosslinking
reactions, which can be used to optimize the printing process and to build up materials
into desired 3D structures. Traditionally, three different photocrosslinking reactions have
been utilized in bioprinting to induce the conversion of precursor bioinks and bioresins into
solid materials at various stages of the bioprinting process (Figure 3.1) – these include
free-radical chain polymerization, thiol-ene photocrosslinking, and photo-mediated redox
crosslinking. Each respective photocrosslinking approach exhibits distinct advantages and
disadvantages, but all have been leveraged to fabricate 3D printed constructs. This
section will be used to provide a basic background on each of these techniques to better
inform the design of bioprinting processes.
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3.2.1

Free-Radical Chain Polymerization
Materials crosslinked via free-radical chain polymerization generally undergo three

reaction stages: initiation, propagation, and termination. Each reaction stage contains its
own associated kinetics, which may individually change the microscopic and macroscopic
characteristics of formed networks. For a free-radical chain polymerization to occur, a
radical species must first be generated. During initiation, the first stage of a free-radical
chain polymerization, photoinitiators are transformed into reactive radical species through
photolysis, or light-induced cleavage (Figure 3.2a). The rate of formation of these initial
radical species varies as a function of: i) incident light intensity, ii) efficiency of the
photoinitiator, iii) photoinitiator concentration, iv) quantum yield, and v) the number of
effective radicals generated per photolysis event (typically, homolytic photolysis yields two
reactive radical species).1
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Figure 3.2: Overview of free-radical chain polymerization. A) General mechanism for the
free-radical chain polymerization of bioinks and bioresins, including initiation, propagation, and
termination. B) Schematic of polymer chains containing reactive groups crosslinking through
free-radical chain polymerization, where kinetic chains form to crosslink polymers together. C)
Common functional groups employed in free-radical chain polymerization in bioprinting. D)
Change in storage (G’, closed) and loss (G’’, open) moduli measured via oscillatory shear
rheology (1 Hz, 0.5% strain, 25°C) during the free-radical chain polymerization of hyaluronic
acid modified with methacrylate groups (MeHA, 30% modification, 3 wt%) in the presence of
photoinitiator Irgacure 2959 (0.05 wt%) at variable UV light intensities (320-390 nm; I0 =2.5
mW/cm2, 5 mW/cm2, 7.5 mW/cm2). E) Change in storage (G’, closed) and loss (G’’, open)
moduli measured via oscillatory shear rheology (1 Hz, 0.5% strain, 25°C) during the freeradical chain polymerization of MeHA (30% modification, 3 wt%) in the presence of UV light
(320-390 nm, I0 =5 mW/cm2) with variable concentrations of Irgacure 2959 (0.025 wt%, 0.05
wt%, 0.10 wt%).

After successful initiation, free radicals can then react with specific functional
groups on polymer chains, effectively forming new covalent bonds and reactive radical
intermediates. These reactive intermediates may then proceed to react with subsequent
reactive groups, resulting in the propagation of radical species and the formation of a
kinetic chain (Figure 3.2a,b). Specifically, radicals propagate through unreacted double
bonds (e.g., methacrylates, acrylates, acrylamides) (Figure 3.2c). Since the reaction
between growing polymer chains and unreacted groups largely occurs during the
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propagation phase, the consumption of double bonds may be approximated as a second
order reaction.1
This process of propagation is ultimately concluded when termination occurs,
which can encompass the quenching of reactive radical species via radical coupling (two
chain ends combine to form one continuous chain), disproportionation (two chain ends
terminate, one with a saturated terminal group and one with a non-saturated terminal
group), or the transfer of radicals away from propagating polymer chains via a chain
transfer event (Figure 3.2a). If the total radical species concentration is assumed to be at
pseudo-steady state (i.e., rate of initiation is equal to the rate of termination) and the
photoinitiator yields two reactive radical species upon photolysis, the rate of
polymerization (Rp) may then be described by Equation 3.1:

where kp is the polymerization rate constant, ϕ is the quantum yield, ϵ is the molar
extinction coefficient of the photoinitiator, I0 is the intensity of incident light, kt is the
termination rate constant, [M] is the concentration of unreacted monomer, and [I] is the
concentration of photoinitiator.
The kinetics of free-radical chain polymerization for common reactive functional
groups such as acrylate and methacrylate derivatives have been extensively studied via
pulsed-laser polymerization and size exclusion chromatography (PLP-SEC).8–15 For
example, it is well-established that acrylates homo-polymerize appreciably faster than
methacrylates.14 In addition, the reactivity of different functional groups can be readily
modulated. Typically, acrylates and methacrylates with adjacent groups that withdraw
65

electrons react faster because these adjacent groups impart stability to intermediate
radical species. Thus, reactivity increases with larger alkyl chains on acrylates and
methacrylates.10,12
Monitoring of hydrogel mechanics is also commonly used to characterize reaction
behavior and the transition of a hydrogel precursor (i.e., bioink, bioresin) into a solid
hydrogel. Specifically, oscillatory shear rheology can be performed to track the evolution
of mechanics in real time, where the storage modulus (G’) and loss modulus (G’’) correlate
to the elastic and viscous character of a material, respectively. As an example, a
methacrylated hyaluronic acid (MeHA) was cured in the presence of the photoinitiator
Irgacure 2959 and ultraviolet light (note: additional discussion on polymers and
photoinitiators is provided in a later section) (Figure 3.2d,e). The rate of polymerization
increased in the representative crosslinking of MeHA as both the light intensity and
photoinitiator concentration increased, highlighting parameters that can be used to tailor
the reaction kinetics of bioinks and bioresins. The optimization of reaction kinetics is
required for any given bioprinting technique and even the specific bioprinter used, but
generally can occur very rapidly.
While the rapid nature of free-radical chain polymerization allows the fast
crosslinking of bioinks and bioresins, these reactions do exhibit complex kinetics;
specifically, the propensity for peroxyl radicals to form (via chain transfer) can result in
oxygen inhibition.16 This is very important in the context of bioprinting, where the presence
of ambient oxygen – which is normally always the case for bioprinting of cell-laden bioinks
and bioresins – may impede complete crosslinking of precursor materials during the
fabrication process. Incomplete crosslinking negatively impacts print fidelity and
downstream maintenance of shape fidelity, which are both critical criteria for successful
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3D bioprinting of complex constructs and tissues.17 The intensity of light and total number
of radical species generated should be minimized, as both have been shown to exhibit
cytotoxicity to cells.17
Further, the structure and crosslink density of photocrosslinked networks formed
via free-radical chain polymerization may be tuned via changes in initiator concentration,
reactive group concentration, and light intensity. Typically, higher degrees of crosslinking
within polymer networks yield higher mechanical properties and slower degradation times
in the case of degradable materials.1,18 The distribution of propagating kinetic chain
lengths achieved also introduces heterogeneity to local network structures. This
heterogeneity may be attributed to the rapid formation of concentration gradients and
diffusion limitations as kinetic chains rapidly form, resulting in auto-acceleration of
propagation and diffusion-controlled termination.24,25 Specifically, as polymer networks
begin to evolve during polymerization, steric hindrance limits the ability for radicals to
terminate, thus effectively increasing the total radical concentration. As a result, the rate
of polymerization increases, leading to auto-acceleration. Towards the end of
polymerization, auto-deceleration occurs, as the consumption of radicals is diffusionlimited and termination predominantly occurs through disproportionation. Due to the
heterogeneous reaction behavior that arises from these phenomena, intramolecular chain
transfer events may also occur, in which mid-chain radical species result in the branching
and cyclization of polymer backbones, as well as the formation of non-idealities within
networks.
3.2.2

Thiol-ene Photocrosslinking
Thiol-ene reactions have garnered appreciable attention throughout the

biofabrication community due to the control over the crosslinking approach, particularly in
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comparison to free-radical chain polymerization, while still leveraging the benefits of light.
Thiol-ene reactions give rise to polymer networks with less heterogeneity, as the network’s
crosslink density, mesh size, and mechanics may be tuned as a function of crosslinker
functionality, length, and concentration.19–21 Furthermore, radical-mediated thiol-ene
polymerizations are insensitive to oxygen and exhibit less network relaxation or stress
accumulation after crosslinking.20
When radicals are generated via initiation, sulfide groups within thiol-containing
molecules are converted into reactive thiyl radicals. These intermediate thiyl radicals
may then form thioether bonds with secondary molecules containing electron-rich or
strained -enes (Figure 3.3a).
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Figure 3.3: Overview of thiol-ene photocrosslinking. A) General mechanism for radicalmediated thiol-ene photocrosslinking. After initiation, reactive thiyl radicals form thioether
bonds with molecules containing reactive -enes. Thereafter, propagation may proceed via step
growth polymerization (chain transfer events) or kinetic chain growth (homopolymerization).
Termination occurs when all of the monomer is consumed, disulfide formation depletes the
total number of radicals, or radicals are quenched through disproportionation. B) Schematic of
polymer chains containing reactive groups crosslinking through radical-mediated thiol-ene
reactions. C) Common –ene groups employed in radical-mediated thiol-ene reactions.
Functional groups are listed in descending order of reactivity (left to right, top to bottom),
although reactivity of –enes will vary with different thiols.22–25 D-E) Change in storage (G’,
closed) and loss (G’’, open) moduli measured via oscillatory shear rheology (1 Hz, 0.5% strain,
25°C) during the thiol-ene crosslinking of hyaluronic acid modified with norbornene groups
(NorHA, 20% modification, 3 wt% in PBS) in the presence of either D) UV light (320-390 nm,
I0 =10 mW/cm2), 0.05 wt% Irgacure 2959, and variable stoichiometric amounts of dithiothreitol
(DTT) crosslinker (XDTT= 0.25, 0.5, 1.0) or E) visible light (400-500 nm, I0=10 mW/cm2),
constant DTT crosslinker (XDTT= 1.0), and variable amounts of lithium phenyl-2,4,6trimethylbenzoylphosphinate (LAP) photoinitiator (0.025-0.1 wt% LAP).

Although it is possible for chain growth to occur in thiol-ene reactions, polymer
chains are predominantly crosslinked via a step growth mechanism. Step growth reactions
involve the sequential conjugation of macromers or polymers, resulting in a gradual
increase in polymer molecular weight. When crosslinkers have a functionality of at least
two (thiol or -ene moieties), the addition of crosslinkers to polymer chains results in the
formation of a network. In bioinks and bioresins, the reaction most commonly occurs
through the reaction of a reactive polymer with a multi-functional thiolated crosslinker for
network formation (Figure 3.3b).
69

While these step growth reactions typically proceed without the presence of chain
growth reactions (i.e., homopolymerization of a single reactive group), it is important to
note that some thiol-ene reactions can occur concurrently with free radical chain
polymerization, in what is termed mixed-mode polymerization.20 It has previously been
shown that the use of functional groups associated with both thiol-ene photocrosslinking
and free radical chain polymerization in a single material system permits copolymerization,
such that crosslinking occurs via both mechanisms.20 For example, a multifunctional thiol
may react with acrylates or methacrylates to form crosslinks in a step growth manner,
while the same acrylates or methacrylates can independently form crosslinks via the
propagation of kinetic chains. Alternatively, more complex, ternary systems comprising a
thiol, an acrylate or methacrylate, and an alkene that does not undergo free radical chain
polymerization can be employed to effectively tune the extent of crosslinking achieved via
each respective mechanism. Mixed-mode polymerizations may be of interest and provide
further advantages in tailoring bioink properties, such as, to mitigate oxygen-inhibition
associated with conventional free radical chain polymerizations and/or to modulate the
kinetics of a thiol-ene reaction. However, the resultant kinetics of these polymerizations
are complex, and formed networks may potentially exhibit phase separation between
networks crosslinked via different mechanisms.20
The reactivity of –ene groups is determined by their electron density, stability of
intermediate carbon-centered radicals, and steric hindrance. Terminal -ene groups with
larger electron densities are typically more reactive than internal –enes or –ene groups
with less electron density (Figure 3.3c).22 Conversion alone does not reflect the inherent
kinetics of different thiol-ene reactions, as the propensity for homopolymerization between
-enes and effects such as auto-acceleration and diffusion-controlled termination that arise
from high crosslinking can lead to similar stoichiometric conversions in systems with
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different reaction kinetics. However, thiol-ene reactions allow for enhanced control over
reactive group consumption relative to free-radical chain polymerization, since the degree
of crosslinking is modulated by the concentration of crosslinker used rather than the
concentration of reactive groups. Thus, it is possible for multiple crosslinking events to be
induced in a sequential manner. Furthermore, the use of thiol-ene chemistry permits the
incorporation of signaling ligands important for tissue engineering into the networks.
Similar to free-radical chain polymerization, there are numerous parameters that
can influence the rate of polymerization and the final network properties. In general,
reactions can be quite rapid, with crosslinking on the order of seconds, and the final
network properties achieved can be modulated through the extent of crosslinking. As
described above, oscillatory shear rheology can be performed to track the evolution of
mechanics in real time, where the storage modulus (G’) and loss modulus (G’’) correlate
to the elastic and viscous character of a material, respectively. As an example, the
crosslinking of norbornene-modified hyaluronic acid (NorHA) in the presence of a
crosslinker (dithiothreitol, DTT), ultraviolet light, and the Irgacure 2959 photoinitiator was
monitored (note: additional discussion on polymers and photoinitiators is provided in a
later section) (Figure 3.3d). The crosslinker amount did not greatly change the rate of the
reaction but did modulate the final material properties. As an additional example, the
reaction behavior was monitored with variations in the concentration of lithium phenyl2,4,6-trimethylbenzoylphosphinate (LAP) photoinitiator used in the presence of visible
light and photocrosslinking was more rapid with increased photoinitiator concentration
(Figure 3.3e). Overall, thiol-ene photocrosslinking is a highly tunable approach in the
processing of bioinks and bioresins in bioprinting applications.
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3.2.3

Photo-mediated Redox Crosslinking
Finally, photo-mediated redox reactions have been employed to photocrosslink

bioinks; specifically, polymers modified with phenyl groups may be photocrosslinked in
the presence of a photosensitizer via photooxidation and subsequent radical coupling
between reactive groups (Figure 3.4a-c).26,27

Figure 3.4: Overview of photo-mediated redox crosslinking. A) General mechanism for
photo-mediated redox reactions. After a photosensitizer excites oxygen to its singlet state,
generated radicals will form intermolecular bonds between paired reactive groups. Termination
occurs when all the reactive groups are consumed and/or all of the photosensitizer is
deactivated. B) Schematic of polymer chains containing reactive groups crosslinking through
photo-mediated redox reactions. C) Common functional groups employed in photo-mediated
redox reactions in bioprinting. D-E) Change in storage (G’, closed) and loss (G’’, open) moduli
measured via oscillatory shear rheology (1 rad/s, 1% strain, 20°C) during the photo-mediated
redox crosslinking of hyaluronic acid modified with tyramine groups (HA-Tyr, 7.8%
modification, 3.5 wt% in PBS) in the presence of visible light (350-700 nm, I0 =134 mW/cm2)
with variable amounts of D) eosin Y (0.01-0.03 wt%) and E) rose bengal (0.025-0.1 wt%)
photosensitizers.

Photosensitizers here are defined as dyes or additives that can absorb light and
undergo transition into excited states, rendering them capable of oxidizing reactive groups
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of interest. It is important that a photosensitizer exhibit a high absorption coefficient within
the spectra of incident light used, a high quantum yield, and sufficient stability to catalyze
photooxidation.28 If each of these criteria are met, then sensitizers may generate free
radicals via electron transfer or hydrogen-atom abstraction with a substrate.
It is important to note that in the presence of oxygen, photosensitizers undergo
additional side reactions, leading to the generation of singlet oxygen, superoxides, and
potentially hydrogen peroxide.28 All of these side reactions result in the regeneration of
ground state photosensitizers and the consumption of photosensitizer radicals, with the
advantage of further increasing the overall rate of photooxidation and reactive group
crosslinking. The first type of side reaction involves energy transfer via collision between
an excited photosensitizer (i.e., triplet state) and oxygen in its ground state. This reaction
yields excited singlet oxygen species, that can readily oxidize hydroxyl, sulfide, and amine
groups due to their high electrophilicity. Alternatively, after photosensitizers undergo
electron transfer or abstract a hydrogen from a substrate, their radical derivatives may
undergo a different side reaction with triplet oxygen to form reactive oxygen species such
as superoxides. If photosensitizer intermediate radical species undergo coupling, they
may then react with ground state oxygen to produce hydrogen peroxide.
It has previously been shown that under anaerobic conditions, appreciable
photocrosslinking does not proceed.26 Therefore, although singlet oxygen may not be
directly involved in reacting with functional groups, oxygen is required to mediate the
photo-oxidation and crosslinking of hydroxyphenyls. As a result, it is also important that
photosensitizers exhibit the ability to readily transfer energy to triplet oxygen. This is in
stark contrast to conventional free radical chain polymerization, where the presence of
oxygen inhibits photocrosslinking.
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Photosensitizers such as rose bengal, eosin Y, and flavin mononucleotide are
examples that have been used to catalyze photooxidation of tyrosine and tyramine
functional groups applied to photocrosslinking.26–29 As examples, hyaluronic acid with a
tyramine modification was photocrosslinked in the presence of various concentrations of
rose bengal and eosin Y (note: additional discussion on polymers and photoinitiators is
provided in a later section) (Figure 3.4d,e). The reactions occurred within minutes with
modest changes based on the initiator concentration and initiator type. For further
discussion on the selection and use of photosensitizers to generate reactive singlet
oxygen, an extensive review has been performed on the photo-physical properties of
previously used photosensitizers.28 Prior to use in bioprinting, however, consideration
should be given to the cytotoxicity of photosensitizers, as well as the generation of reactive
oxygen species during photocrosslinking. These adverse effects may be mitigated using
low photosensitizer concentrations, so long as favorable crosslinking kinetics are
conserved.
3.3

LIGHT-BASED BIOPRINTING METHODS
As aforementioned, light is a powerful tool in bioprinting given that it permits

spatiotemporal control over the reaction behavior of bioinks and bioresins, using the range
of photocrosslinking reactions that were just described. In this section, we detail more
specifically how light may be utilized to process bioinks and bioresins and highlight the
critical design specifications associated with extrusion-based and lithography-based
bioprinting.
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3.3.1

Extrusion-Based Bioprinting

3.3.1.1 Traditional Fabrication Window
One of the most significant considerations when engineering a bioink for extrusionbased bioprinting is its printability, or ability to be readily extruded and deposited with high
shape fidelity to directly replicate the CAD designed 3D geometry of interest. To
successfully 3D print a bioink via extrusion printing, the initial bioink formulation residing
in the print head reservoir or syringe must exhibit suitable rheological properties so that it
can flow through a small diameter print head nozzle (generally 100-800 µm) to dispense
a filament. Due to the nozzle constriction, bioinks that have a lower viscosity are typically
easier to initially extrude and deposit in a layer-by-layer manner due to the high shear
stress experienced in the nozzle. However, after initial extrusion and deposition of a bioink,
the printed construct must also have sufficient mechanical integrity to maintain shape
fidelity and structure to withstand external forces (e.g., gravity). Typically, the printability
of bioinks is validated via oscillatory shear rheology experiments and the assessment of
filament stability post extrusion via washing, imaging and/or mechanical testing;30 these
criteria for bioink printability have been extensively reviewed to identify materials that are
amenable to extrusion-based bioprinting.31
With these criteria in mind, bioink formulations comprised of high viscosity
materials or high polymer contents often yield printed constructs with higher resolution
and shape fidelity than those of low viscosity materials.30 However, a balance much be
achieved so that embedded cell viability and cell function such as migration, spreading,
and extracellular matrix formation are supported after crosslinking. Traditionally, the need
to design bioinks with the requisite printability and functionality for cell culture has led to
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the identification of a biofabrication window, within which materials possess the critical
properties required to achieve both high shape fidelity and bioactivity.32 A number of
techniques have been developed to 3D print photocrosslinkable bioinks within this
biofabrication window or to circumvent the traditional design criteria for bioink printability
for low viscosity bioinks.
With regards to photocrosslinkable bioinks, light can be applied simultaneously
during the entire printing process, after the entire construct is printed, or with multiple
photocrosslinking steps after the deposition of each printed layer. This depends on the
stability of the material after extrusion and how quickly further stabilization is needed. For
example, Trachtenberg, et al. extruded up to ten alternating layers of perpendicular fibers
with a subsequent UV crosslinking step after the printing of each layer.33 The resulting
scaffold was then exposed to additional UV light during a post-processing step to ensure
complete crosslinking of the bioink.33 While this printing approach results in an even
amount of light exposure within a single layer, there is the potential to overexpose the
initially deposited layers due to multiple light exposures. Therefore, there has been a
gradual shift towards using visible light photoinitiators to avoid continuous UV
exposure.17,34
As an alternative, multi-step crosslinking can be used to improve the processing
of hydrogel bioinks. For example, tyramine-modified hyaluronic acid (HA) was first
enzymatically crosslinked to enable cell encapsulation and extrusion capability in the form
of a soft gel. Subsequently, photo-redox crosslinking was utilized to stabilize deposited
filaments via green-light irradiation in the presence of the photoinitiator eosin-Y.35 These
approaches exploit the control that is possible over the material photocrosslinking to
achieve the appropriate material processing to build desired structures.
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3.3.1.2 Rheological Additives and Sacrificial Materials
Another very common strategy to manipulate a bioink’s rheological properties for
extrusion bioprinting is to introduce additives that impart non-Newtonian flow properties.
These additives support rapid switching between low viscosity nozzle flow and high
viscosity gelation upon exiting the nozzle. A range of materials have been utilized to
introduce non-Newtonian shear-thinning properties to a bioink of interest, thereby allowing
for a rapid reduction in viscosity with applied stress.32 Bioinks with these additives then
exhibit the ability to recover their properties upon removal of shear stress so that they
retain shape fidelity post-extrusion. With light-based bioprinting techniques, it is important
that rheological additives are transparent to the light used to avoid any light attenuation in
thicker constructs.
Nanosilicates and nanocellulose have been employed to impart shear-thinning
behavior to bioinks.36–39 For example, Xavier et al. demonstrated that the nanosilicate
Laponite could be incorporated into a photocrosslinkable bioink, rendering it amenable for
layer-by-layer extrusion printing. This was attributed to the zwitterionic character of the
Laponite nanosilicate, which enables electrostatic interactions between both the
nanosilicates themselves and between nanosilicates and the polymer. As a result,
physically crosslinked networks with shear-thinning properties were formed.40 Importantly,
these nanosilicates exhibit optical transparency in solution, allowing for orthogonal,
photocrosslinking of bioinks after printing.
In addition to these rheological additives, other materials that may be physically
crosslinked are also often exploited to tune bioink printability and stability upon extrusion.
Physical crosslinking refers to any type of reversible, non-covalent interaction that imparts
structure through the formation of a polymer network. These types of crosslinking
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chemistries include the self-assembly of peptides, ionic bonding, and supramolecular
interactions.41 Oxidized alginate has been crosslinked via electrostatic interactions with
calcium chloride to permit extrusion-based fabrication of biodegradable hydrogels.42,43
Colosi et al. showed that alginate could be utilized as a sacrificial material to render nonviscous polymers printable (Figure 3.5a).44

Figure 3.5: Overview of techniques commonly employed in extrusion-based bioprinting.
A) Schematic of coaxial printing of GelMA-alginate blended bioink.44 As the liquid bioink is
deposited in the presence of calcium chloride, alginate undergoes ionic crosslinking.
Afterwards, GelMA is photocrosslinked via UV irradiation to form a covalent network. Then,
the sacrificial alginate network may be washed away to obtain the final print construct
comprised of solely gelatin. B) Direct printing of acrylamide-modified HA-BP into a support
bath.46 With this approach, shear-thinning, photocrosslinkable inks were printed into support
baths, cured and extracted to yield user-defined print structures. C) Schematic of precrosslinking, post-crosslinking, and in situ crosslinking techniques.47. In situ crosslinking
involves the photocrosslinking of bioink as it transits through a photopermeable lumen. In this
representative example, methacrylated-HA is printed with light exposure before (precrosslink), after (post-crosslink) or during (in situ crosslink) bioink extrusion. Unlike precrosslinking and post-crosslinking techniques, in situ crosslinking results in the formation of
overlaying filaments that do not flow and exhibit high print fidelity. Images adapted from 44,47,48.

A coaxial extrusion system was utilized such that an alginate-gelatin ink blend was
extruded through an internal needle, while calcium chloride was extruded through an
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external needle. At the terminus of the coaxial needle, alginate would then crosslink in the
presence of calcium, allowing for the deposition of the alginate-gelatin polymer blend.
Thereafter, gelatin was photocrosslinked and the ionically crosslinked alginate was
subsequently washed away. Materials that exhibit sol-gel transitions that are temperature
dependent have also been printed with photocrosslinkable polymers as sacrificial
materials. For example, poly(N-isopropylacrylamide) (pNIPAM) has been conjugated to
hyaluronic acid to impart thermal sensitivity to a desired ink; HA-pNIPAM was co-printed
with methacrylated hyaluronic acid (MeHA) onto a heated stage at 37 °C. Thereafter,
printed constructs were photocrosslinked with UV light, so that HA-pNIPAM could be
subsequently removed via cooling below the lower critical solution temperature.45
HA-based hydrogels modified with guest-host moieties and methacrylate groups
have similarly been synthesized to permit shear-thinning and recovery of bioinks during
extrusion-based bioprinting and stabilization via post-print UV crosslinking.35 Dynamic
covalent chemistries have also been employed to impart non-Newtonian flow properties
to a bioink of interest.49 Importantly, photocrosslinkable polymers can be readily
incorporated within these inks to enable the formation of light-induced interpenetrating
networks.49 While physically crosslinked networks exhibit rapid crosslinking, their transient
nature and propensity to undergo dissolution often limit their utility as individual networks.
However, double network hydrogels have been engineered with both covalently and
physically crosslinked networks that coexist in an interpenetrating manner. The ability for
physical crosslinks to reform spontaneously may be leveraged in these systems to impart
enhanced mechanics via load dissipation and subsequent network recovery, with
photocrosslinking used to introduce covalent networks.50,51
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3.3.1.3 Embedded Printing and Granular Media
Conventionally, extrusion-based bioprinting has been utilized to fabricate
constructs in a layer-by-layer manner through the continuous deposition of overlaying
filaments. However, more complex structures, such as architectures found in native
vasculature (e.g., branching networks or bifurcations) require modifications to traditional
approaches. Therefore, alternative techniques that enable omnidirectional printing of a
bioink are of growing interest. For example, support baths have been developed as a
method of depositing a bioink of interest anywhere in arbitrary 3D space, using embedded
printing techniques.46,52–56 These materials exhibit the ability to confine an ink wherever it
is deposited, but are equally able to yield and recover as a needle or printer nozzle
translates through them. Thus, hydrogels can be readily suspended within a contained
volume prior to photocrosslinking for stabilization and subsequent release from the
support material. This approach allows for biofabrication of bioinks independent of their
viscosity or viscoelasticity, such as with very low viscosity bioinks that do not meet the
traditional, requisite properties for extrusion-based bioprinting.
The reversible nature of physically crosslinked hydrogels makes them suitable as
support inks for embedded printing of constructs with high aspect ratios. For example, HA
hydrogels modified with supramolecular moieties have been previously employed for the
printing of non-viscous hydrogels into a support bath.56 HA was modified with cyclodextrin
(CD-HA) and adamantane (Ad-HA) moieties that spontaneously interact with one another.
These functional groups allow for the rapid association and dissociation of supramolecular
bonds, such that a needle can readily transit through the support bath while concomitantly
depositing ink. To this end, CD-HA and Ad-HA have also been adorned with
photosensitive methacrylates, so that the support bath may be photocrosslinked upon
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deposition of an interstitial, sacrificial material. This approach has been utilized to print
negative features within a support bath to fabricate open-lumen structures that recapitulate
native vasculature.56,57 Alternatively, photocrosslinkable inks can be deposited into
support baths to fabricate complex geometries normally not possible with conventional
layer-by-layer extrusion bioprinting.46,56 For example, Shi et al. modified HA
with bisphosphonate (HA-BP) so that it formed dynamic metal-ligand coordination bonds
with calcium ions, creating a support bath that enabled direct printing of inks and bioactive
ligands into a self-healing hydrogel (Figure 3.5b).46
Gelatin microparticle slurries are often employed as support baths, as they enable
facile deposition of bioink and can be readily melted away at 37 °C.52,53 Similarly,
polyacrylic acid (PAA)-based granular media have been utilized to fabricate complex
geometries within a support bath.55,58 Electrostatic interactions between PAA
microparticles result in the formation of a stable support bath with shear-thinning and selfhealing capabilities. An important consideration when printing photosensitive bioinks into
support baths is the degree to which the support bath itself may potentially attenuate light.
Furthermore, attention must be given to the mechanism employed to remove printed
constructs from support baths, as this may prove difficult for highly porous and/or soft
bioinks.
In addition to their use as support baths, granular media may also be utilized as
bioinks themselves in extrusion-based bioprinting.59,60 Photocrosslinking is used
frequently to make hydrogel particles from emulsion batches, through microfluidics, or
through photolithography approaches.61 When microgels are jammed into close proximity,
they are immobilized, giving rise to elastic properties. The application of shear allows for
the transient disruption of these physical interactions, such that jammed microgels can be
readily printed as shear-thinning bioinks.59 Photocrosslinking can then be used to
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introduce inter-particle crosslinks to stabilize the printed structures. Highley et al. and Xin
et al. have used this approach to print HA and PEG-based hydrogel microparticles,
respectively, via thiol-ene photocrosslinking.59,60
3.3.1.4 In Situ Crosslinking Technique
To address the need for both bioink fluidity and mechanics, additional methods of
crosslinking bioinks have been employed to optimize printed construct shape fidelity and
properties. Ouyang et al. demonstrated that in situ crosslinking of hydrogels during
extrusion with light can appreciably improve the resolution of printed constructs relative to
those fabricated via pre-crosslinking or post-crosslinking bioinks (Figure 3.5c).47 As
opposed to crosslinking precursor macromer before or after extrusion, in situ crosslinking
involves the fabrication of filaments via irradiation of bioink as it transits through a
photopermeable capillary or lumen. Unlike some of the other approaches described
above, in situ crosslinking permits extrusion printing of non-viscous bioinks without the
addition of additives or post-processing steps. Moreover, complex structures such as coreshell structures may also be readily fabricated using this in situ crosslinking technique.
Galarraga et al. described the steps needed to apply this in situ crosslinking technique
towards the bioprinting of a specific non-viscous bioink, including the assessment of
photorheology during bioink curing, light attenuation across the capillary, and design
specifications (e.g., capillary width and length, bioink flowrate, light intensity).62
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3.3.2

Lithography-Based Bioprinting

3.3.2.1 Engineering Printability in Lithographic Techniques
SLA and DLP techniques utilize similar concepts for processing. In SLA
(developed in the 1980s), a concentrated laser spot is swept across a vat of liquid resin
following a specified design, inducing spatial polymerization wherever the laser has
travelled.63,64 In a typical setting, instead of shining the laser directly into the resin, the
laser is often localized to a designated point through deflection off a rapidly moving
mirror galvanometer.65 After photocrosslinking of the first layer, the platform is moved
away from the surface to be recoated with a fresh liquid resin for photocrosslinking of the
second layer. To this end, multi-layered constructs with precise features can be
achieved (Figure 3.6a).
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Figure 3.6: Representative examples of constructs fabricated with lithography-based
bioprinting technologies. A) SLA printing of poly(ethylene glycol)-based hydrogels to create
multi-layered, heterogeneous constructs comprised of multiple materials. Scale bar = 1mm. B)
DLP printing of a poly(vinyl alcohol)-based bioresin into user-defined shapes, including i-iii)
pyramids, iv-vi) woven mat, and vii-iv) gyroidal structure with 25µm petals and 500µm pore
size.67 Scale bars = (ii) 2mm, (iii) 500µm, (v) 1mm, (vi) 500µm, (viii) 1mm, (ix) 500µm. Images
reproduced with permission from ref 11. Copyright 2018 IOP Publishing. C) CAL allows for the
rapid fabrication of complex geometries, including a i) trabecular bone with high porosity, ii)
validated via μCT, and iii) containing MSCs.68 Scale bars=1mm.
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In contrast, DLP operates by using a digital mirror device (DMD), an array of up to
several millions of mirrors, to mask the light that passes through. The photocrosslinking of
the resin takes place through projection of the light through this digital mask,
photocrosslinking an entire layer in a single exposure. Given that no scanning of the resin
is required as in SLA, DLP offers a faster total build time, as each layer only depends on
the set layer thickness and required exposure time, and is independent of the layer
geometry complexity (size in x-y plane). However, conserved across both of these lightbased bioprinting approaches are the requisite bioresin properties for printability. A
bioresin must be readily photocrosslinked via irradiation (i.e., rapid curing kinetics) and be
able to flow, such that uncured resin continuously interfaces with previously cured layers
on the computer-driven build stage. If a bioresin is too viscous, then it will be incapable of
recoating the build stage with precursor material in between layers, rendering it impossible
to build up a 3D structure.66
A typical resin consists of a mixture of photocrosslinkable components,
photoinitiators, reactive diluents, and inhibitors.63,69 Currently, the photocrosslinkable
components are mostly oligomers, elastomers, monomers or macromers grafted with
unsaturated vinyl moieties such as acrylamides,63 vinylesters,70,71 vinylcarbonates,70
acrylates,72,73 and methacrylates.72,74 In SLA and DLP, the control of the thickness of each
layer that is cured is essential. For most resins, the cure depth is determined by the
depth/thickness of the cured layer during photocrosslinking and is dependent on the light
energy and photoinitiator concentration in the resin.75 This energy can be controlled by
adjusting the power of the light source, and the scanning speed (for SLA), or the exposure
time (for DLP). Although theoretically the photocrosslinking mechanism with the different
stages of the reaction (e.g., initiation, propagation, termination) is well documented and
modeled, the kinetics of the crosslinking reaction remains quite complex. Specifically,
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most commercial resins consist of mixed multi-functional monomers and macromers,
complicating the reactions.76 For most resins used in SLA and DLP, it is important to first
determine the working curve, which can be extrapolated from Equation 3.2 below, and is
absolutely fundamental to not only understand this technology, but also to determine the
correct settings for the fabrication process.67,75–77

Where Cd = cure depth, Dp = penetration depth into the resin, E = applied irradiation
dosage per area, and Ec = critical irradiation dosage to reach the gel point. This empirical
equation is an adapted form of the Beer-Lambert equation, which relates the attenuation
of the intensity of light as it passes through a medium in which it is absorbed. In
photocrosslinking reactions, the time required to reach the gel point depends linearly on
the intensity of the light at that specific location. Therefore, Cd increases logarithmically
with the total applied irradiation dosage. Specifically, for lithography-based approaches,
the reactivity and printability of the resin are characterized by both Ec and Dp, where the
total applied light irradiation dosage has to exceed the Ec to allow solidification of the initial
layer on the build plate. The penetration of light into the resin is further characterized by
Dp and has been previously reported to not only be dependent on the resin properties that
influence light attenuation, but also the photoinitiator concentration.75 Although it is often
implied that increasing photoinitiator concentration increases Cd by facilitating more
double-bond conversion of the monomer/macromer in the resin, Lee et al. reported that a
higher photoinitiator concentration in fact decreases the Cd.75 As the photoinitiator
concentration increases, the penetration depth of the photons decreases, where the freeradical initiation is thus localized closer to the surface. Lin et al. also reported that
increasing the photoinitiator concentration decreases print resolution due to excess radical
86

production and diffusion.69 Hence, besides controlling the irradiation dosage, an optimal
photoinitiator concentration has to be determined for most resins to be successfully
applied to SLA or DLP printing.
Furthermore, conversion at the interface between the layers should be targeted to
be slightly higher than the gel point to ensure adequate chemical and mechanical bonding
between the layers during printing. This overexposure may result in overcuring into the
preceding layer, which can be particularly problematic when preparing porous constructs
or objects with open channels. A high extinction coefficient of the resin corresponds to a
low Dp and allows more accurate control of the polymerization process and minimal
overcure. The penetration depth can be decreased by either increasing the photoinitiator
concentration or by including a photoabsorber in the resin that competes with the
photoinitiator in absorbing light. For example, a study by Lim et al. demonstrated that
addition of 1wt% Ponceau 4R (red food coloring) was required to reduce the Dp of a
poly(vinyl alcohol)-methacrylate based bioresin, allowing improved control over print
resolution.67 With the incorporation of Ponceau 4R into bioresins, complex geometries
could be readily printed (Figure 3.6b). Similarly, Grigoryan et al. examined a number of
additives such as tartrazine (yellow food coloring), curcumin (from turmeric), anthocyanin
(from blueberries) and inorganic gold nanoparticles, as effective photoabsorbers to
increase the resolution of DLP-printed perfusable poly(ethylene glycol)-diacrylate
(PEGDA) hydrogels.78 Other photoabsorbers such as Phenol Red and Orasol Orange G
have also been used in DLP bioprinting.69,79
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3.3.2.2 Computed Axial Lithography Bioprinting
A recent breakthrough from Kelly et al. addressed the limitations of the
aforementioned but relatively slow processes of 3D printing by projecting a series of 2D
patterned optical light fields to fabricate a 3D object within a rotating liquid resin volume.80
This new computed axial lithography (CAL) technology adopted from computed
tomography produces an optical 3D dose distribution of light by combining 2D light
patterns to photocrosslink a material.80,81 Each image projection propagates through the
material from a different angle, where the superposition of exposures from multiple angles
results in a sufficient 3D energy dose to facilitate solidification. The printing technique is
also dependent on oxygen inhibition. Free radicals are generated by light activation and
then rapidly quenched and deactivated by oxygen during the initial, inhibition phase of
printing. For the material to photocrosslink at a given position within the volume, sufficient
depletion of oxygen at the local focal point is required, where the non-linear oxygen
inhibition process sets the critical dose threshold.
Another major parameter in CAL is the rotation rate of the uncured polymer which
must be time-sequenced with respect to the projection intensity. As such, the resins used
are either highly viscous or solid (thermal gelled) precursor materials to minimize relative
motion between the printed object and the precursor. After exposure, solvent rinsing is
used to remove uncured material, combined with moderate heating or further curing using
light to enhance material properties. For materials that are not susceptible to oxygen
inhibition, other inhibiting molecules (photoabsorbers) such as food dyes can be utilized
where the CAL requires penetration of the curing wavelength through the printing volume,
but dye can be added to block other wavelengths and tune component opacity. The CAL
approach has several advantages over conventional layer-based printing methods,
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particularly the ability to print large volumes several orders of magnitude faster. Bernal et
al. further showed that large, free-form cell-laden structures, could be fabricated using this
volumetric CAL technology, with a print speed much faster (within seconds) than
conventional bioprinting methods with high cell viability (Figure 3.6c).81
3.3.2.3 Other Lithographic-Based Printing Techniques
Given that both SLA and DLP crosslink bioresins in a layer-by-layer manner, then,
depending on the exposure time of each layer, the fabrication process has often been
considered slow. Most resins or bioresins adopted for SLA/DLP are crosslinked using freeradical chain polymerization which is prone to oxygen inhibition. Typically, oxygen
inhibition occurs when oxygen rapidly scavenges the radicals required for the radical
polymerization, or create peroxides by combining with the free radical from the
photoinitiator, causing incomplete crosslinking of the resins.82,83 In most conventional
lithography techniques, the photocrosslinking occurs at an air-resin interface, where an
adequate irradiation dosage (intensity and exposure time) is required to overcome the
effect of oxygen inhibition, further restricting the print speed to a few millimeters per
hour.67,84 Tumblestone et al. conducted DLP above an oxygen-permeable build window,
termed continuous liquid interface production (CLIP), to utilize the oxygen-containing
“dead zone” for rapid replenishing of resin during printing. By taking advantage of the
oxygen-inhibited dead zone, the print speed is greatly enhanced, allowing fabrication of
constructs of 5 cm in less than 10 minutes.85 While the CLIP process has not been applied
to bioresins, it does possess the potential to rapidly fabricate cell-laden constructs, at a
much faster speed than SLA or DLP processes.
Another biofabrication technology that is also highly specific to light-curable
materials is two-photon polymerization (2PP). 2PP adopts two-photon optics, which
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leverages the two-photon absorption of near-infrared (NIR) radiation and multiphoton
polymerization, allowing fabrication of constructs with features om the submicron to nanoscale.29,86 The most simple 2PP setup consists of a laser source, a focusing objective, a
translational stage, a laser power control system, and a shutter. Most 2PP resins have
been adopted from established lithography-based technologies, and also require relatively
longer fabrication speeds due to the nano-scale precision.87 However, unlike conventional
lithography techniques, 2PP involves extremely high laser irradiation dosage/intensities,
mostly on the order of terawatts per cm2. Moreover, in conventional 2PP processes, the
height of the printed structure is limited by the working distance of the microscope
objective used for focusing laser pulses into the photosensitive material.88
While the technologies reviewed thus far have focused on the building up of
materials through additive manufacturing technologies, it may also be of interest to employ
photodegradation (i.e., subtractive manufacturing) to fabricate constructs with desired 3D
structures. For example, it has been previously shown that the incorporation of orthonitrobenzyl (o-NB) moieties in hydrogel crosslinks can render hydrogels degradable via
near-UV irradiation (365 nm), allowing spatiotemporal control over hydrogel degradation,
including with two-photon techniques.89–91 For example, Lunzer et al. reported on the
controlled erosion of PEG-HA hydrogels via two-photon photopatterning, including with
the incorporation of photosensitizers to increase the efficiency of o-NB degradation and
under cytocompatible conditions.91 Coumarin-fluorophores have also been previously
incorporated into PEG hydrogels containing o-NB moieties to enhance the efficiency of
two-photon-mediated photolysis.92
Beyond o-NB moieties, alternative photodegradation chemistries susceptible to
variable wavelengths of light have been developed. For example, coumarin-derivatives
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have been incorporated into both PEG93 and PVA94 hydrogels for degradation under either
visible or UV light. Rapp et al. developed photodegradable crosslinkers that are sensitive
to visible light (400-540 nm) through the incorporation of ruthenium-based crosslinkers
(i.e. Ru-aldehyde, [Ru(bpy)2(3-pyridinaldehyde)2]Cl2) into HA hydrogels.95 Similar
ruthenium-based complexes have also been used to induce the degradation of
supramolecular hydrogels via two-photon optics.96 Advances in two-photon optics,
photosensitizers,

and

photodegradation

chemistries

will

enable

the

continued

development and fabrication of complex, negative features within bioresins via subtractive
manufacturing.
3.4

OVERVIEW OF MATERIALS IN LIGHT-BASED BIOPRINTING
With the implementation of each of the aforementioned light-based bioprinting

techniques, there are a range of photocrosslinkable materials, photoinitiators, and
photosensitizers that have been utilized to offer a library of possible bioink formulations
and crosslinking conditions. This section describes the various materials that have been
developed or applied to bioprinting that utilize photocrosslinking during fabrication.
3.4.1

Reactive Polymers used for Photocrosslinkable Bioinks and Bioresins
Hydrogels are water-swollen polymer networks comprised of natural and/or

synthetic materials, and are of special interest in the development of bioinks for bioprinting
because they can be rationally designed and crosslinked to emulate features and
organization of native tissues for applications in tissue engineering. At the most simple
level, the highly hydrated environment (i.e. > 90 wt% water content) of hydrogels
recapitulates the aqueous environment of in vivo tissue systems and permits additional
complexity via the encapsulation of cells, bioactive molecules, and peptides.18 Printable
hydrogel platforms are also used in 3D bioassembly to encapsulate and fabricate complex
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cellular aggregates or modular components, such as tissue spheroids and cell-laden
microcarriers.97,98 Furthermore, hydrogels are generally biodegradable and can be readily
engineered to capture a range of physiochemical properties.1 For example, the degree of
crosslinking achieved in hydrogels can be directly tuned to yield scaffolds with well-defined
mesh sizes.99 Networks that support diffusivity are necessary in printed hydrogels to
ensure that encapsulated or seeded cells distributed throughout constructs receive
nutrients, metabolites, and oxygen,99 and to allow cells to secrete extracellular matrix
and/or undergo vascularization.100,101 Crosslink density also directly influences the bulk
mechanics of hydrogels and may be controlled to yield scaffolds with viscoelasticity and
stiffness comparable to native tissues. Finally, engineered hydrogels can be functionalized
with bioactive molecules and peptides to direct signaling, adhesion, migration,
proliferation, and differentiation of encapsulated cells.102 Each of these respective
characteristics make hydrogels appealing as biomaterials for the repair of diseased
tissues. However, hydrogels previously implemented in bioprinting have been very diverse
in both their composition and crosslinking chemistry. Here, we provide an overview on the
types of natural, synthetic, and hybrid hydrogel materials that have been used as bioinks
and bioresins in bioprinting applications (Table 3.1).
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Table 3.1: Representative hydrogels used in bioprinting, including the polymer, introduced
reactive group, crosslinking chemistry, and bioprinting technique employed.
Polymer

Reactive Group
Modification

Crosslinking
Chemistry

Bioprinting
Technique

Gelatin

Methacryloyl

Free-Radical Chain
Polymerization

Extrusion,31,111–126,
DLP,84,106,119–121
CAL80,81

Methacrylamide

Free-Radical Chain
Polymerization

Extrusion122

Allyl glycidyl ether

Thiol-ene

DLP, 123 Extrusion123

Norbornene

Thiol-ene

2PP124,125

Thiol

Thiol-ene

Extrusion126

Methacrylate

Free-Radical Chain
Polymerization

Extrusion 45,127–134

Norbornene

Thiol-ene

Extrusion47

Tyramine

Photo-Redox

Extrusion35

Thiol

Thiol-ene

Extrusion126,135,136

Acrylamide

Free-Radical Chain
Polymerization

Extrusion46

Glycidyl methacrylate

Free-Radical Chain
Polymerization

DLP106,137

Silk Fibroin

Glycidyl methacrylate

Free-Radical Chain
Polymerization

DLP138

Decellularized
ECM

Innate proteins

Photo-Redox

Extrusion139

Collagen

Methacrylate

Free-Radical Chain
Polymerization, Thiolene

Extrusion136

Chondroitin
Sulfate (CS)

Glycidyl methacrylate

Free-Radical Chain
Polymerization

Extrusion140

Dextran

Hydroxyethyl
methacrylate

Free-Radical Chain
Polymerization

Extrusion141

Hyaluronic Acid
(HA)

93

Acrylate

Free-Radical Chain
Polymerization

Extrusion,108,126,135,142–
144 SLA145,146 , DLP84

Methacrylate

Free-Radical Chain
Polymerization

Extrusion,130,147,148
SLA,145,149 DLP69

Thiol

Thiol-ene

Extrusion60,112

Norbornene

Thiol-ene

Extrusion60,112

Alkyne

Thiol-yne

Extrusion135

Poly(ethylene
oxide) (PEO)

Methacrylate

Free-Radical Chain
Polymerization

SLA149

Poly(glycidol)

Allyl glycidyl ether

Thiol-ene

Extrusion150,151

Thiol

Thiol-ene

Extrusion150,151

PEG-codepsipeptide

Methacrylate

Free-Radical Chain
Polymerization

DLP64

Poly(vinyl
alcohol) (PVA)

Methacrylate

Free-Radical Chain
Polymerization

DLP67

Poly(ethylene
glycol) (PEG)

3.4.1.1 Natural Materials
Natural materials are often used as the primary component for many bioinks and
bioresins since they typically exhibit high biocompatibility, biodegradability, and bioactivity.
For example, gelatin, which is derived from denatured collagen, contains innate adhesive
peptide sequences (i.e., RGD) that allows embedded cells to attach and spread along its
matrix. Furthermore, gelatin contains peptide sequences that are sensitive to endogenous
enzymes (matrix metalloproteinases), imparting responsive degradability. To engineer
gelatin so that it can photocrosslink via free radical chain polymerization, gelatin is most
commonly modified with methacryloyl groups via esterification with methacrylic anhydride.
In lieu of methacryloyl groups, gelatin can also be modified with reactive groups that are
amenable to thiol-ene polymerizations. For example, gelatin has been previously modified
with both allyl groups and norbornenes. To obtain allyl-modified gelatin, allyl glycidyl ether
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is reacted with gelatin at 65 °C under alkaline conditions.123 To modify gelatin with
norbornene, 5-norbornene-2-carboxylic acid can be reacted with primary amines in gelatin
via traditional carbodiimide/N-hydroxysuccinimde (EDC/NHS) coupling.152 Both of these
gelatin derivatives are capable of reacting with multifunctional-thiol crosslinkers to form
hydrogels. However, gelatin may also be modified with pendant thiol groups, offering an
additional functional handle that can be leveraged to incorporate desired biomolecules or
crosslinks into a designed hydrogel. To thiolate gelatin, dithiobis(propanoic dihydrazide)
(DTP) or dithiobis(butyric dihydrazide) (DTB) is first coupled to the backbone of gelatin
again using EDC/NHS chemistry. Thereafter, disulfides contained within DTP or DTB can
be reduced in the presence of excess dithiothreitol (DTT), giving rise to thiol-modified
gelatin.153
Hyaluronic acid (HA) is a non-sulfated glycosaminoglycan that is found in many
connective tissues and is involved in a number of biological processes such as wound
healing, development and normal tissue homeostasis.154 HA is attractive for
photocrosslinkable bioinks because it may be readily cleared by the body via
hyaluronidases and oxidative species, and it contains many pendant groups that can be
readily modified. For example, HA has been modified with methacrylates via esterification
with methacrylic anhydride or reaction with glycidyl methacrylate in the presence of
triethylamine.127,137 Carbodiimide chemistry has also been utilized to modify HA with
photocrosslinkable acrylamide groups.46 Similar to gelatin, HA may also be modified with
norbornenes via di-tert-butyl-dicarbonate (Boc2O) coupling of 5-norbornene-2-carboxylic
acid to its primary alcohol or benzotriazole-1-yloxytris(dimethylamino)phosphonium
hexafluorophosphate (BOP) coupling of 5-norbornene-2-methylamine to the carboxylic
acid group.155,156 Similar approaches have been used as previously described to thiolate
HA (i.e., via conjugation of DTP or DTB, followed by reduction with DTT),157 but it is also
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possible to react methacrylated-HA in the presence of excess DTT to obtain pendant
thiols, albeit in a less controlled manner. However, it has been previously shown that
modification of the carboxylic acid group within HA can attenuate its ability to interact with
cell-binding sites such as CD44.158 Therefore, alternative strategies have been developed
to modify the primary alcohol of HA with cysteines via an ether bond.159 HA has also been
modified with maleimide groups via BOP coupling of N-(2-aminoethyl)maleimide
trifluoroacetate.160 To render HA amenable to photo-mediated redox polymerization,
tyramine groups have been conjugated to the carboxylic acid of HA via 4-(4,6-dimethoxy1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride (DMTMM) amide-coupling.29 All of
these derivatives of HA provide a multitude of possible crosslinking timescales and
network architectures, effectively expanding upon the range of scaffold properties that can
be engineered in HA hydrogels.
Chondroitin sulfate (CS) is a proteoglycan found in connective tissues such as
cartilage that may be enzymatically degraded and modified with glycidyl methacrylate. To
achieve methacrylation, chondroitin sulfate is first converted into its tetrabutylammonium
salt and then undergoes esterification with glycidyl methacrylate in the presence of
dimethylaminopyridine (DMAP).140 Other naturally derived materials that may be used for
photocrosslinkable bioinks and bioresins include dextran,141 silk fibroin,138 collagen,161
decellularized ECM,139 alginate,162

-carrageenan,163 and chitosan.164

All of these

biopolymers can similarly be modified with reactive functional groups that are suitable for
photocrosslinking. While dextran has been reacted with methacrylic anhydride as
previously described to achieve methacrylate modification,141 silk fibroin has been
methacrylated via reaction with glycidyl methacrylate in lithium bromide at 60 °C.138 To
methacrylate chitosan for use as a biomaterial ink, carbonyldiimidazole was used to
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activate hydroxyethyl methacrylate (HEMA), allowing for HEMA conjugation to the
alcohols of chitosan.164
The advantage to using all these natural materials over synthetic materials when
designing a bioink or bioresin is that they contain either native adhesive surfaces for cells,
signaling cues that impart bioactivity, innate degradability, minimal immunogenicity, and/or
pendant groups that can be easily modified. However, one major limitation of naturally
derived polymers is that they may exhibit unpredictable composition (e.g., dispersity) and
batch-to-batch variations, such that their mechanical properties and degradation rates are
not always easy to control.
3.4.1.2 Synthetic Materials
Generally, synthetic hydrogels offer high batch-to-batch uniformity with more
controllable and reproducible scaffold structures, gelation kinetics, degradation rates, and
mechanical properties when compared to naturally-derived materials. Poly(ethylene
glycol) (PEG) is one of the most commonly utilized synthetic polymers in bioprinting, as it
can be easily modified with a range of functional reactive groups and exhibits high
hydrophilicity, attenuating protein adsorption in culture and in vivo.1 PEG has been reacted
with acryloyl chloride and methacryloyl chloride in the presence of triethylamine to achieve
pendant acrylate and methacrylate moieties that can be photocrosslinked via free radical
chain polymerization.1 To allow for hydrolytic degradation of PEG networks, ɑ-hydroxy
acids have been incorporated between these photosensitive end-groups and the PEG
backbone.165 PEG can also be modified with pendant thiol or norbornene groups so that it
may be photocrosslinked via thiol-ene reactions.60,112 Poly(vinyl alcohol) (PVA) has also
found use as a bioink due to its hydrophilicity and readily modified alcohol groups.67 Similar
to the abovementioned naturally-derived polymers, polyvinyl alcohol can be methacrylated
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via esterification with methacrylic anhydride.67 PVA has also been modified with tyramine
groups by carboxylation via succinic anhydride and subsequent coupling via carbodiimide
chemistry, allowing it to be crosslinked via photo-mediated redox polymerization.166
Although synthetic materials permit a high level of tunability and control,
unmodified synthetic hydrogels (e.g., PEG, PVA) commonly lack suitable binding sites for
cells to adhere. Furthermore, these hydrogels are also limited in their ability to support cell
differentiation. Therefore, modifications that have been applied to enhance cell-instructive
capacity include incorporation of adhesive sequences (e.g., RGD) or heparin-binding
sites.102,167 The incorporation of MMP-sensitive crosslinkers has also been used to enable
cell-mediated degradation and remodeling of synthetic matrices.168 Since synthetic
materials often fail to incorporate the bioactivity of naturally derived materials, some
bioinks combine both natural and synthetic materials to achieve the advantages each
class of materials offers in the form of hybrid bioinks and bioresins.67,120,142,169
3.4.2

Photoinitiators and light sources used for bioinks and bioresins
Despite the vast application of photocrosslinking in 3D bioprinting, the conditions

(e.g., light source, light intensity, exposure time, irradiation wavelength and photoinitiator
concentration) in which this occurs varies greatly across laboratories. This makes it
challenging to compare results between different studies, even when identical
compositions and photoinitiators are used. As most photocrosslinking processes are
dependent on free radicals, understanding the effects of these radicals on cells is
important, given that free radicals can react with cell membranes, proteins, DNA,
potentially causing cellular damage.170–174 Moreover, in the context of applying
photocrosslinking to bioprinting, understanding the fundamental reaction mechanism is
even more important to ensure that the targeted shape fidelity and resolution are not
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jeopardized, while preserving overall cell viability and functionality. This section will cover
various photoinitiators and light sources used during the photocrosslinking reactions within
bioprinting.
3.4.2.1 Free-Radical Photoinitiators
Free-radical photoinitiators are the most commonly employed type of photoinitiator
in bioprinting, as their reaction mechanisms are well studied and established. In general,
these photoinitiators use light to dissociate into radicals, which then facilitate
photocrosslinking. Photoinitiators can be further classified into Type I or Type II, where the
former is usually a single component photoinitiator, while the latter requires two
components, usually a photoinitiator in combination with a co-initiator.
Type I Photoinitiators
When incident light is absorbed by type I photoinitiators, a homolytic cleavage
process starts once the molecules reach the excited singlet or triplet state.175,176 This
photochemical cleavage creates free radicals, mostly from Norrish type I reactions, which
can subsequently induce the polymerization process. Cleavage can occur at any weak
bond, but usually takes place at the α-position of the carbonyl group (α-cleavage). Bryant
et al. previously conducted a comprehensive and systematic cytocompatibility comparison
between a range of type I photoinitiators, 2,2-dimethoxy-2-phenylacetophenone (Irgacure
651),

1-hydroxycyclohexyl

phenyl

ketone

(Irgacure

184),

2-methyl-l-[4-

(methylthio)phenyl]-2-(4-morpholinyl)-1-propanone (Irgacure 907), and 2-hydroxy-l-[4(hydroxyethoxy)phenyl]-2-methyl-l-propanone (Irgacure 2959), which concluded that
Irgacure2959 promoted the best cell viability of chondrocytes encapsulated within
acrylated PVA hydrogels.170 One of the advantages of Irgacure 2959 is that it possesses
a p-hydroxyethoxy group, which gives it a hydrophilic nature with slight water solubility of
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0.7w/v%.170 This water solubility is an important feature, as it allows cells to be
encapsulated in hydrogels without the presence of any toxic organic solvents. Another
benefit of Irgacure 2959 is that it does not produce cytotoxic benzaldehyde as a by-product
of the photo-cleavage reaction.177 To this end, Irgacure 2959 has been extensively used
to fabricate cell-laden hydrogel constructs in the last two decades.
For efficient polymerization, understanding the absorption spectrum of the
selected photoinitiator is important. Irgacure 2959 absorbs within the UV range (200-370
nm), where upon absorption of a UV photon, the excited singlet state converts to a triplet
state via inter-system crossing, and this triplet state dissociates to form benzoyl and ketyl
radicals.177,178 In most cases, the benzoyl radicals then react with unsaturated double
bonds, facilitating free-radical chain polymerization or thiol-ene photocrosslinking.179–181
However, the use of light at the lower wavelength UV range (<300 nm) has been
associated with phototoxicity and mutagenicity,171,182,183 which is impractical for cell
encapsulation purposes. As such, most research groups have been using Irgacure 2959
with a light source of 365 nm, which is closer to the visible light range to minimize
cytotoxicity and genotoxicity.184 Using Irgacure 2959 at higher wavelength comes with a
cost of low reaction efficiency, since the molar extinction coefficient of Irgacure 2959 at
365 nm is very low (only 4 M-1cm-1) (Figure 3.7).185
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Figure 3.7: Absorption spectra and molar extinction coefficients of commonly used
photoinitiators for light-based bioprinting.

Therefore, most studies have either used much higher light intensity, longer
exposure times or higher photoinitiator concentrations (Table 3.2) to circumvent the low
polymerization efficiency of Irgacure 2959 at 365 nm. Bioinks containing Irgacure 2959
have been used for both extrusion and lithography-based bioprinting.
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Table 3.2: Photocrosslinking parameters used for various photoinitiators during light-based
bioprinting.
Photoinitiator

Concentration

Intensity, Wavelength

Duration

Bioprinting
Technique

Irgacure
2959

0.2 wt%
0.5 wt%
0.05 wt%
0.5 wt%

< 30 sec
60 sec
3 min
Not reported

Extrusion44
Extrusion110
Extrusion123
Extrusion117

0.1 wt%
0.2 wt%
0.1 wt%
0.05 wt%
0.05 wt%

4-6 mW/cm2, 365 nm
6.9 mW/cm2, 360-480 nm
30 mW/cm2, 365 nm
Intensity not reported, 250365 nm
1.2 mW/cm2, 365 nm
500 mW/cm2, 290-320 nm
150 mW/cm2, 365 nm
6 mW/cm2, 365 nm
103 mW/cm2, 300-600 nm

5 min
2 min
100-230 sec
10 min
69 sec

Extrusion131
Extrusion107
Extrusion118
Extrusion147
Extrusion130,14

0.05 wt%
0.1 w/v%
0.1 w/v%

10-15 mW/cm2, 320-390 nm
3-240 mW/cm2, 365 nm
2.6 mW/cm2, 365 nm

Extrusion127
Extrusion116
Extrusion111

0.5 wt%
0.05 wt%

10 mW/cm2, 365 nm
130 mW/cm2, 365 nm

2 min
10 sec - 5 min
30 min immersed
in Irgacure 2959
bath
5 min
2 sec/layer, total
of 20 layers
30 sec
15 sec
5 min
10 sec
Continuous during
printing
1-5 min
5 min
45 sec/layer
2-10 sec/layer
10 min

0,148

0.5 wt%
0.5 w/v%
0.01 w/v%
0.1 w/v%
0.1 w/v%

3.95
365 nm
850 mW/cm2, 365 nm
1.3 mW/cm2, 365 nm
Not reported
20 mW/cm2, 365 nm

0.3–2 wt%
1 wt%
0.05 wt%
0.5 wt%
0.4 w/v%

Not reported
1.3 mW/cm2, 365 nm
Not reported
65-78 mW/cm2, 325 nm
Power=36 W, Wavelength not
reported
10 mW/cm2, 320-390 nm

0.05 wt%
0.3 wt%
0.1 w/v%
0.2 w/v%

LAP

W/cm2,

1 w/v%
0.05-0.1 w/v%
Not reported
0.037 wt%
0.5 wt%

5 mW/cm2, Wavelength not
reported
3 mW/cm2, 365 nm
5 mW cm2, Wavelength not
reported
20 mW cm2, 350-450 nm
18 w/cm2, 365 nm
14-16 mW/cm2, 365nm
Power = 6.4 W, 405 nm
0.5 – 2 mW/cm2, 365 nm

0.5 w/v%
4.46 mM

2 W/cm2, 365 nm
700 mW/cm2, 365 nm
Intensity not reported, 400410 nm
7 mW/cm2, 405 nm
5 mW/cm2, 365 nm

0.5 w/v%

0.5 W/cm2, 365 nm

0.05 wt%
0.1 wt%
0.1 wt%
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Continuous during
printing
60 sec
10 min
5 sec/layer, 6 min
after printing
5 min
2-4 sec
2-3 min/layer
23 sec
Throughout
printing
120 sec
10 sec
5 min
2 min
Continuous during
printing
30 sec

Extrusion186
Extrusion150,15
1

Extrusion187
Extrusion105
Extrusion142
Extrusion136
Extrusion114
Extrusion 104
Extrusion143
Extrusion132
SLA145,188
Extrusion48
Extrusion47
Extrusion103
Extrusion128
Extrusion112
Extrusion141
Extrusion135
SLA149
CAL81
Extrusion186
Extrusion189
Extrusion133
Extrusion108
Extrusion113
Extrusion114
Extrusion,121
DLP121

34 mM
0.05 w/v%
0.05 wt%

88 mW/cm2, 365 nm
30 mW/cm2, 365 nm
Intensity not reported, 365 nm
Intensity not reported, 400450 nm
5 mW cm2, Wavelength not
reported
16.4 mW/cm2, 405 nm
6.09 mW/cm2, 365 nm
15 mW/cm2, 400-500 nm

0.05 wt%

5-15 mW/cm2, 400-500 nm

Not reported
0.15-0.22 w/v%
0.25 w/v%

60 mW/cm2, 365 nm
88 mW/cm2, 365 nm
Not reported

1.1 w/v%
0.5 wt%
0.5-5 wt%
20 mol%
0.01 w/v%

1. 2 mw/cm2, 365 nm
130 mW/cm2, 365 nm
Not reported
4 mW/cm2, 365 nm
80 mW/cm2, 505 nm

0.1 mM
1/10 mM

Intensity not reported,
514 nm
30 mW/cm2, 400-450 nm

1/10 mM
0.2/2 mM
1/10 mM
0.5/5 mM

50 mW/cm2, 400-450 nm
7.25 mW/cm2, 400-450 nm
3 mW/cm2, 400-450 nm
30 mW/cm2. 400-450 nm

0.15-0.3 w/v%
0.2 w/v%
0.6 w/v%
0.2-0.6 wt%
0.2 w/v%

VA086

Eosin-Y

Ru/SPS

Not reported
4 sec/layer
Not reported
Not reported

DLP106
DLP138
DLP120
DLP69,79

5 sec/layer, 6 min
after printing
Not reported
10 sec
Continuous during
printing
Continuous during
printing
3 min
Not reported
100, 120, or 160
sec/layer
5 min
60 sec
1-5 min
7.5 min
Throughout
printing
2 min/layer

Extrusion112

3 min
15 min
10 sec/layer
5 min
3 min

DLP84
Extrusion190
Extrusion47
Extrusion62
Extrusion60
DLP119
DLP64
Extrusion144
Extrusion134
Extrusion104
Extrusion122
Extrusion35
SLA146
Extrusion,123,1
91 DLP123
Extrusion17
DLP67
Extrusion192
Extrusion27

Another commonly adopted type I photoinitiator is lithium phenyl-2,4,6trimethylbenzoylphosphinate (LAP), which was initially synthesized by Majima et al. and
reported to be water-soluble up to 8.5w/v%. Fairbanks et al. then conducted a comparative
study between Irgacure 2959 and LAP, and reported that LAP has a much higher molar
extinction coefficient (218 M-1cm-1) at 365 nm, hence allowing much more light to be
absorbed at this wavelength.185 This higher light absorption leads to more rapid gelation
(using PEGDA hydrogel) due to a higher initiation rate and subsequent polymerization
rate.185 Another interesting feature of LAP is that it also absorbs mildly in the visible light
range (405 nm), with a molar extinction coefficient of 25 M-1cm-1. Therefore, LAP has been
widely used in the biofabrication community at either 365 nm or 405 nm, with varying
concentrations and irradiation conditions. Similar to Irgacure 2959, LAP has been applied
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to a range of bioinks and bioresins that undergo either free-radical chain polymerization
or thiol-ene photocrosslinking, and also for both extrusion-based and lithography-based
bioprinting. In recent years, 2, 2′-azobis[2-methyl-n-(2-hydroxyethyl) propionamide] (VA086) has also been exploited for use in extrusion or lithography bioprinting applications.
VA-086 is water soluble and absorbs at 375nm with a molar absorption coefficient of 30
M-1cm-1, which is 7-times higher than Irgacure 2959. It was shown that the generated
radicals as a product of the photo-dissociation of VA-086 are less cytotoxic to cells when
compared to Irgacure 2959.162,193 To date, VA-086 has only been applied to free-radical
chain polymerization, mainly methacrylates and methacrylamides.122,194,195 One drawback
of VA-086 is the generation of N2 gas as a product of the azo-bond (N=N) dissociation of
the photoinitiator, resulting in cloudy or opaque hydrogels.146,194
Type II Photoinitiators
In contrast to type I photoinitiators, type II photoinitiators often have a more
complex initiating mechanism, where following photon absorption, the excited initiator
abstracts a hydrogen atom from a co-initiator, forming H-donor radicals that initiate the
photocrosslinking process.196 One of the most widely used type II photoinitiators is 2,3bornanedione, also known as camphorquinone, which has a long-standing history in
photocuring dental composites. Although camphorquinone has been successfully used to
encapsulate cells within hydrogels with adequate cell viability,170 its poor water solubility
poses an additional practical challenge for most bioprinting applications. Alternatively, the
organic dye eosin-Y has been used as a photoinitiator for tissue engineering due to its
high water solubility.197,198 Eosin-Y absorbs green light, with a molar extinction coefficient
of 60803 M-1cm-1 at 539 nm.199 Upon excitation, eosin-Y undergoes rapid intersystem
crossing to the lowest energy triplet state, which has a life time of 24 μs.200 Subsequently,
the photo-excited eosin-Y extracts hydrogen atoms from an amine-functionalized co104

initiator, such as triethanolamine.197,201 The deprotonated radical then serves as the main
component to facilitate photocrosslinking.198 However, this reaction is often slow and
requires additional accelerants such as N-vinylpyrrolidone or N-vinylcaprolactam.146,175,198
The need for additional co-initiators and accelerant species has become a practical
drawback for the use of eosin-Y in bioprinting applications, as it is often more challenging
to optimize the concentrations of a set of initiators as opposed to just a single component
such as type I photoinitiators. It is also important to ensure that each of the components
are applied within a non-cytotoxic concentration threshold and that the combination of all
three components do not produce toxic by-products that can cause cell death. In addition
to the free-radical chain polymerization and thiol-ene photocrosslinking mechanisms,
eosin-Y has also been reported to facilitate photo-mediated redox reactions, without the
need of a co-initiator or accelerant. Loebel et al. showed the successful fabrication of HATyr hydrogels through di-tyramine crosslinking using eosin-Y and 2PP.202
In recent years, another photo-initiating system of interest is tris(2,2-bipyridyl)
dichlororuthenium (II) hexahydrate (Ru), which is based on a transition metal complex. Ru
has been previously characterized to be highly absorptive in the visible light range, with a
molar extinction coefficient of 14600 M-1cm-1 in the visible light range (450 nm).17,203 When
irradiated with visible light, the ground state Ru2+ gets photo-excited and then oxidizes into
Ru3+ through donating electrons to a co-initiator such as sodium persulfate (SPS). After
accepting electrons, SPS dissociates into sulfate anions and sulfate radicals, where the
newly generated sulfate radicals can either trigger free-radical chain polymerization or
thiol-ene photocrosslinking. Interestingly, the photo-excited Ru3+ can also facilitate photomediated redox reactions by oxidizing aromatic residues such as tyrosine.203,204 These
oxidized tyrosine groups are further converted into tyrosyl radicals, which are then

105

subsequently quenched by forming di-tyrosine bonds with other nearby tyrosine
groups.205,206
3.4.2.2 Light Sources used for Bioprinting and Light Attenuation
Photoinitiators are activated through their absorption of specific wavelengths; thus,
the light source used must be compatible with the photoinitiator used. One source that has
been used in bioprinting is light emitting diodes (LEDs), which have a number of
advantages such as low heat generation, low energy consumption, low operating costs,
less maintenance, portability, compact design, and easy and safe handling. LED light
sources have already been integrated in the dentistry space for the past few decades and
are also used in 3D printing technologies such as digital inkjet printing. Commercial LEDs
can be obtained at 365, 385, 395, 405, 455 or 477 nm. Interestingly for bioprinting, most
type I photoinitiators absorb in the UV range, whereas type II photoinitiators are often
irradiated in the visible light range. The intensity of the light used and its compatibility with
the selected initiator combine towards alterations in the kinetics of bioink gelation.
An important design criterion when engineering a bioink or bioresin is the degree
to which they may attenuate light, including all components (e.g., rheological additives).
In the case of curing large constructs, it is possible that over long length scales (i.e., many
millimeters), the intensity of light will decrease. Deceased light intensities may give rise to
differential reaction kinetics and degrees of crosslinking throughout a photocrosslinked
construct, resulting in heterogeneous network properties. To understand this, quantitative
Beer-Lambert law calculations are often performed to understand how much light
attenuation occurs due to absorbing species within a bioink. Specifically, the intensity drop
across a length scale of interest, L, due to a single absorbing species may generally be
described by Equation 3.3:
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where Io is the initial light intensity, ϵ is the molar extinction coefficient for the absorbing
species (i.e., photoinitiator), C is the concentration of the absorbing species, and I is the
final intensity. If there are multiple components within a bioink that significantly attenuate
light, the Beer-Lambert Law may be further updated. Obstacles introduced by significant
light attenuation may be overcome through the implementation of dual initiator systems or
photobleaching initiators.1
3.5

CELLULAR CONSIDERATIONS IN LIGHT-BASED BIOPRINTING
One of the main components of bioinks and bioresins are cells. Although there has

been much success with bioprinting of cell-laden constructs, considerations must be made
to ensure the viability and function of the cells. This was highlighted above by the selection
of the appropriate material to be included within the bioink or bioresin. However, the
printing process itself must also inform bioink or bioresin formulation design. For example,
features such as the potential for shear forces on cells during the printing process, the
exposure of the cells to light and radicals during photocrosslinking, and the settling of cells
throughout potentially extended print times elicit important consideration. Furthermore, in
most reports, bioink and bioresin properties are characterized in the absence of cells. It
should be noted that the presence of cells may indeed change a number of bioink or
bioresin properties (e.g., light attenuation, rheological properties, crosslinking efficiency)
depending on the cell concentration used. To this end, the incorporation of cells and the
cell density within a bioink or bioresin may require changes or optimization of either the
ink formulation or the printing process. In this section, we discuss various printing
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parameters in the context of cells and how each can be tuned through the design of the
bioink or bioresin and their processing to maximize cell viability and functionality.
3.5.1

Shear forces
To achieve optimal cell cytocompatibility and functionality, it is important to ensure

that cells within the bioinks or bioresins survive the printing process. In terms of extrusion
bioprinting, the influence of external forces such as shear stress on cell viability should be
first evaluated. For example, in scenarios were bioprinted constructs are subjected to light
irradiation post extrusion, the initial cell damage due to the shear stress during flow
through the print head nozzle must be considered, as the mechanically disrupted cells
could be more vulnerable to oxidative damage arising from photocrosslinking reactions.
Shear stress is the specific sum of forces that impose a deformation on a material in a
plane parallel to the direction of the force. For instance, gelatin and HA based bioinks often
exhibit a shear-thinning behavior, where the viscosity of the bioink formulation decreases
by shear force.127,207 However, during extrusion, the shear field that is present within the
syringe nozzle might also contribute to mechanical disruption of the cell membrane,
leading to cell damage or cell death. During bioink extrusion from a syringe nozzle,
mechanical cell disruption is a direct consequence of shear, where fluid at the nozzle walls
undergo shear-thinning behavior while remaining in laminar flow.
Hydrogel bioinks have been previously reported to be cell-protective, where cells
extruded in a hydrogel experience plug-flow rather than the detrimental Pouseille flow
experienced when cells are simply extruded in solution.108,208,209 Blaeser et al. used
fibroblast-laden alginate hydrogel bioinks to model the effect of shear forces on cell
viability, and showed a significant reduction in cell viability when shear forces >10kPa
were exerted.210 It was also reported that the shear stress increased with the viscosity of
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the alginate bioink. Billiet et al. further showed that the shapes of the needles also play an
important role in controlling the shear stress exerted onto cells within the bioink. For
example, a high cell viability was obtained by flow through a conically shaped needle
instead of cylindrical needles. Interestingly, although higher shear stresses were obtained
for the conical needle type, the shear stress built-up was only observed close to the fluid
outlet (1 mm). On the other hand, flow through a cylindrical needle type resulted in lower
peak shear stresses that were exerted for an increased passage length (>16 mm). This
result suggests that generally, short exposure to higher shear stresses is instead
favorable, where extended exposure to lower shear stresses results in the accumulation
of mechanical damage to cells.
In contrast to extrusion-based bioprinting, in lithography-based bioprinting
technologies, cells are generally exposed to lower shear stresses. Shear forces would
include when the resin bath is filling with the bioresin from the surrounding vat. Overall,
the printing process and material may both play a role on the shear forces generated on
cells.
3.5.2

Photoirradiation conditions
The selection of photoinitiator is important for most light-based bioprinting

technologies, as the efficiency and reactivity of the photoinitiators influence the irradiation
conditions (light intensity and exposure time) needed. As summarized in Table 3.2, a wide
variety of photoinitiator concentrations, light intensities, and exposure times have been
used during light-based bioprinting. Taking Irgacure 2959, the most commonly used
photoinitiator, as an example, the employed concentrations ranged over at least 20-fold
from 0.05 to 1wt%, and the light intensity varied from 1.2 to 850 mW/cm2. Although
Irgacure 2959 exhibits a low molar absorptivity at 365nm, most research groups have still
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chosen to utilize the photoinitiator at this wavelength to mitigate the use of low-wavelength
UV irradiation (200-300 nm), which is well documented to be cytotoxic and genotoxic.183,211
However, the low reactivity of Irgacure 2959 might compromise the hydrogel crosslinking
efficiency, leading to the need for higher UV irradiation dosages or higher Irgacure 2959
concentrations. For example, Lim et al. showed that GelMA constructs bioprinted via freeradical chain polymerization were susceptible to oxygen inhibition when irradiated in
normoxic environment, causing the constructs to collapse due to incomplete
crosslinking.17 This oxygen inhibitory effect can be circumvented by using higher
photoinitiator concentration or irradiation dosage. However, when using Irgacure 2959,
increasing its concentration from 0.05 to 0.5wt% or light intensity from 3 to 100 mW/cm2
significantly reduced the cell viability. This was improved with the use of an alternative
Ru/SPS and visible light system. Similarly, Colosi et al. reported that increased UV
exposure time reduced cell viability.44 Billiet et al. also showed that increasing irradiation
doses of UV (365nm) from 1350 mJcm-2 to 5400 mJcm-2 significantly reduced the viability
of Hep-G2 cells from 90% to 56% in extruded GelMA constructs.122 Tigner et al.
demonstrated that due to a higher molar absorptivity than Irgacure 2959 at 365 nm, LAP
resulted in faster photocrosslinking of gelatin bioinks.
However, it remains unclear as to whether the observed cytotoxicity is due solely
to UV exposure. Mironi-Harpaz et al. previously reported that short exposure of cells to
UV irradiation at 365nm within PEGDA hydrogels is not cytotoxic.212 Furthermore, a recent
study by Rustkowitz et al. showed that exposing fibroblasts and MSCs to a low-dose of
365nm light (10 minutes, 1 to 20 mWcm-2) did not affect cellular proliferation rates, induce
apoptosis of the cells, or change their proteome.213 These studies suggest that perhaps
the radical species following photo-cleavage of photoinitiators is responsible for the
reported cytotoxicity. A comparative study between Irgacure 2959 and VA-086 revealed
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that at a similar photoinitiator concentration and UV (365nm) irradiation dosage, HepG2
cells encapsulated in GelMA using VA-086 exhibited much higher cell viability.122 This is
in agreement with a study conducted by Rouillard et al. where radicals generated via
photo-dissociation of Irgacure 2959 are said to be the cause of the cytotoxicity effect
observed.162 Therefore, bioinks may generally be printed using UV light if the total dosage
of light used is mitigated.213 However, since the cytotoxic effects of radicals may
appreciably impede cell behaviors, it is imperative that cell-laden printed constructs be
washed after light exposure whenever possible to remove any potentially harmful radical
species.
3.5.3

Cell Settling
One challenge to the incorporation of cells into bioinks and bioresins is the settling

of cells during printing. While extrusion bioprinting is amenable to the fabrication of large
constructs and is highly modular, printing times may take on the order of hours for
completion. Additionally, lithography-based bioprinting techniques are typically used to
achieve print features with higher resolution (25 – 50µm), however, printing can be slow.
For example, for a 5mm x 5mm x 5mm cube, a typical DLP process can take up to 1.5
hours.67,111,214 The time that it takes to print the desired construct, as well as the viscosity
of the bioink or bioresin determine whether the settling of cells is a concern to obtain
uniform cell distributions throughout a printed construct.
Chan et al. previously reported that in a typical top-down SLA approach, cells
mixed within the bioresin settled to the bottom of the resin reservoir during the printing
process, causing inhomogeneous cell distribution within the printed construct. In addition,
Lin et al. showed that 37.5 (v/v%) of Percoll was required as an additive in a PEGDA
bioresin to match the buoyant density of the cells to prevent cell settling.69,73 It is therefore
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desirable for any bioresin to have rheological properties that limit potential cell settling
within the resin bath during fabrication, so as not to yield inhomogeneous cell distributions
throughout prints. For extrusion bioprinting, cell settling is usually not observed when
viscous bioinks are utilized. However, for the cases of non-viscous inks, it is possible that
cells within a loaded syringe may settle prior to deposition, resulting in printing of
inhomogeneous features. These challenges may be circumvented through the
employment of microfluidic printing or viscosity modulators.116,207,215,216
An advantage of CAL bioprinting over these techniques is the low print times
required, which ensures that cells are rapidly encapsulated within the bioresin of interest
upon photocrosslinking.81 Furthermore, bioresins employed in CAL printing are typically
more viscous, mitigating the potential for cell settling during the printing process.80 In
general, cell settling can be mitigated either through the printing technique adopted, and/or
through the control over light exposure, as this will control the properties of the bioink or
bioresin and resulting cell settling.
3.6

CONCLUSIONS
The fundamental understanding and application of photocrosslinking techniques

have been important in the design of a range of bioinks and bioresins tailored for multiple
biofabrication technologies, including the most widely adopted extrusion bioprinting
approaches to control pre-, in-situ-, and post-crosslinking of bioinks, as well as rapidly
advancing lithography bioprinting approaches of photopolymerizable bioresins. As
outlined in this review, understanding the fundamentals of photocrosslinking and their
application in advanced biofabrication is critical to future developments. The rapid uptake
and breakthroughs achieved via photocrosslinking in bioprinting described herein are
largely due to the flexible and tunable photocrosslinking methods that have allowed for
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hydrogel bioink and bioresin designs to be realized and exploited, specifically targeting
unique bioprinting techniques and fabrication technologies (e.g., shear-thinning bioinks for
extrusion bioprinting). Critical considerations in these approaches remain the appropriate
selection of bioink and bioresin materials, including the polymers used within precursors,
the photoinitiator and its inter-related action on cell function, and the optimal light source
and light intensity.
The concept of 4D printing – where materials change over time - has been
embraced within the biofabrication community as a method of probing fundamental
biological questions. One method through which different physiochemical cues can be
spatiotemporally presented to cells within printed constructs is through photopatterning,
which has potential to converge with existing bioprinting approaches to achieve even
greater flexibility and control.217,218 Further, a growing area of interest within bioprinting is
the development of technologies that allow for the design and fabrication of constructs
with heterogeneous materials and cells. As most organs and tissues are composed of
multiple cell types with hierarchical structures, there is a need to create printing processes
through which we can better capture these features. Thus, added complexity will likely be
incorporated into bioprinted constructs in the future as technologies advance.
One major challenge commonly encountered in bioprinting of large constructs for
applications in tissue engineering and regenerative medicine is the need for nutrient
transport and metabolite exchange. The role of photocrosslinking in further improving the
resolution of perfusable and stable prevascularized structures or tissues (e.g., via DLP
lithography-based bioprinting) is likely to grow, offering important solutions to the problem
of fabricating clinically-relevant sized tissues for regenerative medicine. This can be
achieved through the added spatial control of photocrosslinking techniques or through the
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implementation of light-based degradation methods, where photosensitive materials are
eroded in 3D throughout hydrogel constructs.89,219–221 This control of both building and
eroding materials will enhance the formation of hierarchical structures, including vascular
components.
Novel photocrosslinking chemistries and approaches such as in situ crosslinking
and multi-step redox and photoredox approaches are further providing novel strategies to
expand the existing biofabrication window, allowing greater flexibility for processing a
wider range of printable low viscosity bioinks. This will enhance our ability to harness cell
functionality through changes in bioink or bioresin stiffness, chemical variations with multimaterial bioinks,222 and gradients in cell-instructive cues through precise control of light
exposure to facilitate improved tissue formation and function.223,224 This is further
evidenced by exciting developments in new bioprinting approaches such as CAL
bioprinting,80,81 where again our understanding and control of photocrosslinking
mechanisms of hydrogel bioinks is leveraged to drive rapid gelation of projected light for
the formation of large centimeter-scale, complex cell-laden constructs within seconds. Our
advancing knowledge of photocrosslinkable, biocompatible hydrogel bioinks supports the
rapid development of such new bioprinting technologies towards clinical translation given
the speed advantages offered to fabricate clinically relevant sized, centimeter-scale
constructs with patient specific and anatomical shapes.
As progress in bioprinting continues to enable the fabrication of more precise
constructs, future work will aim to further improve in vitro models and to elucidate how
biofabrication can be employed to understand fundamental biological questions
surrounding development and disease. To this end, innovations towards the fabrication of
multimaterial constructs, recapitulating dynamic cellular and signaling events via
114

photopatterning, and engineering larger vascularized constructs will continue to advance
the field.
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CHAPTER 4: 3D BIOPRINTING VIA AN IN SITU CROSSLINKING TECHNIQUE
TOWARDS ENGINEERING CARTILAGE
The following chapter is adapted from:
Galarraga, J.H., Kwon, M.Y., Burdick, J.A. 3D bioprinting via an in situ crosslinking
technique towards engineering cartilage tissue. Sci Rep 9, 19987 (2019).
4.1

INTRODUCTION
Cartilage is a load-bearing connective tissue found in articulating joints that

permits movement between bones with minimal friction. When articular cartilage is
damaged due to disease or traumatic injury, loss of cartilage throughout the joint surface
may occur, resulting in reduced joint mobility and eventually osteoarthritis.1 Since native
cartilage does not possess any regenerative capacity, surgical interventions are often
required to mitigate the progression of cartilage degeneration in afflicted patients.
Procedures such as microfracture aim to stimulate cells (e.g., mesenchymal stromal
cells, MSCs) in the underlying bone marrow, while cell-based therapies such as matrixassisted autologous chondrocyte implantation (MACI) focus on scaffolds to elicit tissue
formation from donor cells.2 Despite their clinical use, these approaches have only
exhibited limited success, as they fail to fully restore the function of healthy cartilage.
These findings have motivated the use of tissue engineering to improve the quality of
repair cartilage for clinical applications.
Within the field of tissue engineering, 3D bioprinting enables the fabrication of
cell-laden hydrogel scaffolds with anatomically relevant structures and patient-specific
geometries, improving the prospects for repair tissue integration.3 For example,
poly(ethylene glycol) (PEG)-based hydrogel implants with embedded chondrocytes have
been fabricated via extrusion-based printing and shown to integrate with peripheral
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cartilage tissue in ex vivo osteochondral plugs.4 Unlike alternative fabrication
approaches such as micromolding, 3D bioprinting permits the modular and scalable
design of precise scaffold features that better recapitulate properties of native tissue.
Specifically, 3D bioprinting allows for unparalleled spatial control over materials5,6 or cell
types7 in 3D space, which has been used to mimic the zonal stratification of properties
found in cartilage or osteochondral units.8 Daly et al. used the inkjet printing of cell
spheroids into 3D printed polycaprolactone (PCL)-based microchambers for guidance of
spheroid growth and fusion, permitting the formation of neotissues with depth-dependent
collagen architectures.9 PCL has also been utilized to increase the mechanics of printed
hydrogels (e.g., fibrin-collagen, alginate, agarose, PEG) with embedded chondrocytes or
MSCs towards cartilage formation,10–13 including through the combination of melt
electrowriting of PCL with extrusion-based printing of gelatin-methacryloyl (GelMA).14
Other hydrogel inks that have been previously used for engineering cartilage include
hyaluronic acid (HA),7 decellularized extracellular matrix (ECM),15 and gellan gum.7,16
Bioinks, which are typically comprised of a hydrogel precursor solution containing
cells,17 must exhibit a number of requisite design specifications to be printable with
traditional printing technologies. For example, in extrusion-based 3D bioprinting, bioinks
must first have suitable rheological properties such that they can readily flow through a
printer head. If a candidate bioink is too viscous, appreciable shear forces will be exerted
on encapsulated cells, reducing cell viability and long-term functional properties of printed
constructs. Beyond flow, bioinks must also possess sufficient mechanical integrity upon
deposition so that extruded filaments are stable and can be deposited in a layer-by-layer
manner. A number of bioinks have been designed with these specific criteria in mind, such
as with guest-host supramolecular hydrogels that are shear-thinning and self-healing and
can be stabilized via secondary covalent crosslinking.18 However, if a bioink is non132

viscous, it will flow rapidly upon deposition due to gravity, limiting printed filament
resolution.
While many advances have been made in the design and implementation of
bioinks, including towards cartilage tissue engineering, it is of interest to expand on the
possible properties available with printable bioinks rather than only using inks that meet
current printing criteria. As described by Malda et al, the traditional window for bioprinting
is often not optimal for maintaining desired cell behavior, including cell viability.19 Further,
it may be of interest to harness diverse bioink properties, as it is now well known that
biochemical and biophysical properties of hydrogels influence encapsulated cells - for
example, the presentation of signaling cues such as ECM ligands and mechanics are
known to regulate cell differentiation, proliferation and migration.20 Thus, generalizable
techniques that allow the printing of a wider range of bioinks are of interest for tissue
engineering to introduce optimal cellular environments.
To overcome the challenges of printing bioinks that do not meet traditional criteria,
several strategies have been pursued.

One approach involves the introduction of

rheological additives, such as silicates21–23 or nanocellulose24,25 into bioinks to impart
desired rheological properties for extrusion-based printing. Support hydrogels have also
been developed, where hydrogels can be printed in any arbitrary space, allowing for
embedded printing of geometries not feasible by traditional layer-by-layer fabrication. For
example, hydrogels have been printed into self-healing, supramolecular guest-host
hydrogels26 and into granular support baths comprised of either a gelatin slurry27 or
Carbopol microgels.28 Sacrificial materials have also been utilized, where polymers such
as alginate can be introduced into an ink for stabilization (e.g., via calcium through a
coaxial needle) and then later washed away after the desired ink material is stabilized,
such as with photocrosslinking.29 Lastly, jammed microgels have recently been used for
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printing, as many materials can be formed into microgels and jammed to meet printing
requirements, including with encapsulated cells.30 While each of these approaches
expands upon the number of candidate bioinks available, the need for additives or postprocessing steps could impede or compromise the design of target cellular
microenvironments.
In the context of photocrosslinkable bioinks, we recently developed an approach
to print non-viscous polymers, where light exposure occurs prior to bioink deposition as it
passes

through

a

photopermeable

capillary

(Figure

4.1).31

Figure 4.1: Schematic of in situ crosslinking approach for 3D printing. Bioinks are loaded
into a syringe and irradiated with light through a photopermeable capillary during extrusion,
resulting in the plug flow of filaments through the end of the capillary. There are numerous
variables within the printing approach, including the bioink formulation, the printing
parameters, and the capillary setup, all of which can influence printing success. These should
be balanced to regulate the residence time of the bioink within the light path (Q, L, W), as well
as the reaction kinetics of crosslinking ([I], I0). The intensity of light across the capillary lumen
varies as a function of light attenuation due to the capillary walls and absorbing species within
the designed bioink.

With this in situ crosslinking approach, stable hydrogel filaments are readily
extruded across many hydrogel types, while the shear forces generated on cells are
attenuated so that high cell viability is conserved. Furthermore, this printing approach does
not require post-processing steps or the use of rheological additives, allowing for one-step
3D printing of bioactive materials. Here, we selected one potential bioink of interest for the
3D bioprinting of cartilage tissue, based on norbornene-modified hyaluronic acid
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(NorHA)32 that can be crosslinked via a thiol-ene reaction in the presence of visible light
and a water-soluble photoinitiator.33 HA is a promising biomaterial in cartilage tissue
engineering, particularly towards influencing MSC chondrogenesis;34–36 however, the
NorHA bioink is non-viscous and does not meet traditional printing requirements. In this
study, we explain the various steps used to implement in situ crosslinking with this NorHA
bioink and illustrate its utility in engineering cartilage with encapsulated MSCs.
4.2

METHODS

4.2.1

Materials
Sodium hyaluronic acid (HA, MW=74 kDa) was purchased from Lifecore

Biomedical (Chaska, MN) and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP)
was purchased from Colorado Photopolymer Solutions (Boulder, CO). All other reagents
were purchased from Sigma-Aldrich (St. Louis, MO) unless specified otherwise.
4.2.2

NorHA Synthesis and Characterization
Sodium HA was converted into its tetrabutylammonium salt (HA-TBA) and then

modified

with

norbornene

functional

groups

via

benzotriazole-1-yl-oxy-tris-

(dimethylamino)-phosphonium hexafluorophosphate (BOP) coupling as previously
described.49 Upon dissolving HA in distilled H2O, Dowex 50Wx200 resin was added to the
solution in a 3:1 mass ratio. After mixing for 30 minutes, the Dowex resin was filtered via
vacuum filtration, and the filtrate was titrated with tetrabutylammonium hydroxide solution
to a pH of 7.02-7.05. The HA-TBA solution was then frozen and lyophilized. Thereafter,
5-norbornene-2-methylamine was added to lyophilized HA-TBA and dissolved in
anhydrous DMSO under inert nitrogen. BOP was then added via cannulation to the
reaction round bottom flask, and the reaction was allowed to proceed for 2 hours at room
temperature. The reaction was quenched with the addition of cold DI H2O (4˚C) and
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dialyzed for 5 days at room temperature. Then, the crude product solution was filtered to
remove precipitates and dialyzed for an additional 3-5 days. Finally, the product was
frozen and lyophilized. All synthesized polymers were stored under inert nitrogen at -20˚C
and the extent of modification of HA with norbornene was quantified via 1H-NMR (Bruker
360 MHz, Figure 4.2). To ensure the same level of norbornene modification (~40%) was
achieved across different synthesis reactions (i.e. batches), 1H-NMR was performed after
every reaction; further, all experiments with a specific outcome were performed using the
same batch of NorHA.

b

a

Figure 4.2: 1H NMR characterization of NorHA in D2O. Norbornene modification was
determined by integrating the a) vinyl protons of norbornene (2H, ~5.8-6.3 ppm) relative to
the b) methyl group of HA (3H, ~1.8-2.0 ppm) to obtain a relative norbornene modification of
~40% of the disaccharide repeat units of HA.

4.2.3

Hydrogel Formation and Rheological Characterization
One bioink formulation was investigated: 2 wt% NorHA, 0.05 wt% LAP, and 0.08

wt% DL-dithiothreitol (DTT). The absorbances of bioink components were determined
using a Tecan Infinite M200 spectrometer and cuvettes with a pathlength of 1 cm.
Rheological measurements were performed using an AR2000 stress-controlled rheometer
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(TA Instruments) fitted with a 20 mm diameter cone and plate geometry, 59 min 42 s cone
angle, and 27 μm gap. The bioink formulation was placed on the rheometer and
rheological properties were examined by time sweeps (1.0 Hz, 0.5% strain) in the
presence of visible light (Exfo Omnicure S1500 lamp, 400−500 nm filter) applied at
variable light intensities (I2, expected light intensity after attenuation through the capillary
and bioink). Gelation profiles obtained from oscillatory shear time sweeps are reported as
the percent of the maximum storage modulus (G’) observed after 10 minutes of irradiation
with visible light.
4.2.4

3D Printing of NorHA

Constructs were printed using a custom-modified 3D FDM printer (Velleman K8200) and
in situ crosslinking at variable capillary lengths (L=15-60 mm, Masterflex 96410-13),
volumetric flow rates (Q=0.8-3.2 mL/h) and light intensities of (I1=5-15mW/cm2, =400500 nm). Upon loading inks (acellular or cellular) into a 1 mL BD syringe, Repetier software
was used to slice computer-aided design (CAD) models and control the ink deposition. An
Exfo Omnicure S1500 lamp with a collimating lens was used to irradiate the
photopermeable capillary during material extrusion (Figure 4.3).
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Figure 4.3: In situ crosslinking technique setup. a) Image of the 3D printing setup
employed to print NorHA bioinks via in situ crosslinking. b) Zoomed image of collimated, visible
blue light irradiation through a photopermeable capillary. NorHA bioink is extruded through a
syringe, such that stable filaments are formed and deposited via CAD/controller

4.2.5

Cell Encapsulation and Viability
All macromers were sterilized under germicidal irradiation prior to use. Primary

juvenile mesenchymal stromal cells were isolated from the bone marrow of bovine femora
and tibiae (Research 87, Boylston, MA) as previously described.35 Thereafter, MSCs (P1)
expanded in Dulbecco’s modified eagle medium (+10% fetal bovine serum +1%
penicillin/streptomycin) were washed, trypsinized (0.05%), centrifuged, and resuspended
(20x106 cells/mL) in NorHA dissolved in phosphate buffered saline (PBS) and manually
transferred to a 1 mL BD syringe. Following 3D printing, constructs were cultured in
chondrogenic media (2.50 µg mL−1 amphotericin B, 1 × 10−3 M sodium pyruvate, 40 µg
mL−1 L-proline, 1 × 10−7 M dexamethasone, 50 µg mL−1 ascorbic acid 2‑phosphate, 1%
ITS+, and 5 ng mL−1 TGF‑B3). For cell viability analyses, printed hydrogels were stained
with calcein AM/ethidium homodimer (0, 3, 7 days) according to manufacturer’s
instructions (Invitrogen). Confocal images (Leica SP5) of stained, cell-laden constructs
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were analyzed using Image J software to assess both the cell viability and cell density of
the top, middle, and bottom thirds of printed constructs. Cell viability was calculated as the
number of live cells per total cells within a single image (n≥3 gels, 9 images per group).
Cell density was calculated by counting the total number of cells within randomly placed
600x600 m2 image frames (n≥3 gels, 9 images per group).
4.2.6

Gene Expression Analysis
PCR was performed for MSCs encapsulated in printed discs as previously

described.55 After 3 days of culture, samples were mechanically agitated using a handheld
tissue homogenizer so that RNA could be isolated via Trizol (Invitrogen). Isolated RNA
was reverse transcribed to cDNA, and PCR was then conducted on an Applied
Biosystems 7300 Real-Time PCR system. Type II-collagen (COLII), aggrecan (ACAN),
type I-collagen (COL I) and SOX9 were selected as targets, with glyceraldehyde 3phosphate dehydrogenase (GAPDH) used as a housekeeping gene. Gene expression
relative to MSCs expanded on tissue culture plastic was determined using the ΔΔCT
method, where the fold difference is found by 2−ΔΔC.
4.2.7

Construct Mechanical and Biochemical Characterization
Upon printing of hydrogel bioinks (2 wt% NorHA, 0.05 wt% LAP, 5.2 mM DTT),

mechanical testing was performed (TA Instruments, DMA Q800) to determine the
compressive moduli of samples. Hydrogels were secured within a fluid cup via a 0.01 N
pre-load, compressed until failure at a rate of 0.5 N min-1, and the moduli calculated as
the slope from 10-20% strain. After culture for 0, 28, and 56 days, constructs were fixed
in 10% buffered formalin for 2 hours at room temperature and then washed three times
with PBS. Constructs were cut into halves for either biochemical or histological analysis.
Towards quantifying the biochemical content of constructs, samples were first digested
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via papain (0.56 U mL−1 in a mixture of 0.1 M sodium acetate, 10 M cysteine hydrochloric
acid, and 0.05 M ethylenediaminetetraacetic acid, pH 6.0, ~1 mL/construct) at 60 °C
overnight. Dimethylmethylene Blue (DMMB), PicoGreen, and hydroxyproline assays
(Abcam Hydroxyproline Assay Kit, ab222941) were subsequently performed to quantify
sulfated glycosaminoglycan (GAG), DNA, and collagen (COL) contents, respectively.56
4.2.8

Construct Histological Characterization
To histologically analyze samples, constructs were first embedded in paraffin and

incubated for 24 hours at 4°C. Thereafter, embedded samples were sectioned (5 µm) and
stained with alcian blue (1%, pH 1.0, Newcomer Supply), anti-collagen type I (COL I,
mouse monoclonal anticollagen type 1, Millipore Sigma), or anti-collagen type II (COL II,
mouse monoclonal anticollagen type II, Developmental Studies Hybridoma Bank)
antibodies to observe GAG, COL I, and COL II, respectively. Native tissue samples were
isolated from the femoral condyle of a juvenile bovine joint and processed in the same
manner. To quantify staining, images were first converted to 8-bit and then inverted as
previously described.55 For each section, mean intensities for three distinct and randomly
selected frames were measured in Image J.
4.2.9

Statistical Analysis
All data are reported as mean ± standard deviation and n≥3 unless specified

otherwise, and all statistics were performed using GraphPad Prism 7 software. For
comparisons between two groups, Student t-tests were performed with two-tailed criteria
and significance determined at p<0.05. For comparisons between more than two groups,
one-way analysis of variance (ANOVA) was performed with post hoc testing and
significance determined at p<0.05. Holm-Sidak correction was used for multiple
comparisons with

=0.05.
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4.3

RESULTS AND DISCUSSION

4.3.1

Design of In Situ Crosslinking Approach Based on Bioink Formulation
HA was modified with pendant norbornene functional groups, such that

approximately 40% of disaccharide repeat units contained norbornene (NorHA), as
determined by quantitative 1H NMR (Figure 4.2). Bioinks were formulated from 2 wt%
NorHA, 0.05 wt% LAP, and 0.08 wt% DTT (Figure 4.4a). To assess how much light each
ink component attenuates, the absorption spectra of NorHA, LAP and DTT were measured
from 300-500 nm (Figure 4.4b).

Figure 4.4: NorHA bioink composition and crosslinking. a) Chemical structures of
components incorporated into NorHA bioinks and their b) absorption spectra, including for
NorHA (2wt%, square), LAP (0.05 wt%, circle), DTT (0.08 wt%, diamond), and their
combination into a single bioink formulation (triangle). c) Schematic of thiol-ene reaction
employed to crosslink the NorHA bioink in the presence of visible light and LAP photoinitiator.
d) Representative photorheology time sweep (1 Hz, 0.5% strain) during the photocrosslinking
of the NorHA bioink with visible light (400-500 nm) at I1=10 mW/cm2, illustrating increases in
storage (G’, closed circles) and loss (G”, open circles) moduli over time.

After elucidating each of these respective absorption spectra, the molar extinction
coefficients (ϵ) of ink components were determined using Beer-Lambert Law (Equation
4.1), which states that the absorption of a species of interest is proportional to the
141

pathlength of light (W), the concentration of the species (c), and the degree to which the
species absorbs that specific wavelength of light (ϵ).

As shown in these spectra, the degree of light attenuation due to DTT within the
bioink is negligible, whereas both NorHA and LAP absorb light up to ~420 nm. To better
understand the potential for light attenuation through the printer’s photopermeable
capillary, the maximum amount of attenuation possible, which occurs at 400 nm, was
quantified. Since the molar extinction can be determined using equation (1) and
absorbance measurements of NorHA and LAP samples with known concentrations, the
molar extinction coefficient for LAP at 400 nm was determined to be ~0.078 cm-1mM-1,
while the coefficient for NorHA was ~855 cm-1mM-1. The light attenuation (of 400 nm light)
due to multiple absorbing species can then be quantified via an alternative form of BeerLambert law, given by Equation 4.2.

Thus, the drop in light intensity across the capillary lumen (W=800 µm) due to the bioink
used in our printing setup was negligible (Figure 4.3), as the initial intensity within the
capillary (I1) only decreases ~3% across the width of the capillary (I2); however, larger
decreases in light intensity could be expected if a higher concentration of initiator ([I]),
wider tubing (increased W), or different wavelength (λ) of light were employed (Figure
4.5).

142

b
Absorbance

4

[I] = 0.34 mM
[I] =1.70 mM
[I] =3.40 mM
[I] =8.50 mM

3
2
1
0
300

350
400
Wavelength (nm)

c
Iw (mW/cm2)

20

450

Molar Extinction
Coefficeint (mM-1 cm-1)

a

1.0

0.5

0.0
300

350
400
Wavelength (nm)

−W (ϵ
[I] + ϵ
[NorHA])
LAP
NorHA
Iw =I0 e

I1 = 5 mW/cm2
I1 = 10 mW/cm2
I1 = 15 mW/cm2

15
10
5
0
0.0

0.2

0.4
0.6
W (mm)

0.8

Figure 4.5: Influence of light absorbance on printability. a) Absorbance measurements
and b) quantified molar extinction coefficients of the LAP photoinitiator at variable
concentrations ([I]) and light wavelengths (λ). c) Quantification of light attenuation across the
width of the capillary (IW), due to absorbing species within the NorHA bioink (1.70 mM LAP),
where IW=I2 for W=800µm (experimental parameter in this study). Drops in light intensity:
I1=5.00 mW/cm2 to I2=4.86 mW/cm2 (triangle); I1=10.0 mW/cm2 to I2=9.72 mW/cm2 (square);
I1=15.0 mW/cm2 to I2= 14.6 mW/cm2 (circle).

Finally, to target a specific I1 within the photopermeable capillary, experimental
relationships of light attenuation due to the capillary walls themselves were developed
(Figure 4.6).
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Figure 4.6: Light attenuation through the capillary. a) Schematic illustrating the various
light intensities during in situ crosslinking, including directly from the light guide (I0), at the inner
edge of the capillary lumen (I1), after passing through the capillary lumen (I2), and at the
opposite side of the capillary (I3). An equation describing this relationship is shown to account
for light attenuation by the capillary itself. b) Experimental measurements of the incident light
intensity (I0) compared to the light intensity at the opposite end of the capillary from the light
source (I3). c) Calculated calibration curve to determine the required I0 to achieve a desired I1
to cure the bioink.

4.3.2

Photorheology to Identify Permissible Printing Regimes
The NorHA within the bioink undergoes a thiol-ene reaction for crosslinking

(Figure 4.4c), which can be monitored experimentally with photorheology to assess the
kinetics of gelation for our distinct ink formulation (Figure 4.4d). Photorheology time
sweeps were performed at I2 ~ 4.86, 9.72 and 14.6 mW/cm2 (corresponding to I1=5, 10
and 15 mW/cm2, respectively) towards creating gelation profiles that could predict
permissible printing regimes (Figures 4.4, 4.7).
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Figure 4.7: Rheological properties of bioinks across various light intensities.
Representative photorheology time sweeps (1 Hz, 0.5% strain) during the photocrosslinking
of the NorHA bioink with visible light (400-500 nm) at either a) I1=5 mW/cm2 or b) I1=15
mW/cm2, illustrating increases in storage (G’, closed circles) and loss (G”, open circles) moduli
over time.

When NorHA inks were initially subjected to shear at 1 Hz and 0.5% strain, the
storage (G’) and loss moduli (G”) were on the order of 1-10 Pa, consistent with a nonviscous material. It was not possible to measure the viscosity of the initial bioink
formulation. However, upon irradiation with visible light, a rapid evolution of mechanics
was observed (increasing G’), indicating NorHA crosslinking into an elastic hydrogel.
These photorheological time sweeps were normalized to their maximum value to
develop a heuristic for the time required for G’ to plateau; it has previously been shown
that the percent of maximum storage G’ correlates with the conversion of crosslinker in
thiol-ene reactions.37 This metric was therefore used to quantitatively estimate the extent
of reaction as a function of time. Since the capillary length, bioink volumetric flow rate, and
incident light intensity are all user-defined parameters for in situ crosslinking, we aimed to
elucidate how each of these variables can be tuned in conjunction with these normalized
gelation profiles to enhance ink printability.
First, an analysis was performed on the influence of capillary lengths on ink
printability, while setting the light intensity and flow rate at constant values (I1=10 mW/cm2,
Q=0.8 mL/h). If the time of light exposure (Figure 4.4d; x-axis) is multiplied by the ink
velocity (which is set by the flow rate and the width of the capillary lumen), then a
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relationship between the percent of maximum G’ versus capillary length can be generated
(Figure 4.8a). By experimentally printing the bioink under various conditions, it is clear
that the quality of printed filaments is dependent on the capillary length. Here, a capillary
length of 60 mm was needed for good print resolution, whereas capillary lengths of 15 mm
and 30 mm resulted in irregular and spread filaments, indicating that the curing was not
complete.

Figure 4.8: Identification of permissible printing conditions via photorheology. a) Left:
Percent of maximum G’ as a function of variable capillary lengths and Right: representative
images of overlaying filaments, with I1=10 mW/cm2, Q=0.8 mL/h and variable capillary lengths
(L=15, 30, 60 mm). b) Left: Percent of maximum G’ as a function of variable flow rates and
Right: representative images of overlaying filaments, with L=60 mm, I1=10 mW/cm2 and
variable flow rates (Q=0.8, 1.6, 3.2 mL/h). c) Left: Percent of maximum G’ as a function of
capillary residence time across variable light intensities (dashed line indicates the fixed
residence time of 135 seconds) and Right: representative images of overlaying filaments, with
L=60 mm, Q=0.8 mL/h and variable light intensities (I1= 5, 10, 15 mW/cm2). Scale bar = 1 mm.
Note: the same representative image was used for the printing parameters used subsequently
in this study (L=60mm, Q=0.8 mL/h, I1=10 mW/cm2).

Similarly, these gelation profiles can be employed towards understanding how
bioink flow rate influences the in situ crosslinking process, while setting the light intensity
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and capillary length at constant values (I1=10 mW/cm2, L=60 mm). A relationship between
the percent of maximum G’ versus bioink flow rate was obtained (Figure 4.8b) by
converting the time of light exposure (Figure 2d; x-axis) into volumetric flow rate using
Equation 4.3 below, where W=0.8 mm for this experiment and t is time.

Again, the NorHA bioink was printed with varied bioink flow rates to observe the
influence of printing conditions on filament quality (Figure 4.8b). Here a flow rate as slow
as 0.8 mL/h was needed for high resolution filaments, as faster flow rates did not permit
sufficient times for bioink curing under this in situ crosslinking setup and resulted in spread
filaments.
Finally, the influence of light intensity on crosslinking was explored, where
increased light intensities led to more rapid curing (Figure 4.8c). While selecting a
common ink residence time of 135 seconds (Figure 4.8c; L=60 mm, Q=0.8 mL/h), it was
clear that at least 10 mW/cm2 light intensity was needed for filament curing, whereas lower
light intensities were not sufficient for crosslinking under the specific in situ crosslinking
setup. Overall, the most consistently printable and stable filaments were achieved when
printing conditions resulted in NorHA bioinks reaching >85% of their maximum G’. It should
be noted that the maximum G’ achieved after 10 minutes of irradiation may decrease
appreciably if the reaction kinetics are slow (i.e., significantly lower light intensities);
therefore, the predictive power of these gelation profiles is only valid if a plateau in storage
modulus is observed in the photorheology studies.
Through the implementation of this approach, a set of optimal printing conditions
was determined (L=60 min, Q=0.8 mL/h, I1=10 mW/cm2) and utilized to print larger,
multilayered constructs. Specifically, in situ crosslinking was employed to create large
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constructs with anatomically relevant features, such as a femoral condyle (Figure 4.9a).
In addition, discs (~1.5 mm thickness, ~6.5 mm diameter) were printed (Figure 4.9b) and
shown to retain their structure after immersion in PBS for one week (Figure 4.10).

Printed Cylinder Diameter (mm)

Figure 4.9: Representative multi-layered constructs printed via in situ crosslinking. Left:
Schematic of in situ crosslinking method and Right: CAD design and representative image of
a printed construct (labeled with food coloring) for designs of a) a model femoral condyle or b)
a disc (~1.5 mm thickness, ~6.5 mm diameter). Scale bars = 1 cm (a) and 5 mm (b).
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Figure 4.10: Stability of discs printed via in situ crosslinking technique. Printed discs
were immersed in PBS for 0, 3, or 7 days and imaged to quantify any changes in the disc
diameter over time. n≥3, n.s. = not significant.

To demonstrate the reproducibility of this printing approach, we quantified the
percent error between the targeted and observed dimensions of printed filaments and
discs, which both exhibited on average ~3% error (Figure 4.11).
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Figure 4.11: Quantification of printing error associated with in situ crosslinking
technique. Percent errors between target dimensions and observed dimensions are reported
for both printed filaments (target dimension: 800 µm diameter) and printed discs (target
dimension: 6.3 mm diameter). n≥7 constructs.

To ensure the viability of this printing approach towards fabricating constructs for
long-term culture and neocartilage formation, we also validated that the printing process
does not alter the swelling behavior or the mechanics of NorHA hydrogels (Figure 4.12).
Specifically, the volumetric swelling ratios and compressive moduli of both printed and
casted discs incubated in PBS were determined at 0,1,3 and 7 days, and no differences
were observed across these timepoints.
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Figure 4.12: Swelling behavior and mechanics of printed versus casted NorHA discs. a)
Volumetric swelling ratios are reported for printed and casted discs as the ratio between
hydrogel wet weights and dry weights. Samples were incubated in PBS and analyzed at days
0,1,3 and 7. b) Compressive moduli for printed and casted discs at days 0,1,3 and 7. n≥3. n.s.
= not significant.

4.3.3

In Situ Crosslinking of NorHA Bioink for MSC Encapsulation
To assess the cytocompatibility of the printing process, primary juvenile bovine

MSCs were isolated, printed into discs, and cultured in chondrogenic media for up to one
week. Confocal images of constructs stained with Live/Dead assays indicated that high
cell viabilities (>85%) persisted through 7 days after printing, although small decreases in
viability were observed from the initial time point (day 0) to 3 and 7 days. To ensure that
the observed cytocompatibility was conserved throughout all depths of the printed
constructs, confocal images for distinct thirds (top, middle, bottom) of each disc were
analyzed (Figure 4.13a,b). At all timepoints (days 0, 3, 7), cell viabilities in distinct regions
of the discs exhibited no significant differences, indicating that large constructs could be
readily printed while retaining consistent cell viability throughout the duration of printing
(Figure 4.13c).
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Figure 4.13: Cell viability and distribution in printed constructs. a) Schematic
demonstrating the binning of acquired Live/Dead confocal images for analysis of the top,
middle and bottom thirds of printed discs. b) Representative Live/Dead images (scale bar =
200 µm), c) quantification of cell viability, and d) quantification of cell density for the top, middle
and bottom thirds of printed discs after 0, 3, and 7 days of culture. n≥3, *p<0.05, **p<0.01, n.s.
= not significant.

One challenge in the printing of bioinks is cell sedimentation and achieving a
homogenous distribution of cells throughout a printed construct.38 Thus, cell densities
were also quantified throughout different depths of the printed discs to demonstrate that
cell settling did not impact cell distribution at the print times employed with the in situ
crosslinking technique. At each timepoint, the cell density was within the range of 750-820
cells/mm2, with no significant differences existing between different depths of the
constructs or across different timepoints (Figure 4.13d). Therefore, in situ crosslinking
supported the fabrication of multi-layered constructs with viable and well-distributed
MSCs.
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4.3.4

Neocartilage Formation in 3D Printed NorHA Constructs
After validating the printability and cytocompatibility of NorHA hydrogels printed via

in situ crosslinking, we next printed constructs for long-term culture to investigate
neocartilage formation. Printed discs were cultured for up to 56 days in chondrogenic
media; upon fixing, all samples were characterized to assess changes in biochemical
content, mechanics, and matrix distribution over time. Initially, printed discs were analyzed
after three days of culture via PCR to ensure that encapsulated MSCs would undergo
chondrogenesis (Figure 4.14); the observed expression of chondrogenic markers such as
type II-collagen (COLII), aggrecan (ACAN), and SOX9 indicated that printed constructs
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were conducive to neocartilage formation.
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Figure 4.14: Relative gene expression of encapsulated MSCs in printed NorHA
constructs. Mean fold difference of type II-collagen (COLII), aggrecan (ACAN), type Icollagen (COLI) and SOX 9 gene expression for printed discs cultured for 3 days relative to
MSCs cultured on tissue culture plastic (i.e., day 0, 2D control). Dashed line represents
expression level of control group, which are cells at the time of encapsulation. n≥5 printed
discs, *p<0.05.

After 56 days of culture, printed discs exhibited an increase in normalized DNA
content, suggesting that viable cells proliferated and persisted throughout the duration of
culture (Figure 4.15a). Further evidence of neocartilage formation is provided by metrics
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of increased sulfated glycosaminoglycan (GAG) and collagen (COL) contents (Figure
4.15b,c).
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Figure 4.15:
Mechanical characterization and biochemical analysis of printed
constructs. a) DNA content, b) sulfated glycosaminoglycan (GAG) content, c) collagen (COL)
content, and d) compressive moduli for printed constructs after 0, 28, and 56 days of culture.
n≥3, *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s. = not significant.

Both of these extracellular matrix components are indicative of MSC
chondrogenesis and tissue maturation, demonstrating that printed discs formed into
neocartilage. Sulfated GAG content increased to over 100 µg/µg DNA by 56 days, likely
enhancing the mechanics of the printed constructs, as these polysaccharides impart
osmotic swelling and high compressive properties to native tissue.39 Collagen, the main
ECM-protein found in cartilage, was also deposited by embedded cells, with collagen
content increasing 7-fold from 0 to 56 days. These results were corroborated by dynamic
mechanical analysis, which showed increases in the compressive moduli of printed discs
from 5.2±1.5 kPa initially to 42.0±13.9 kPa after 56 days of culture (Figure 4.15d).
Although these mechanics pale in comparison to those of native bovine articular cartilage,
which has been shown to possess Young’s moduli on the order of 0.3-0.6 MPa40 and
aggregate moduli ranging between 0.5 MPa and 1.0 MPa,41 the observed increases in
compressive moduli demonstrate the evolution of functional tissue properties in printed
constructs.
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Histological analyses were subsequently performed to assess the distribution of
ECM components within the printed discs. Alcian blue staining indicated that GAGs were
homogenously distributed by encapsulated MSCs by as early as 28 days, with staining
intensities increasing over time and trending towards native tissue levels (Figure 4.16a).

Figure 4.16: Histological evaluation of printed constructs. Left: Representative images
and Right: staining quantification of a) alcian blue staining for glycosaminoglycans (GAG), b)
immunohistochemistry for type II collagen (COL II), and c) immunohistochemistry for type I
collagen (COL I) for printed constructs after 0, 28, and 56 days of culture or native bovine
articular cartilage. Scale bars = 100 µm, n≥15 sections, 45 images per group, *p<0.05,
**p<0.01, ****p<0.0001.

Collagen II (COLII), one of the most abundant matrix proteins found in cartilage,
was also detected in printed constructs, indicating that appreciable matrix was formed
over long-term culture (Figure 4.16b). The observed increases in COL II staining intensity
are of interest, as COLII imparts tensile strength to cartilage in native tissue.39
Furthermore, the deposition of COLII in printed discs was disperse and well distributed,
albeit less homogenous than the observed GAGs. Noticeably, COLII staining was most
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intense at 56 days within the pericellular space of encapsulated cells. Finally, the
distribution of collagen I (COL I), which is more prevalent in fibrocartilage, was measured
to qualitatively assess the phenotype of the fabricated neocartilage (Figure 4.16c). While
increases in COLI staining were observed from the initial timepoint to 56 days, there was
appreciably less COL I than COLII in printed constructs, suggesting that the tissue formed
more closely resembles hyaline cartilage over fibrocartilage.
It is noteworthy that this in situ crosslinking technique may also be leveraged
towards the design and fabrication of neocartilage into more complex geometries. To this
end, femoral condyles were printed and cultured for 56 days in a similar manner to printed
discs (Figure 4.17a), resulting in the formation of larger tissue constructs.

Figure 4.17: Culture and characterization of printed femoral condyles. a) Schematic of
printed femoral condyle and image of printed construct after 56 days of culture. b) Schematic
of five distinct print regions biopsied from printed femoral condyle models for analysis. c) DNA
content, d) sulfated glycosaminoglycan (GAG) content, e) collagen (COL) content, and f)
compressive moduli for construct biopsies after 56 days of culture. Left: Representative
images and Right: staining quantification of g) alcian blue staining for glycosaminoglycans
(GAG), h) immunohistochemistry for type II collagen (COL II), and i) immunohistochemistry for
type I collagen (COL I) for construct biopsies after 56 days of culture. Scale bars = 1 cm (a)
and 100 µm (g-i), n=3 printed constructs, n≥15 sections, 45 images per group, n.s.=not
significant.
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To assess the homogeneity and quality of neotissue formed in these constructs, condyles
were biopsied such that 4mm discs were isolated from five distinct print regions (Figure
4.17b). As anticipated, each of these biopsies exhibited biochemical content associated
with neocartilage, including elevated amounts of normalized DNA content (Figure 4.17c),
sulfated GAG content (Figure 4.17d) and collagen content (Figure 4.17e).

Tissue

samples isolated from printed condyles also showed enhanced compressive properties
relative to acellular constructs (Figures 4.8, 4.17f). It should be noted that any
discrepancies observed between the moduli of biopsied tissue samples (i.e., from printed
femoral condyles) and previously printed discs may be attributed to differences in sample
topography, as the biopsied condyle samples possessed a convex surface. Interestingly,
no significant differences in biochemical content or compressive moduli were observed
across the five biopsied print regions of femoral condyles, suggesting that in situ
photocrosslinking supports the fabrication of neocartilage in a controlled and scalable
manner. Similarly, all five biopsied print regions displayed an appreciable amount of ECM
deposition, as demonstrated by histological analysis (Figure 4.17g-i). Staining intensities
for GAG, COLII and COLI did not vary significantly between distinct print regions, and the
relative amounts of COLII and COLI observed suggest that femoral condyle models were
successfully printed to form hyaline cartilage.
4.3.5

Evaluation of In Situ Crosslinking Approach
To engineer precise tissues for clinical medicine, the development of scaffolds with

complex, hierarchical structures are of great interest, particularly with patient-specific
defect geometries.42 3D printing is a promising approach towards this, including for the
repair of cartilage;3,43 however, the design of 3D printed scaffolds has been limited to only
a small number of bioinks with the requisite properties for printability. This inherently limits
3D printing in tissue repair, as cells are responsive to their local environment and we would
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like to print materials to guide cell behavior, rather than use materials only because they
are printable. To address this, we recently developed an approach that permits the printing
of non-viscous, photocrosslinkable bioinks without the use of additives or sacrificial
materials.31
Our in situ crosslinking approach is simple - the non-viscous bioink is cured with
light as it passes through a photopermeable capillary, prior to deposition onto a surface
(Figures 4.1, 4.2). The design of the system includes many variables that can be balanced
to ensure crosslinking as the hydrogel precursor transits through the capillary; thus, it is
important to understand both the reaction kinetics of the specific bioink composition and
the residence time of the material within the capillary. The steps to in situ crosslinking
include: (i) selecting a desired bioink (macromer, crosslinker, initiator/concentration), (ii)
characterizing the gelation behavior for this bioink using the light wavelength and intensity
available for the printing setup, and (iii) designing the capillary (width/length) and bioink
flow rate for crosslinking to occur prior to deposition.

For example, as the bioink’s

residence time within the capillary increases (e.g., increased capillary length, lower
volumetric flow rate), the light exposure time and time permitted for in situ crosslinking
increases, resulting in elevated crosslinking until maximum conversions are reached.
Similarly, increased reaction rates (e.g., increased initiator concentration or light intensity)
increase the rate of gelation and support altered printing setups (e.g., lower capillary
lengths). Attention should be given to the exposure of cells to any harmful components
(radicals, shear forces), but the photoencapsulation of cells and extrusion of cells from
needles has now been performed extensively, and any issues are mitigated by following
general considerations of these prior studies.44–46 Too much curing during printing should
also be considered, as it may lead to clogging of the capillary during the curing process.
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HA-based hydrogels are of particular interest in cartilage repair since HA is a
natural component of cartilage, biodegradable, non-toxic, and may be easily modified to
form hydrogels with a range of properties; in addition, HA is already used in numerous
clinical applications, such as in joint viscosupplements or tissue-fillers.47 Therefore, NorHA
was selected as a photocrosslinkable macromer to comprise our bioink for engineering
cartilage. NorHA is crosslinked into hydrogels via a thiol-ene reaction, where radical
species are first generated (e.g., light exposure of a photoinitiator) to subsequently form
reactive thiyl radical intermediates in the presence of thiol-containing molecules; these
intermediates may then undergo reactions with free norbornene groups.33 Here, the
photoinitiator LAP was selected since it is a water-soluble, visible light photoinitiator that
has limited cytotoxicity and has been previously employed towards the formation of HAbased hydrogels.48 Although visible light is used in this approach, macromer solutions
were still stable under ambient light and the process can be used across a wide range of
wavelengths with the appropriate initiator systems. Further, DTT was selected as the dithiol crosslinker due to previous use in cell encapsulation.49
To implement this in situ crosslinking approach, careful consideration must first be
given to the distinct components incorporated into the bioink (Figure 4.4a). NorHA was
used at a relatively low concentration (2 wt%), as it has been previously shown that lower
crosslink densities give rise to hydrogels with increased nutrient transport and ECM
dispersion by encapsulated cells.35 Similarly, the concentration of LAP (0.05 wt%) was
selected to ensure appreciably quick gelation kinetics while mitigating any potential
cytotoxic effects. Varying DTT concentration has been shown to modulate the mechanics
of NorHA hydrogels, as the degree of crosslinking is dependent on the number of
crosslinks formed;32 thus, 0.08 wt% DTT (ca. 5.2 mM) was used in the identified bioink to
obtain gels with compressive moduli of approximately 6 kPa. The light absorbance of the
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bioink is dependent upon the selection of these components and their concentrations;
thus, we characterized absorbance to understand both radical generation and potential
light transmittance across the capillary.

Significant light attenuation can alter the

uniformity of reaction across the capillary and should be minimized where possible to
reduce filament heterogeneity.

To address this, quantitative Beer-Lambert Law

calculations were performed to determine how light intensity varies during printing as a
function of light wavelength, ink formulation, and capillary width (Figure 4.5). These
calculations were imperative for elucidating the reaction conditions experienced by NorHA
bioinks during the in situ crosslinking process.
With these irradiation conditions determined, photorheology experiments were
performed to identify how user-defined printing parameters (capillary length, bioink flow
rate, and light intensity) influenced the in situ crosslinking printing process. Specifically,
bioink gelation profiles were created to demonstrate how the extent of reaction within the
photopermeable capillary effects bioink printability. Longer capillary lengths resulted in
greater ink residence times within the capillary, effectively increasing the extent of thiolene reaction and degree of ink crosslinking. This phenomenon was demonstrated by
representative prints fabricated at variable capillary lengths (Figure 4.8a). Under these
printing conditions, both 15 mm and 30 mm capillaries did not permit sufficient time for
stable overlaying filaments to form, resulting in unstable filament structures. While the final
capillary length evaluated resulted in successful filaments (60 mm), it is important to note
that if the capillary length is too long, inks may clog the capillary over time, compromising
printability and giving rise to high shear forces. Clogging of the capillary could indicate
interactions at the capillary interface with the hydrogel filament, which may be overcome
through capillary selection or treatment of the lumen.
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As expected, printing with faster bioink flow rates resulted in shorter ink residence
times within the capillary and printing of unstable filaments, whereas printing with slower
flow rates resulted in more precise filaments and sufficient time for the thiol-ene reaction
to proceed (Figure 4.8b). Lower light intensities (I1=5 mW/cm2) reduced the rate of
polymerization within the capillary during printing, such that unstable filaments were
formed; however, stable filaments were readily printed when I1=10 mW/cm2 and I1=15
mW/cm2 (Figure 4.8c). While suitable print resolution was obtained with these print
conditions at I1=15 mW/cm2, capillary clogging commonly occurred, suggesting that an
upper-limit of printability exists. Thus, there is a balance between appropriate curing
conditions to obtain stable filaments and the potential for clogging of the capillary with
extended residence times or too rapid of crosslinking (i.e., increased light intensity).
Upon identifying permissible printing conditions via photorheology time sweeps,
NorHA bioinks were printed via in situ crosslinking to form multilayered constructs of
various shapes, including condyles and simple discs that could be used for cell culture.
The process was cytocompatible, as the in situ photocrosslinking of NorHA bioinks
resulted in constructs with high cell viability (>85% at 7 days after printing) and
homogenously distributed MSCs. Variations in cell densities may be a concern with very
long print times, but this was not an issue with the printing regimes used in the current
study. There was no change in cell numbers over the first week of culture, likely due to
encapsulation

in

the

covalently

crosslinked

hydrogel

and

MSCs

undergoing

chondrogenesis. Further, these inks could be printed into constructs amenable to longterm culture and tissue formation. With 56 days of culture in chondrogenic media, printed
constructs exhibited significant increases in compressive moduli and biochemical content
associated with cartilaginous tissue. Histological analyses validated the production of both
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GAG and COL by encapsulated MSCs, indicating the formation and maturation of
neocartilage.
An important consideration in the design of hydrogels for cartilage tissue
engineering is their ability to degrade, as it has been shown that hydrogels that can readily
degrade enable improved tissue formation and matrix distribution by encapsulated
cells.50,51 Since NorHA hydrogels were filled with extracellular matrix upon culture, we
were unable to monitor NorHA degradation in the presence of cells; however, the
elaboration of this matrix by encapsulated cells indicates that NorHA hydrogels support
cartilage formation. Importantly, the degradability of NorHA hydrogels can be tuned if
desired via the incorporation of degradable (e.g., matrix metalloproteinase-degradable)
crosslinkers.31 The success of this study, including printed construct stability over time,
cell viability, and tissue formation, validates the approach presented here to use in situ
crosslinking to 3D print a selected bioink. Towards translating these printed tissue
constructs in the future; it will be important to consider how neocartilage may be integrated
into articular focal defects for the repair of diseased cartilage. It is expected that with the
development of ex vivo osteochondral defect models52 and hydrogel adhesives,53
constructs printed via in situ crosslinking may be amenable to implantation.

4.4

CONCLUSIONS
The example presented here with the visible light crosslinking of NorHA to

encapsulate MSCs towards chondrogenesis and cartilage formation is only meant to be
illustrative of this printing approach. The bioink composition can be greatly varied across
macromers that undergo crosslinking through light exposure, including both radical
polymerizations or thiol-ene reactions in the presence of photoinitiators.54 For example,
Vega et al. recently developed a screening platform to identify optimal cellular
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environments within photocrosslinkable hydrogels.49 Bioinks can then be readily designed
from information from these types of screening platforms and implemented into the in situ
crosslinking 3D printing approach. Further, the applications of printed constructs using this
approach can be easily expanded depending on the cell types and tissue of interest, and
include not only for clinical applications of tissue repair, but also for in vitro models to probe
fundamental biological questions or for drug screening.
4.5
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CHAPTER 5: FABRICATION OF MSC-LADEN COMPOSITES OF HYALURONIC
ACID HYDROGELS REINFORCED WITH MEW SCAFFOLDS FOR CARTILAGE
REPAIR
The following chapter is adapted from:
Galarraga, J.H., Locke, R.C., Witherel, C.W., Stoeckl, B.D., Castilho, M., Mauck, R.L.,
Malda, J., Levato, R., Burdick, J.A., Fabrication of MSC-laden composites of hyaluronic
acid hydrogels reinforced with MEW scaffolds for cartilage
repair. Biofabrication 14, 014106 (2021).
5.1

INTRODUCTION
Articular cartilage damage is a pervasive problem that significantly inhibits quality

of life and joint mobility in afflicted patients 1. Focal defects on the articulating surface of
joints may form in patients due to trauma, sports injuries, or daily activities associated with
joint function 2. Native cartilage unfortunately does not possess significant regenerative
capacity 3, and these defects may further progress if left untreated, resulting in significant
pain and dysfunction 4. To this end, a number of clinical approaches have been developed
for cartilage defect repair, including microfracture, mosaicplasty, and matrix-assisted
chondrocyte implantation (MACI) 5. However, despite their promise, these surgical
procedures often result in repair cartilage with inferior composition and mechanical
properties when compared to healthy hyaline cartilage 1,6,7. Thus, there is a continued and
significant clinical need for the development of new approaches that support the
restoration of functional cartilage.
Hydrogels have emerged as a promising approach for the encapsulation of cells
that then synthesize and organize nascent cartilagenous extracellular matrix. A range of
materials have been used for the formation of neocartilage from cell-laden hydrogels 8,
and advancements in both hydrogel processing and our ability to incorporate
physiochemical cues within hydrogels (e.g., patterning of singaling ligands, controlled
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release of biochemical signals) have improved the quality of engineered cartilage in vitro
9

. Towards translating these hydrogels into the clinic, biofabrication approaches have

enabled the fabrication of cell-laden hydrogels with patient-specific geometries and high
porosity. For instance, the biopen is a handheld device that permits extrusion of bioinks
into focal cartilage defects intraoperatively, such that cartilage repair can occur in situ
within defects

10,11

. Other extrusion-based bioprinting techniques have facilitated the

expansion of candidate bioinks for cartilage tissue engineering

12

, while lithographic and

new tomographic bioprinting approaches have drastically improved the resolution and
13,14

throughput with which cell-laden implants can be engineered

. Despite these recent

advances in bioprinting, one of the persistent challenges associated with engineering
hydrogels for cartilage tissue engineering is the balance of two, opposing design criteria.
Specifically, hydrogels with large mesh sizes are promising candidates given their ability
to maintain cell viability and to promote the distribution of deposited matrix, but these
hydrogels have much lower initial mechanical properties 15,16.
Hydrogels with tunable degradability have been engineered to address this
challenge, such that higher initial mechanical properties can be achieved while cellmediated enzymatic degradation ensures that the mesh size increases over time,
permitting matrix distribution and cartilage maturation

17

. Similarly, hydrolytically

degradable polyethylene glycol (PEG) and hyaluronic acid (HA) hydrogels were designed
to improve matrix production and distribution by encapsulated chondrocytes and
mesenchymal stromal cells (MSCs), respectively, when compared to non-degradable
hydrogel controls 18,19. However, these approaches are generally still limited with regards
to initial hydrogel mechanics due to cell viability concerns and they also require that the
rate of hydrogel degradation be carefully balanced with the rate of tissue formation and
maturation to maintain mechanical properties 20.
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Alternatively, a range of strategies have been employed to enhance the mechanical
properties of hydrogels for cartilage repair. Interpenetrating network (IPN) hydrogels,
which are composed of multiple interdigitating networks, are one approach to engineering
hydrogels with high toughness. By tuning the properties of combined brittle and ductile
networks at the molecular scale, non-additive increases in hydrogel moduli can be
achieved

21

. As an alternative, extruded polycaprolactone (PCL) may be incorporated

within 3D printed hydrogels (e.g., fibrin-collagen, alginate, agarose, PEG) containing
encapsulated chondrocytes or MSCs for cartilage formation

22–26

. PCL is a well-

established biomaterial with extended degradation profiles and significantly higher moduli
than traditional hydrogels, such that its combination with hydrogels results in improved
mechanical integrity. To this end, electrospun nanofibrous PCL scaffolds have also been
incorporated into bioprinted hydrogels to improve both the shape fidelity and mechanical
properties of fabricated construct.27 In another approach, IPNs composed of alginate and
methacryloyl-modified gelatin (GelMA) were reinforced with 3D printed PCL templates
towards recapitulating the tension-compression non-linearity of native cartilage.28,29 A
multi-head printing setup enabled fabrication of these composites with encapsulated
MSCs and chondrocytes toward the formation of hyaline cartilage.28 However, while IPNs
or composite scaffolds containing PCL may improve the mechanical properties of cellladen hydrogels, these approaches can also reduce the relative volume available for the
formation of new tissue by embedded cells.30
In response to this design limitation, reinforcement of printed gelatin-methacryloyl
(GelMA) hydrogels with PCL microfibers has been achieved via melt-electrowriting
(MEW).31,32 MEW is a biofabrication process that allows for the controlled deposition of
electrically charged polymer melt fibers in a layer-by-layer manne.33 Similar to
conventional electrospinning, a voltage source is applied to a polymer to extract the
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material from a spinneret onto a collector. However, unlike electrospinning, where large
distances between the spinneret and collector typically lead to whipping instabilities and
unpredictable flow behaviors, MEW permits control over a stable polymer jet. The high
viscosity of the polymer melt, along with a reduced spinneret-to-collector distance and the
applied voltage source helps to stabilize the flow of polymer melt so that it may be
predictably and directly written onto a computer-controlled collector. After controlled
deposition, the rapid cooling of the polymer melt gives rise to a stable, fiber structure.
Thus, the advantage of MEW over electrospinning is its ability to finely control the
organization of polymer melt fibers to fabricate user-defined geometries. Moreover, highly
porous, microfiber meshes can be printed via MEW at even submicron resolutions that
are not possible via traditional extrusion 3D printing.34
Hyaluronic acid (HA)-based hydrogels are a specific class of hydrogels that have
been shown to support the chondrogenesis of MSCs and chondrocytes, but exhibit the
aforementioned limitations with significantly inferior mechanical properties when
compared to native cartilage.35 In consideration of advances in the biofabrication field, the
overall aim of this study was to introduce MEW reinforcement into engineered HA
hydrogels to meet desired design criteria for cartilage repair. To do this, we first screened
formulations of norbornene-modified HA (NorHA) across varied crosslinking densities to
identify a hydrogel formulation that would be most permissive to the formation of
neocartilage. Next, MEW meshes were introduced into NorHA hydrogels to increase the
initial mechanical properties and stability of these soft hydrogels.31 Last, composites of
NorHA and MEW meshes were assessed for their integration potential with native
cartilage rings. Acellular composites, cell-laden composites, and pre-cultured cell-laden
composites were press-fit into cartilage rings, and their integration within rings was
compared to autologous cartilage controls. These studies collectively demonstrate that
171

NorHA-MEW composites maximize the chondrogenesis of encapsulated MSCs while
increasing the mechanical properties of hydrogels, both initially and over extended culture
periods, suggesting that composites may improve in vivo integration and cartilage
formation in future studies.

5.2

METHODS

5.2.1

Materials
Sodium HA was purchased from Lifecore Biomedical (Chaska, MN) and lithium

phenyl-2,4,6-trimethylbenzoylphosphinate

(LAP)

was

purchased

from

Colorado

Photopolymer Solutions (Boulder, CO). Unless otherwise specified, all other reagents and
materials were purchased from Sigma-Aldrich (St. Louis, MO).
5.2.2

Hydrogel Fabrication and Characterization

5.2.2.1 NorHA Synthesis
NorHA was synthesized as previously reported.36 Briefly, sodium HA was first
converted into its tetrabutylammonium salt form (HA-TBA) and then modified with
norbornene

functional

groups

via

benzotriazole-1-yl-oxy-tris-(dimethylamino)-

phosphonium hexafluorophosphate (BOP) coupling. After dissolving sodium HA in distilled
water, Dowex 50Wx200 resin was added to the solution in a 3:1 mass ratio. The solution
was then mixed for 30 minutes, and Dowex resin was subsequently removed via vacuum
filtration. Thereafter, the filtrate was titrated with tetrabutylammonium hydroxide solution
to a pH of 7.02–7.05, frozen, and lyophilized. The resulting lyophilized HA-TBA and 5norbornene-2-methylamine were then dissolved in anhydrous dimethyl sulfoxide (DMSO)
under inert nitrogen. BOP was then added to the reaction solution via cannulation and the
reaction proceeded for 2 hours at room temperature. The reaction was quenched with the
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addition of cold distilled water and subsequently dialyzed for 5 days. Any precipitates
within the crude product solution were then removed via filtration and the solution was
dialyzed for an additional 3-5 days. After freezing and lyophilizing the synthesized NorHA,
the extent of norbornene modification was determined via 1H-NMR to be ~22% of the
disaccharide repeat units of HA (Figure 5.1).

Figure 5.1: 1H-NMR spectra of synthesized NorHA. To characterize the degree of
norbornene modification on the backbone of HA, the vinyl protons of norbornene (2H, ~5.86.3 ppm) were integrated and compared to the integration value of the methyl group of HA
(3H, ~1.8-2.0 ppm). ~22% of the disaccharide repeat units of HA were modified with
norbornene groups.

5.2.2.2 Hydrogel Fabrication
Lyophilized NorHA macromer was dissolved in phosphate buffered saline (PBS)
and LAP photoinitiator was added to a final concentration of 0.05%. DL-dithiothreitol (DTT)
was subsequently added at concentrations of 0.54 mM, 2.17 mM, 5.71 mM, or 13.58 mM
(to obtain compressive moduli of approximately 2, 6, 20, and 60 kPa, respectively). After
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all precursor materials were thoroughly mixed, hydrogels were cast into molds (diameter
~4.8 mm) and irradiated with blue light (400-500 nm, Omnicure lamp with an affixed
collimator, I=10 mW/cm2) for 5 minutes.
5.2.2.3 Compression Testing
To evaluate the compressive properties of hydrogels, samples were subjected to
unconfined, uniaxial compressive testing with a constant loading rate of 0.2 N/min (Q800
DMA, TA Instruments). The compressive modulus was then quantified as the slope of the
stress-strain curves between 10-20% strain.
5.2.3

Cell Culture and Characterization of MSC-Laden Constructs

5.2.3.1 Cell/tissue Isolation and Culture
Juvenile bovine knee joints were obtained (Research 87, Boylston, MA) and
dissected under sterile conditions as previously described.16 Femoral bone marrow was
extracted and MSCs were isolated via plastic adherence during culture in Dulbecco’s
modified eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and
1% penicillin/streptomycin (P/S). After expansion, MSCs were washed, trypsinized
(0.05%), centrifuged, and resuspended in PBS for use. NorHA macromer solution with
sterile filtered LAP and DTT was prepared as described above prior to the suspension and
encapsulation of MSCs (P1, 20 × 106 cells/mL) with blue light exposure. Constructs were
subsequently cultured in chondrogenic media (1% ITS+; 2.50 µg/mL amphotericin B;
1 × 10−3 M sodium pyruvate; 50 µg/mL ascorbic acid 2-phosphate; 40 µg/mL L-proline;
1 × 10−7 M dexamethasone; 10 ng/mL TGF-B3) for up to 56 days.
5.2.3.2 Cell Viability
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To evaluate the cytocompatibility of constructs, hydrogels were stained with
calcein AM and ethidium homodimer (0, 3, 7 days) in accordance with manufacturer’s
instructions (Invitrogen). Cell viability was quantified via analysis of confocal images (Leica
SP5) using Image J software. Viability was calculated as the number of live cells per total
cells within an image (n ≥ 3 hydrogels, 9 images per sample).
5.2.3.3 Gene Expression Analysis and Biochemical Assays
Each sample was immediately placed in 1 mL ice-cold TRIzol (Invitrogen) and
stored at -80°C for later RNA isolation. Pre-processing of samples was performed by first
homogenizing samples in TRIzol on ice, subsequently adding 0.2 mL of chloroform,
vigorously shaking by hand for 15 seconds, and centrifuging for 15 minutes at 4°C. RNA
was then isolated by collecting and mixing the aqueous layer with equal-parts 70% ethanol
via pipetting and proceeding with the RNeasy Mini kit (QIAGEN) per manufacturer’s
instructions; isolated RNA concentrations were then quantified (NanoDrop 1000). RNA
was processed with DNase to remove any DNA impurities and then reverse-transcribed
into cDNA using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems).
qRT-PCR reactions were performed with 10ng cDNA and Taqman probes (Life
Technologies, Table 5.1); type I collagen (Col1a1), type II collagen (Col2a1), aggrecan
(ACAN), and SOX9 were selected as targets, with glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) used as a housekeeping gene. Relative gene expression of
experimental samples was determined using the ΔΔCT method and MSCs expanded on
tissue culture plastic as the control.37
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Table 5.1: qRT-PCR bovine Taqman primers.

Gene

Assay ID

GAPDH

Bt03210913_g1

COL1A1

Bt03225322_m1

COL2A1

Bt03251861_m1

ACAN

Bt03212186_m1

SOX9

Bt07108872_m1

To quantify the biochemical content of cell-laden constructs, samples were minced
and digested via overnight incubation at 60°C in solution containing papain and
hyaluronidase (0.56 U/mL papain and 750-3000 U/mL hyaluronidase were dissolved in
buffer containing 0.1 M sodium acetate, 10 M cysteine hydrochloric acid, and 0.05 M
ethylenediaminetetraacetic acid). The dimethylmethylene blue assay was utilized to
quantify the sulfated glycosaminoglycan (sGAG) content, the hydroxyproline (OHP) assay
was performed to determine collagen content (Abcam Hydroxyproline Assay Kit,
ab222941), and the Picogreen dsDNA assay was performed to measure total DNA content
within cultured constructs.38
5.2.3.4 Histology and Immunohistochemistry
After culture, constructs were fixed in 10% formalin for two hours at room
temperature and then washed in PBS. Samples were then dehydrated, embedded in
paraffin, and sectioned (5 μm) prior to staining. Sulfated glycosaminoglycan (sGAG)
deposition by embedded cells was visualized via Alcian blue staining (1%, pH 1.0,
Newcomer Supply), while deposition of type I and type II collagen were visualized via
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labeling with anti-collagen type I (COL I, mouse monoclonal anti-collagen type 1, Millipore
Sigma) and anti-collagen type II (COL II, mouse monoclonal anti-collagen type II,
Developmental Studies Hybridoma Bank) antibodies and staining with DAB chromogen
(Millipore Sigma). To quantify staining intensity, acquired images were converted to 8-bit
and then inverted.39 For each sample section, the mean intensities for three separate and
randomly selected frames were measured in Image J.

5.2.4

Composite fabrication and characterization

5.2.4.1 MEW of PCL Meshes
Box-structured meshes (4 x 4 cm2) composed of polycaprolactone (Purasorb PC
12, Corbion Inc., Gorinchem, Netherlands) were fabricated with 70 layers (1 mm height)
of overlaying fibers (layered in orthogonal directions) as previously described.40 A custombuilt MEW device equipped with an electrical heating system (TR 400, HKEtec, Germany;
heating temperature = 90 °C) was used to feed PCL polymer melt (feed pressure = 3 bar)
through a 23G spinneret charged by a high voltage power supply (LNC 10000–5 pos,
Heinzinger Electronic GmbH, Rosenheim, Germany). Processed PCL fibers were then
collected on a computer-controlled collector plate (acceleration voltage=5.5 kV, spinning
gap= 3.3 mm, E = 1.3 kV/mm). Each mesh was fabricated with a 90° lay-down pattern and
the spacing between deposited fibers was 200µm, 400 µm or 800 µm. Disc-shaped mesh
constructs were obtained from printed MEW meshes using a 4 mm biopsy punch.
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5.2.4.2 Composite Fabrication
To create composites combining NorHA hydrogels and PCL meshes, lyophilized
NorHA macromer and meshes (4 mm diameter, 1 mm height) were first sterilized via
irradiation with a germicidal lamp in a laminar flow hood. Thereafter, NorHA (matching the
formulation for 2 kPa hydrogels from above) was dissolved in PBS along with sterile
filtered LAP and DTT. Juvenile bovine MSCs were then trypsinized (0.05%), counted, and
suspended in the macromer solution (P1, 20 x 106 cells/mL). This solution was then
carefully pipetted on top of MEW meshes and allowed to fill into the interstitial spaces of
the box-structured scaffolds.41 Meshes were then flipped, so that additional macromer
could be pipetted on the other side. Finally, macromer was crosslinked within the meshes
via photocrosslinking with visible light irradiation as described above.
Cells and meshes within composites were visualized using CellTracker Red
(Invitrogen)

and

fluorescein

isothiocyanate-bovine

serum

albumin

(FITC-BSA),

respectively, and were imaged via confocal microscopy. The density of cells within the top
100 μm and bottom 100 μm of composites was calculated by counting the total number of
cells within randomly placed 600 × 600 μm2 image frames (n ≥ 3 hydrogels, 9 images per
group). Composites were cultured in chondrogenic media for up to 56 days and
characterized

for

cell

viability,

gene

expression,

biochemical

content,

histology/immunohistochemistry, and biomechanics as described above and compared to
hydrogels alone.
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5.2.5

Assessment of ex vivo integration capacity

5.2.5.1 Fabrication of press-fit constructs in cartilage ring explants
Juvenile bovine joints were dissected in a similar fashion as previously described
and osteochondral plugs were biopsied from the trochlear groove to obtain cartilage
explants for ex vivo integration studies. After conditioning osteochondral plugs in serumfree expansion media for 1-2 days (DMEM; 1% P/S; 10mM HEPES, 0.1 mM non-essential
amino acids; 2.50 µg/mL amphotericin B; 1 × 10−3 M sodium pyruvate; 50 µg/mL ascorbic
acid 2-phosphate; 40 µg/mL L-proline),42 cartilage rings were isolated and prepared (8 mm
outer diameter, 4 mm inner diameter, 1 mm thickness) such that acellular composites,
cell-laden composites (i.e., composites immediately after MSC encapsulation), or cellladen composites that were pre-cultured for 28 days in chondrogenic media (cellladen+PC) could be press-fit into the inner cores of cartilage rings. As a control, biopsied
autologous cartilage was press-fit back into the inner cores of rings. Each of these four
different press-fit constructs (i.e., autologous cartilage control, acellular, cell-laden, cellladen+PC) were then cultured within cartilage rings in chondrogenic media for 28 days.
5.2.5.2 Push-Out Testing
The integration strength (i.e., failure stress) of press-fit constructs cultured within
explanted cartilage rings was determined via push-out testing as previously described.43
Briefly, an indenter (3.8 mm) was affixed to an Instron 5848 testing device and used to
push out the central core of the cartilage constructs (0.2 mm/s). The failure stress was
calculated by dividing the load at failure by the lateral surface area of press-fit constructs
(i.e., interfacial area).
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5.2.5.3 MicroCT and Interfacial Contact Area
The integration strength (i.e., failure stress) of press-fit constructs cultured within
explanted cartilage rings was determined via push-out testing as previously described 33.
Briefly, an indenter (3.8 mm) was affixed to an Instron 5848 testing device and used to
push out the central core of the cartilage constructs (0.2 mm/s). The failure stress was
calculated by dividing the load at failure by the lateral surface area of press-fit constructs
(i.e., interfacial area).
5.2.6

Statistical Analysis
All statistical analyses were performed using GraphPad Prism 9 software, data are

reported as mean ± standard deviation, and significance for all performed analyses was
determined at p<0.05. Two-way ANOVAs were performed with construct formulation and
culture time set as independent variables, and multiple comparisons were performed with
α=0.05 and Tukey's honestly significant difference (HSD) post-hoc test. Comparisons
between just two groups were made via student t-tests with two-tailed criteria. For
comparisons between more than two groups, one-way ANOVAs were performed, with
Tukey's HSD post-hoc test; Kruskal–Wallis tests were performed for non-parametric
comparisons (normality assessed via Shapiro-Wilk test, α=0.05), with multiple
comparisons performed via Dunn’s multiple comparison test.

5.3

RESULTS AND DISCUSSION

5.3.1

Influence of Crosslink Density on Cartilage Formation in NorHA Hydrogels
When designing hydrogels for cartilage tissue engineering, consideration must be

given to the choice of material used as well as the crosslinking chemistry selected. Here
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we chose HA, due to its native presence in cartilage and roles in development, wound
healing, and natural extracellular matrix (ECM) organization and maintenance.44 HA
possesses innate bioactivity, can be readily degraded by hyaluronidases and oxidative
species, and can be easily modified with pendant functional groups for crosslinking, all of
which supports its use in tissue engineering applications.45 In this work, we modified HA
with norbornene groups for crosslinking via thiol-ene photocrosslinking (Figure 5.2a),
which enables the crosslink density to be easily modulated by the crosslinker
concentration used during the step-growth crosslinking reaction.46

Figure 5.2: NorHA hydrogels with varied crosslink densities. (a) Hyaluronic acid modified
with norbornene (NorHA) groups undergoes thiol-ene crosslinking in the presence of a dithiol
crosslinker (DL-dithiothreitol, DTT), LAP photoinitiator, and visible light. (b) The crosslink
density and compressive moduli of NorHA hydrogels are tuned (i.e., 2-60 kPa) via the polymer
concentration (w/v%) and the extent of macromer crosslinking (thiol-to-norbornene ratio:
XDTT). ****p<0.0001, n=3.

Although other modifications are possible (e.g., methacrylation or MeHA), it is
challenging to modify crosslinking due to the uncontrolled radical polymerization used for
gelation.16 Further, the use of NorHA not only allows for more modular control of hydrogel
crosslinking, but also enables photopatterning with signaling ligands (i.e., peptides) of
interest.36
By changing both the macromer concentration and crosslinker concentration,
NorHA hydrogels ranging from ~2 to 60 kPa (Figure 5.2b) were fabricated and are
hereafter referred to by their approximate initial compressive moduli (i.e., 2 kPa, 6 kPa,
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20 kPa, 60 kPa). Since the crosslink density of hydrogels has been previously shown to
influence both encapsulated cell viability and matrix distribution by encapsulated cells,15,
we first aimed to identify which hydrogel formulation best supported the viability and
chondrogenesis of encapsulated MSCs. While softer, more loosely crosslinked
hydrogels (i.e., 2 kPa, 6 kPa) exhibited high cell viability after 7 days of culture (~90%),
more densely crosslinked hydrogels (i.e., 20 kPa, 60 kPa) resulted in significant loss in
cell viability over time (Figure 5.3).

Figure 5.3: Viability of NorHA hydrogels with varied crosslink densities. Representative
images (day 0, 3, and 7) and quantification of encapsulated MSC viability in NorHA hydrogels,
where live cells (green) and dead cells (red) are stained with calcein AM and ethidium
homodimer, respectively. *p<0.01, **p<0.005, ***p<0.001, ****p<0.0001, n=3.

Past fluorescent recovery after photobleaching (FRAP) studies in NorHA
hydrogels suggest that the relative diffusivity of macromolecules within these networks
decreases with increasing crosslink density, which may explain the observed differences
in cell viability in these hydrogels.47
To assess the ability of these hydrogel formulations to support MSC
chondrogenesis and cartilage formation, cell-laden hydrogels were cultured for up to 56
days in chondrogenic media and characterized for gene expression, mechanical
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properties, and biochemical content. All hydrogels exhibited increased expression of
aggrecan and type II collagen over time, both of which are hallmark ECM components of
hyaline cartilage and suggest that embedded MSCs underwent chondrogenesis (Figure
5.4a). Generally, expression of each of these genes increased the most within the first
week of culture. Importantly, encapsulated MSCs also expressed SOX9, a marker of
chondrogenesis,48 at early culture times, and type I collagen expression was low and
decreased over culture time for 2 kPa hydrogels (Figure 5.5).

Figure 5.4: Influence of NorHA crosslink density on MSC chondrogenesis and
neocartilage formation. Mesenchymal stromal cell (MSC)-laden hydrogels are cultured in
chondrogenic media for up to 56 days and assessed for (a) chondrogenic gene expression
(Aggrecan, Type II Collagen), (b) compressive moduli, and (c) biochemical content (DNA,
sulfated glycosaminoglycan (sGAG), and collagen (COL)) after 0 (light gray), 7 (dark gray), 28
(blue), and 56 (teal) days of culture in chondrogenic media. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001, n≥3, individual one-way ANOVAs (20 kPa) or Kruskal–Wallis tests (2,6,60 kPa)
performed for each hydrogel formulation for qRT-PCR data.
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Figure 5.5: Influence of NorHA crosslink density on MSC gene expression. Relative gene
expression of (a) type I collagen (COL1A1) and (b) SOX9 in NorHA hydrogels of varied moduli
when cultured in chondrogenic media for up to 56 days. *p<0.05, **p<0.01, ***p<0.001, n≥4,
with individual one-way ANOVAs or Kruskal–Wallis tests performed for each hydrogel
formulation.

The appearance of each hydrogel formulation noticeably changed over 56 days of
culture. While more loosely crosslinked hydrogels turned opaque, suggesting the
elaboration of neotissue by embedded cells, 60 kPa hydrogels remained relatively
translucent (Figure 5.6).

Figure 5.6: Representative gross images of MSC-laden NorHA hydrogels. After 56 days
of culture in chondrogenic media, more loosely crosslinked hydrogels exhibited an opacity
resembling neocartilage, while more densely crosslinked hydrogels (i.e., 60 kPa) remained
translucent after culture.
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All hydrogels also increased in compressive modulus with culture, although to
varying extents based on initial crosslinking density (Figure 5.4b). 2 kPa NorHA hydrogels
resulted in the formation of cartilage with the highest compressive properties, reaching a
compressive modulus of 102.6 ±5.4 kPa after 28 days and 221.4±33.0 kPa after 56 days.
No other group reached values higher than 100 kPa, even after 56 days of culture, and
the 60 kPa NorHA hydrogels barely increased in modulus with culture. These observed
differences in compressive moduli were supported by the relative differences in
biochemical content across each hydrogel formulation (Figure 5.4c). 2 kPa hydrogels
resulted in significant increases in DNA content with culture, likely due to some degree of
cell proliferation, whereas the DNA content within 6 kPa hydrogels and higher were much
more modest and did not significantly change throughout the duration of culture. 60 kPa
hydrogels exhibited decreasing DNA content over time consistent with the observed
reduction in cell viability (Figure 5.3). With regards to biochemical content, 2 kPa
hydrogels exhibited the largest increases in sulfated glycosaminoglycan (sGAG) and
collagen (COL) contents with culture. 6 kPa and 20 kPa hydrogels similarly showed
significant increases in both sGAG and COL content over the course of 56 days of culture,
albeit with lower total amounts produced when compared to the 2 kPa group. Minimal
changes in sGAG or COL content were observed with the 60 kPa formulation.
These results indicate that softer NorHA hydrogels result in neocartilage with
improved functional properties, and so we next aimed to elucidate the organization of
nascent matrix within these hydrogels via histology for sGAG and immunohistochemistry
for type I and type II collagen (Figures 5.7-5.9). Alcian blue staining for sGAG revealed
that 2 kPa hydrogels support increased sGAG deposition and dispersion, as indicated by
significant increases in staining intensity between 28 and 56 days of culture (Figure 5.7).
Moreover, 2 kPa hydrogels stained much more intensely and uniformly than the other
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investigated formulations, particularly at day 56. These results are consistent with past
observations in MeHA hydrogels16 and recent studies that demonstrated that the extent of
nascent matrix dispersion decreases with increasing NorHA crosslink density.47

Figure 5.7: Influence of NorHA crosslink density on matrix production and distribution.
Representative images and quantification of matrix distribution within NorHA hydrogels after
28 and 56 days of culture for (a) sulfated glycosaminoglycans (sGAG) via Alcian blue staining
or (b) type II collagen (COLII) via immunohistochemistry. *p<0.05, **p<0.01, ***p<0.001,
****p<0.0001, n=45 images, 5 sections, 3 constructs.
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Figure 5.8: Alcian Blue and Collagen Immunohistochemistry. Representative images of
Alcian blue staining and type II collagen immunohistochemistry for NorHA hydrogels at day 0
with varied crosslink densities.

Figure 5.9: Influence of NorHA crosslink density on type I collagen elaboration and
distribution. Representative images (days 0, 28, and 56) and quantification of type I collagen
(COLI) distribution within NorHA hydrogels via type I collagen immunohistochemistry. *p<0.05,
**p<0.01, ***p<0.001, ****p<0.0001, n=45 images, 5 sections, 3 constructs.

These observed differences can be attributed to the hydrogel network being
more permissive to matrix dispersion due to its increased mesh size,49 as well as the
increased cell viability in less crosslinked formulations. Similar trends were observed for
type II collagen staining, as 2 kPa hydrogels exhibited type II collagen that extended
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beyond the pericellular space of embedded cells and that was more homogenous
(Figure 5.7b). In contrast, dark staining localized around cells was observed in 6 kPa
hydrogels after 56 days of culture, and both 20 kPa and 60 kPa hydrogels exhibited
minimal type II collagen staining. Importantly, all hydrogels resulted in minimal type I
collagen deposition over culture time, suggesting that hyaline-like cartilage formed within
hydrogels as opposed to fibrocartilage, which is composed of more type I collagen
(Figure 5.9). Taken together, these results indicate that 2 kPa NorHA hydrogels support
the formation of neocartilage in vitro, likely due to an increased mesh size that allows for
increased matrix distribution and increased viability. The greater than 100-fold increase
in compressive modulus achieved in these hydrogels over the culture period is
particularly promising; however, the application of these soft hydrogels for tissue
engineering is still limited by their initial mechanical properties, especially in terms of
handling and stability
5.3.2

Reinforcement of NorHA Hydrogels with MEW Meshes
To address the limitations of soft hydrogels, we reinforced the hydrogels with a

secondary, microfiber mesh. Since MEW meshes can be readily incorporated within
hydrogels to increase their compressive properties,31,50 we first demonstrated that
composites composed of NorHA hydrogels and polycaprolactone (PCL) box-structured
meshes could be formed by curing NorHA macromer within the interstitial spaces of MEW
meshes (Figure 5.10a). The spacing between overlaying fibers within meshes was readily
tuned between 200 μm and 800 μm to change the overall fiber density and porosity of the
mesh (Figure 5.10b). Interestingly, combinations of NorHA hydrogel with PCL meshes
led to synergistic increases in compressive moduli, including an ~50-fold increase from
the initial hydrogel modulus. The increase in mechanics is attributed to the ability of the
hydrogel to mitigate MEW fiber buckling, which effectively increases the load-carrying
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capacity of MEW meshes since the PCL fibers can resist deformation in the transverse
direction when loaded in compression.40 Similarly, the presence of PCL fibers surrounding
the NorHA hydrogel decreases the rate of water efflux from the hydrogel (i.e., syneresis)
upon loading, further increasing the mechanical properties of the entire composite. The
observed increases in compressive moduli are also consistent with similar composite
systems that have leveraged MEW meshes to reinforce alternative hydrogels (i.e., gelatin,
alginate, PEG, fibrin).31,51,52

Figure 5.10: PCL meshes reinforce NorHA hydrogels. (a) (i) Schematic of the meltelectrowriting process (MEW) employed to fabricate fibrous PCL meshes. PCL is heated to
form a polymer melt that can be readily extruded though a printhead with an attached voltage
source to deposit PCL onto a grounded print bed. (ii) PCL meshes are then filled with NorHA
macromer/crosslinker precursor and exposed to visible light in the presence a photoinitiator to
form composites. (iii) Images of composites containing PCL MEW meshes (green) and NorHA
hydrogel (blue). (b) Representative images of MEW meshes of varied interfiber spacing (800
μm, 400 μm, 200 μm). Compressive moduli of NorHA hydrogel alone, PCL MEW meshes of
varied interfiber spacing alone, and composites containing NorHA hydrogel infused into
meshes with varied interfiber spacing. *p<0.05, **p<0.01, ****p<0.0001, n=5.

Importantly, the PCL fibers embedded within composites only account for ~7% of
the composite’s volume fraction, such that constructs may be engineered largely with a
cell-laden hydrogel conducive to neotissue formation.40 As the interfiber spacing
decreases, the total fiber density within composites increases, giving rise to elevated
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compressive moduli (Figures 5.10, 5.11). However, decreasing the interfiber spacing also
resulted in misalignment of overlaying fibers. As a result, composites composed of
meshes with 400 μm spacing were selected and employed for all subsequent studies to
maximize the compressive properties of formed composites while conserving mesh
alignment for optimal filling of macromer within the interstitial spaces of the mesh. All
subsequent studies were also performed with 2 kPa NorHA hydrogel formulations (i.e.,
2% NorHA, XDTT=0.1).

Figure 5.11: MEW Mesh dimensions influence composite mechanical properties.
Representative stress-strain curves corresponding to 2 kPa hydrogels alone (Gel, gray), PCL
meshes alone with varied interfiber spacing (MEW Mesh, teal), and composites (blue)
composed of meshes with varied interfiber spacing.

5.3.3

Neocartilage Formation in MEW-Reinforced NorHA Hydrogels
Although the incorporation of MEW meshes within NorHA hydrogels significantly

improved their compressive properties, it remained unclear how the inclusion of PCL
would impact embedded MSC chondrogenesis and their ability to synthesize and
distribute ECM. Thus, chondrogenesis and cartilage formation was evaluated in hydrogels
alone (2 kPa NorHA) and compared to cell-laden composites containing the same
hydrogel within PCL meshes (Figure 5.12a). Cell viability in composites was high (92.0 ±
2.7%) after one week of culture, and homogenous filling of the hydrogel within composites
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was observed, as indicated by comparable cell densities near the top (716 ± 130
cells/mm2) and bottom (638 ± 77 cells/mm2) of composites (Figure 5.13).

Figure 5.12: Influence of MEW meshes on MSC chondrogenesis and neocartilage
formation. (a) Representative images of MSC-laden hydrogels and composites. Hydrogels
and composites are cultured in chondrogenic media for up to 56 days and assessed for (b)
chondrogenic gene expression (Aggrecan, Type II Collagen), (b) compressive moduli, and (c)
biochemical content (DNA, sulfated glycosaminoglycan (sGAG), and collagen (COL)) after 0
(light gray), 7 (dark gray), 28 (blue), and 56 (teal) days of culture in chondrogenic media.
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, n.s. = not significant, n≥3, individual one-way
ANOVAs (Aggrecan) or Kruskal–Wallis tests (Type II Collagen) performed for each formulation
for qRT-PCR data.
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Figure 5.13: Viability within NorHA-MEW Composites. (a) Representative images (day 7)
and (b) quantification of encapsulated MSC viability in the top and bottom 100 μm of
composites at day 7, where live cells (green) and dead cells (red) are stained with calcein AM
and ethidium homodimer, respectively. (c) Quantification of cell density in the top and bottom
100 μm of composites at day 7. n.s.= not significant, n=3.

While local heterogeneity within cell-laden hydrogels may improve neocartilage
formation,53 the observation of homogenous cell densities throughout constructs ensures
that matrix deposition occurs throughout the full-thickness of composites. As expected,
MSCs exhibited significant increases in aggrecan and type II collagen expression over 56
days of culture, consistent with chondrogenesis and similar to their differentiation in
hydrogels alone (Figure 5.12b). Similarly, MSCs within both hydrogels alone and
composites expressed SOX9 and decreasing amounts of type I collagen over culture time
(Figure 5.14).
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Figure 5.14: Influence of MEW Mesh on MSC chondrogenic gene expression. Relative
gene expression of (a) type I collagen and (b) SOX9 in hydrogels and composites cultured in
chondrogenic media, **p<0.01, n.s. = not significant, n≥3, with individual Kruskal–Wallis tests
performed for each hydrogel formulation.

Composites exhibited a higher compressive modulus than hydrogels alone initially
and continued to increase in their mechanical properties over culture time, possessing a
significantly higher modulus (367 ± 95 kPa) than hydrogels alone (239 ± 119 kPa) after 56
days of culture (Figure 5.12c). Moreover, the compressive moduli of composites
approached previously reported values for the Young’s modulus of native articular
cartilage (0.1-1.6 MPa).54,55 The observed increases in mechanical properties can be
attributed to the deposition of ECM by encapsulated MSCs, since acellular hydrogels and
composites cultured for 56 days exhibited modest decreases in compressive properties
over time due to degradation (Figure 5.15). While all the experimental groups exhibited
increases in DNA content, no significant differences were observed across culture
timepoints or between hydrogels and composites (Figure 5.12d). The sGAG and COL
contents for hydrogels and composites increased with culture time, with no significant
differences between hydrogels or composites observed at the same culture times. Small
differences in the absolute amount of sGAG or COL between composites and hydrogels
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alone may be attributed to the volume fraction of fibers, which slightly decreases the space
available for matrix.

Figure 5.15: Compressive moduli of acellular hydrogels and composites. Compressive
moduli measured after 56 days of incubation in chondrogenic media, illustrating slight
decreases in mechanical properties due to material degradation. *p<0.01, **p<0.005,
****p<0.0001, n≥3.

After 28 and 56 days of culture, dense and opaque tissue was macroscopically
visible in both hydrogels alone and in composites, such that the two were indistinguishable
upon qualitative observation (Figure 5.16). The distribution of sGAG within both hydrogels
and composites was comparable, with no significant differences observed in Alcian blue
staining intensity (Figure 5.17a). Similarly, both hydrogels and composites supported the
deposition of homogenously distributed type II collagen, with no appreciable differences
in staining intensity over culture time (Figure 5.17b). In addition, MSCs in both hydrogels
and composites deposited minimal amounts of type I collagen, consistent with a hyaline
cartilage-like phenotype (Figure 5.18). Although the staining intensity for type I collagen
was significantly higher in composites at day 28 of culture, this may be attributed to the
presence of additional surfaces along fibers, which may modulate gene expression and
local mechanosensing of some cells.56,57 However, no significant differences in type I
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collagen staining intensity between hydrogels and composites were observed after 56
days of culture. Importantly, the observed similarities in chondrogenic gene expression,
biochemical content, and matrix staining between hydrogels and composites suggests that
the inclusion of PCL meshes within cell-laden NorHA hydrogels does not attenuate the
ability of cells to synthesize and distribute ECM. Thus, the higher initial mechanical
properties and improved handling of the composites further motivates additional
exploration of their use in cartilage repair.

Figure 5.16: Representative gross images of MSC-laden 2 kPa hydrogels and
composites. After 56 days of culture in chondrogenic media, both hydrogels alone and
composites were opaque and consisted of dense tissue.
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Figure 5.17: Influence of MEW Meshes on matrix production and distribution.
Representative images and quantification of matrix distribution within NorHA hydrogels and
composites after 28 and 56 days of culture for (a) sulfated glycosaminoglycans (sGAG) via
Alcian blue staining or (b) type II collagen (COLII) via immunohistochemistry. n.s. = not
significant, n=45 images, 5 sections, 3 constructs.
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Figure 5.18: Influence of MEW Meshes on type I collagen elaboration and distribution.
Representative images (day 28 and day 56) and quantification of type I collagen (COLI)
distribution within hydrogels and composites via type I collagen immunohistochemistry.
*p<0.05, **p<0.01, n.s. = not significant, n=45 images, 5 sections, 3 constructs.

5.3.4

Integration of Composites Within Cartilage Explants
Towards translating the developed composites for the repair of focal cartilage

defects, we assessed the ability of composites to integrate with explanted native cartilage
ex vivo (Figure 5.19a). After culture in chondrogenic media for 28 days, the formation of
tissue resulted in changes in the opacity of press-fit cell-laden and cell-laden+PC
composites; specifically, the appearance of cell-laden+PC composites started to resemble
the autologous cartilage controls (Figure 5.20). The integration strength of press-fit
constructs was then measured via push-out testing (Figure 5.21). While acellular
composites were easily displaced from the center of cartilage rings, cell-laden composites
exhibited a much higher integration strength (113 ± 74 kPa; Figure 5.19b,c). The addition
of a pre-culture period and time for nascent matrix to form within composites further
improved the integration strength of cell-laden+PC composites with surrounding cartilage
(221 ± 115 kPa), which did not differ significantly from autologous tissue controls (272 ±
120 kPa) or previously reported integration strengths for autologous controls.33 Uniaxial
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compressive testing was performed on central regions that were pushed out to confirm
that culture within cartilage rings did not significantly impede cartilage formation (Figure
5.22).

Figure 5.19: Integration of composites within explanted cartilage rings. (a) Schematic of
integration studies. (i) Osteochondral plugs are isolated from the trochlear groove of juvenile
bovine knee joints and (ii) defects are created to produce cartilage rings with an outer diameter
of 8mm and an inner diameter of 4mm. (iii) Autologous cartilage or composites (acellular, cellladen, and cell-laden with 28 days of chondrogenic pre-culture (+PC)) are then press-fit into
cartilage rings, cultured for 28 days, and then subjected to push-out testing. (b) Representative
load-displacement curves generated during push-out testing. (c) Quantification of the
integration strength of press-fit constructs with surrounding explanted tissue (red data points
correspond to respective load-displacement curves in (b)). *p<0.05, **p<0.01, ****p<0.0001,
n≥10. Created with BioRender.com.
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Figure 5.20: Representative gross images of constructs press-fit into explanted
cartilage rings. After 28 days of culture in chondrogenic media, tissue resembling
neocartilage is visible within the center of cartilage rings containing cell-laden and cellladen+PC constructs, while acellular constructs remain translucent.

Figure 5.21: Push-out testing set-up. Representative images demonstrate sample
placement for loading to obtain the integration strengths of constructs press-fit into explanted
cartilage rings.
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Figure 5.22: Mechanical analysis after push-out testing. The compressive moduli of
constructs that were press-fit within explanted cartilage rings. ****p<0.0001, n=10.

In addition to push-out testing, microCT was performed on samples to assess the
interfacial contact area between press-fit composites (or autologous cartilage) and
explanted cartilage rings (Figures 5.23, 5.24).

Figure 5.23: Image filtering of MicroCT scans. (a) The raw MicroCT images were
sequentially filtered using a median filter, a mean filter, and then a gaussian filter. (b,c) Image
filters were applied to obtain greater signal-to-noise ratios between the background signal and
cartilage.

200

Figure 5.24: Quantification of composite-cartilage contact area from MicroCT scans.
Contact area between the scaffold and cartilage rings was quantified from MicroCT scans at
rd
rd
3 cross-sectional (x-section) locations of the (a) top 3 , (b) middle, and (c) bottom 3 of the
scaffold from the top-down view (Positions 1, 2, and 3 respectively, see Figure 8). In the TopDown views, the blue plane represents the location of each x-section that was used to quantify
the contact area. The cyan scale bars are representative regions of contact between the
scaffold and cartilage ring in each location, while the black scale bars are representative
regions of non-contact between the scaffold and cartilage ring. The contact area at each
location was averaged to quantify the final contact area for each sample.

The inclusion of cells within composites and the addition of a pre-culture period
significantly improved composite integration with surrounding tissue (Figures 5.25a,
5.26). The contact area between samples and cartilage rings was quantified at three
different cross sections (Figures 5.24, 5.25b) and then normalized to represent a fraction
of the total possible contact area between each sample and the surrounding cartilage
(Figure 5.25c). While the normalized contact area was largest in control samples (0.85 ±
0.06), there were no significant differences from either of the cell-laden groups either
without (0.66 ± 0.25) or with (0.78 ± 0.04) pre-culture. Notably, the normalized contact
area was different between the acellular samples (0.33±0.17) and both the cell-laden+PC
samples and the autologous cartilage control samples. It is likely that the lack of tissue
formation in acellular composites over culture time resulted in attenuated interfacial
strength, as reflected by the displacement of composites and gaps visible between
composites and native cartilage in the microCT reconstructions (Figures 5.25a, 5.26).
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While these features are also pronounced in some cell-laden constructs, cell-laden+PC
constructs generally showed intimate contact with the surrounding cartilage rings.

Figure 5.25: Characterization of composite-cartilage interfaces. (a) Representative
MicroCT reconstructions, Alcian blue staining, and type II collagen (COLII)
immunohistochemistry for constructs press-fit and cultured within explanted cartilage rings. (b)
Schematic illustrating the three cross-sections (i.e., dashed lines; midplane, and planes 1 mm
from the midplane in each respective direction) analyzed to determine the interfacial contact
area (indicated by red boxes). (c) Quantification of normalized contact area between press-fit
constructs and native cartilage at their interfaces. *p<0.05, n=3.
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Figure 5.26: MicroCT reconstructions of constructs press-fit and cultured within
explanted cartilage rings. Representative images of all constructs employed for
quantification of contact area at the construct-native cartilage interface.

To further elucidate the interface of composites and cartilage, we stained
constructs for sGAG and COLII to visualize local ECM organization (Figure 5.25a).
Acellular composites failed to show sGAG or COLII along the entire perimeter of the
interface, consistent with our microCT quantification. While cell-laden samples similarly
possessed some gaps between composites and surrounding cartilage, cell-laden samples
also showed increased sGAG and COLII staining when compared to acellular samples,
suggesting that the presence of nascent ECM improved overall integration. While
significant changes in composite volume were not observed over culture time, the
formation of GAGs within composites might increase overall composite swelling, which
may further improve composite integration within cartilage rings. Of the three composite
groups, cell-laden+PC constructs contained interfaces with the most continuous sGAG
203

and COLII staining and most closely resembled autologous cartilage controls. Taken
together, these results highlight the importance of hydrogel stabilization with MEW
composites, as well as composite pre-culture towards developing a nascent ECM template
that improves tissue integration with cartilage ex vivo.

5.4

CONCLUSIONS
In this study we demonstrated that loosely crosslinked NorHA hydrogels support

MSC chondrogenesis and neocartilage formation with greater properties after culture for
56 days when compared to more densely crosslinked hydrogels. Specifically, softer
NorHA hydrogels provided embedded MSCs with a local microenvironment more
conducive to the production and distribution of ECM consistent with hyaline-like cartilage
(i.e., high sGAG and COLII contents). To address the low initial mechanical properties and
stability of these hydrogels, we reinforced the NorHA hydrogels with melt-electrowritten
PCL scaffolds and showed that this did not inhibit MSC chondrogenesis or neocartilage
formation

while

simultaneously

providing

improved

mechanics

and

handling

characteristics. Finally, we demonstrated that the chondrogenic pre-culture of NorHAMEW composites resulted in improved tissue integration within explanted cartilage rings
relative to acellular controls, informing future approaches for the fixation and maturation
of cartilage implants within cartilage defects in vivo. Future work will implement these
NorHA-MEW composites in the repair of articular cartilage defects in vivo.
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CHAPTER 6: EVALUATION OF MEW-NORHA COMPOSITES IN A PORCINE
CARTILAGE DEFECT MODEL
6.1

INTRODUCTION
A variety of surgical approaches have been developed to treat full-thickness

cartilage defects due to trauma and disease, including arthroscopic debridement,
microfracture, and autologous chondrocyte implantation.1 Importantly, if cartilage defects
are left untreated they may progress to osteoarthritis (OA), which results in significant pain
and dysfunction to the patient.2 Unfortunately, these approaches typically fail to restore
the full function of the damaged cartilage, as the repair cartilage formed in strategies such
as microfracture typically exhibits inferior properties to healthy articular cartilage.3
However, the relative success of each of these respective approaches is a strong function
of the damaged defect size, which dictates the indication for each procedure.1 Bone
marrow stimulation via subchondral microfracture is widely considered to be the first option
for treating relatively small lesions (<2.5 cm2), with defects ranging between 1 - 2.5 cm2
responding well to the treatment.1 However, microfracture has previously demonstrated
poor patient outcomes in the treatment of larger defects (≥4 cm2),1 which typically must
be repaired with osteochondral allografts. For intermediate defect sizes (2 cm2), ACI is
typically used to mediate repair;1 however, ACI is not usually employed for larger defects
(≥4 cm2), since there is typically a limited number of donor cells that can be readily isolated.
In response to the limitations of current approaches for cartilage repair,45 a variety
of new tissue engineering therapies are being developed and several have been evaluated
for cartilage repair in large animals.6–9 These have been met with varied success, but
highlight the importance of selecting models and timepoints that best recapitulate human
cartilage damage in a clinically relevant manner. To this end, canine, caprine, porcine,
and equine models are most commonly used for the investigation of new cartilage repair
213

strategies.10 Porcine models are often employed as large animal models for cartilage
damage because they permit easy operative access to non-load bearing articular cartilage
(i.e., along the femoral trochlea) and possess cartilage with thickness comparable to
human articular cartilage.11 For example, composite scaffolds consisting of woven
polycaprolactone (PCL) and either infilled hydrogels (i.e., self-assembling peptide-based
hydrogels and HA hydrogels) or bone marrow aspirate were previously investigated for
the treatment of cartilage lesions (4mm diameter) in Yucatan minipigs.9 12-months after
implantation, the quality of repair cartilage formed by these composites was characterized
via gross scoring, mechanical testing, MicroCT, and histology. Despite the early
observation of scaffold retention in defects at 6-weeks, ultimately defects treated with
composites performed worse than those treated with microfracture. Similarly, biphasic
composites of PCL and cell-laden PEG hydrogel were evaluated in minipig cartilage
defects for 6 months; explanted composites resulted in O’Driscoll scores (i.e., histological
scoring) that were worse than empty defect controls and significant bone resorption was
observed.6
One challenge to such therapies is the successful fixation and retention of implants
within full-thickness cartilage defects.12,13 A range of approaches have been investigated
for implant fixation,14 including press-fitting, suturing with an overlaying periosteal flap,
application of fibrin glue/sealant, and the use of bone anchors to integrate implants with
the underlying bone. While simple press fitting of implants may be appropriate for
osteochondral defects or instances in which full thickness cartilage defects are surrounded
by healthy thick cartilage,15 often times samples are dislodged from defects due to the
complex loads experienced within the joint.

14,16

Fibrin glue has similarly been combined

with press-fitting of implants, but only marginally improved the fixation strength and
retention of implants.

16–18

Suturing of periosteal flaps to secure implants within defects
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unfortunately leads to loss of chondrocytes and ECM at the local suture site, as well as
the formation of fissures reminiscent of partial thickness defects.19 Bone anchors have
been shown to more reliably ensure the retention of implants within defects,9 but they often
lead to underlying subchondral bone remodeling or voids.18,20 In a recent study, biphasic
scaffolds composed of hydroxyapatite and PCL microfiber meshes fabricated via MEW
were evaluated in an equine model of osteochondral damage. 6 months after implantation,
marginal cartilaginous ECM was observed in the chondral phase of implants, while
MicroCT results showed the collapse of bone anchors used to fix the implants within
defects.7 Generally, both the cartilage defect size and geometry, as well as the properties
of the implant itself must be considered when selecting the optimal fixation method for
scaffolds.
In Chapter 5, MEW-NorHA composites were shown to support MSC
chondrogenesis and neocartilage formation while also achieving high initial construct
mechanical properties, using juvenile bovine MSCs. The impressive compressive moduli
and biochemical contents achieved in these composites in vitro, taken together with their
ability to integrate with native articular cartilage ex vivo motivates additional exploration of
their therapeutic potential in a clinically-relevant model of cartilage damage. Thus, the
aims of this study were to (i) explore adult porcine MSC behavior within composites, (ii) to
elucidate the fixation of MEW-NorHA composites within cartilage defects, and (ii) to
assess the ability of the composites to support the repair of full-thickness cartilage defects
in a minipig model.

215

6.2

METHODS

6.2.1

Materials
Sodium hyaluronic acid was obtained from Lifecore Biomedical (Chaska, MN) and

lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) was obtained from Colorado
Photopolymer Solutions (Boulder, CO). Unless otherwise specified, all other reagents and
materials were purchased from Sigma-Aldrich (St. Louis, MO).
6.2.2

MEW Mesh-NorHA Composite Fabrication and Cell Culture
Adult mesenchymal stromal cells (MSCs) were isolated from bone marrow aspirate

derived from the iliac crest of three adult Yucatan minipigs (12-14 years old; Sinclair
Research, Auxvasse, MO) via plastic adherence during culture in Dulbecco’s modified
eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin/streptomycin (P/S).
NorHA was synthesized as previously described in Chapter 5 and dissolved in
phosphate buffered saline (PBS) with LAP photoinitiator (0.05%) and DTT crosslinker
(0.54 mM) to obtain macromer precursor solution.21 Similarly, polycaprolactone (Purasorb
PC 12, Corbion Inc., Gorinchem, Netherlands) MEW meshes (diameter ~4 mm,
height~1mm, 400 m fiber interspacing) were fabricated as described in Chapter 5.22 The
macromer solution was then used to fill in the box-structure PCL MEW meshes with or
without porcine MSCs (pMSCs, P1, 20x106 cells/mL) and irradiated with blue light (400500 nm, Omnicure lamp with an affixed collimator, I=10 mW/cm2) for 5 minutes to obtain
composites similar to those investigated in Chapter 5 (i.e., 400 µm spacing PCL MEW
meshes, 2 kPa NorHA gel). Composites were then cultured in chondrogenic media (1%
ITS+; 2.50 µg/mL amphotericin B; 1 × 10−3 M sodium pyruvate; 50 µg/mL ascorbic acid 2216

phosphate; 40 µg/mL L-proline; 1 × 10−7 M dexamethasone; 10 ng/mL TGF-B3) for up to
28 days.
6.2.3

Screening of Porcine Donors for pMSC Chondrogenic Potential
After culture in chondrogenic media for 28 days, the compressive moduli of

composites were determined via unconfined, uniaxial compressive testing with a constant
loading rate of 0.2 N/min (Q800 DMA, TA Instruments) and the modulus was quantified
as the slope of the stress-strain curves between 10-20% strain.
The biochemical contents of composites were quantified as detailed in Chapter 5.
Samples were minced and digested via incubation with papain and hyaluronidase
overnight at 60°C. Sulfated glycosaminoglycan content, collagen content, and DNA
content were then determined via the dimethylmethylene blue assay, the hydroxyproline
(OHP) assay (Abcam Hydroxyproline Assay Kit, ab222941), and the Picogreen dsDNA
assay.23
To evaluate the deposition and distribution of extracellular matrix (ECM) by
encapsulated cells within composites, composites were first fixed (10% buffered formalin),
paraffin embedded, and sectioned (5 μm). Alcian blue staining and immunohistochemistry
for type I (COL I, mouse monoclonal anti-collagen type 1 antibody, Millipore Sigma) and
type II collagen COL II, mouse monoclonal anti-collagen type II antibody, Developmental
Studies Hybridoma Bank) were then performed as described in Chapter 5. The mean
staining intensities of sGAGs, COL I, and COL II in composites were quantified using
Image J software.24
6.2.4

Cell Viability
To evaluate the cytocompatibility of cell-laden composites prepared for

implantation, live/dead staining with calcein AM and ethidium homodimer was performed
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in accordance with manufacturer’s instructions (Invitrogen) after 7 days of culture in
chondrogenic media. Cell viability was quantified using Image J software as the number
of live cells per total cells within images acquired via epifluorescence microscopy (n ≥ 3
hydrogels, 9 images per sample).
6.2.5

Animal Procedures and Stifle Joint Surgery
Skeletally mature (12-14 mo old at time of surgery) male Yucatan minipigs were

acquired (Sinclair Bioresources, Auxvasse, MO, USA) for the evaluation of composites in
the repair of cartilage defects in vivo (n=9). All animal procedures were approved by
the Institutional Animal Care and Use Committee at the University of Pennsylvania. Adult
animals were selected over skeletally immature animals to better recapitulate the patient
populations that develop full-thickness cartilage defects and to mitigate the degree of
subchondral bone remodeling that occurs with cartilage defect creation.25 Unilateral stifle
joint surgeries were performed on the right hind limb of each animal as previously
described.16,26,27
Animals were first anesthetized with inhaled isoflurane before undergoing
endotracheal intubation according to the protocol. The right stifle joint was then shaved,
cleaned, and surgically prepared with Betadine. Bupivicaine was injected into the joint
prior to a 4 cm medial parapatellar skin incision. The subcutaneous tissue was then
incised, homeostasis was attained, and the medial patellar tendon border was palpated
prior to leg extension. Thereafter, an incision was made through the joint capsule under
the patellar tendon and the trochlea was exposed via medial parapatellar arthrotomy (and
patella dislocation laterally). A minimum of four full-thickness chondral defects were then
created (two proximal and distal medial defects and two proximal and distal lateral defects)
using a 4mm biopsy punch and a curette to excise cartilage within the bounds of the
scored defect while ensuring the underlying subchondral bone was not damaged.
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Groups included empty defects, microfracture, acellular composites, and
composites containing pMSCs that were precultured for 28 days. In formed defects treated
with microfracture, a surgical awl was used to create three holes to stimulate the
underlying bone marrow. After the fixation of composites (described below) within defects
and the creation of microfracture holes, the patella was relocated, all instruments and
retractors were removed, and the knee was then ranged to ensure that the patella was
stable. The joint capsule was then closed with 0 Vicryl interrupted sutures, the
subcutaneous tissue layer was closed with 2-0 Vicryl simple interrupted sutures, and the
skin layer was closed with a 3-0 monocryl running suture (all sutures were from Ethicon).
All animals received postoperative analgesia, antibiotics, and anti-inflammatories, with
unrestricted cage activity permitted 2 to 3 hours after recovery from anesthesia.
Either PLDLLA pins (Aesculap FR736, Center Valley, PA) or fibrin glue (Tisseel,
Baxter) were used to fix composites within created defects as previously reported.16 To
pin composite implants within defects, composites were press-fit into the defects and pilot
holes were then created through the implant and into the subchondral bone. A 3-pronged
fixation guide (Aesculap FR720, Center Valley PA) was then placed on top of composites
and used to insert the pins into the created pilot holes. In two animals (Surgeries 1-2), an
additional fifth defect was introduced on the lateral side of the femoral trochlea to replace
medial distal defects in which insufficient fixation of implants with PLA pins was initially
achieved (i.e., poor seating of composites within the created defect and misaligned pinning
at the time of fixation). Each of these additional, lateral distal defects were evaluated in
lieu of the medial distal defects in all the performed analyses.
To fix composites within defects using Tisseel, the fibrin glue was first applied to
the underlying subchondral bone. Tisseel fibrin glue was selected since it has been
previously shown to possess higher compressive properties than alternative commercial
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(Evicel, Ethicon) and autologous (Angel, Anthrex; ProPlaz, Biorich) fibrin glue products.28
Composites were then press-fit into defects on top of the glue and manually held in place
for 3 minutes via application of force with a spatula and a surgical curette. Additional fibrin
glue was then applied along the top of the composite interface, and force was again
manually applied on top of the composite for 3 minutes.
6.2.6

Arthroscopy and Gross Observations
12 weeks after cartilage defect creation, animals were euthanized, and the stifle

joints were retrieved for post-mortem analyses. Dry arthroscopy was first performed to
visualize the cartilage defects in situ using an adapted protocol.16 A 1 cm vertical incision
was made to establish a medial subpatellar arthroscopic portal, which allowed for
placement of a trocar and arthroscopic probe within the medial aspect of the stifle joint.
Images of each defect were then taken to qualitatively evaluate the smoothness of repair
cartilage and its integration with the surrounding tissue.29
The stifle joint was then dissected to expose the patellofemoral joint, and both the
trochlea and patella were explanted. To characterize any potential damage along the
surface of the patella due to the presence of pins or fibrin glue on the opposing articulating
surface, India ink staining was performed. Cartilage defects along the trochlear groove
were then macroscopically imaged to qualitatively assess the retention of implants and
the quality of repair cartilage formed in defects.30
6.2.7

Indentation Testing of Composites and Repair Cartilage
To evaluate the mechanical properties of composites prior to implantation and

repair cartilage 12 weeks after defect creation, creep indentation testing was performed
as previously described using an Instron 5948 Universal Testing System (Instron Inc,
Norwood, MA) with an affixed 1mm diameter spherical indenter.31 Since large
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deformations during physiologic creep testing may significantly alter the local
compositional characteristics of immature tissue constructs (i.e., acellular composites),
relatively lower loads were employed during all indentation testing to ensure the accurate
quantification of composite mechanical properties prior to implantation.32 Generally, a load
of 0.1 N was applied to all samples at a loading rate of 0.1 N/s and then held for 900 s
(after the load setpoint was reached) while the creep displacement was measured.
Acellular and precultured composites were submerged in PBS prior to indentation testing.
Alternatively, osteochondral samples were first fixed into place within a low-melting
temperature bismuth alloy to secure samples while maintaining the cartilage defect
surface upright. Samples were then submerged in PBS and positioned under the indenter
setup using a custom XY positioning stage and a goniometer to ensure that the cartilage
surface was perpendicular to the indenter. Repair cartilage within the center of defect
samples (or directly adjacent to pins in instances where pins were still visible and exposed
on the cartilage surface) was then indented.
After osteochondral sample fixation and decalcification, defects were cut along
their midplane to determine the thickness of cartilage samples. The compressive modulus,
tensile modulus, and permeability of all indented samples was then quantified by fitting
the collected creep data to a Hertzian biphasic model.33
6.2.8

MicroCT and Histological Evaluation of Cartilage Defects
To qualitatively visualize any subchondral bone remodeling or bone resorption that

occurred during the 12-week time course, explanted cartilage defects (and healthy tissue
controls) were imaged via microCT as previously described.34 Osteochondral samples
were incubated in Lugol’s solution overnight at room temperature and then imaged using
a Scanco MicroCT 45 system (Scanco Medical, Southeastern, PA, USA; exposure: 600
ms, voltage: 55 kVp, isotropic voxel size: 10 µm), with cross-sectional and top-down
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images of samples acquired via DragonFly software (Object Research Systems, Montreal,
Canada).
After microCT imaging, samples were fixed (10% formalin, 24-48h incubation
overnight at 4°C) and decalcified via incubation in Formical-2000 for 4 weeks (solution
changed weekly). Thereafter, samples were embedded in paraffin, sectioned (8 μm), and
stained with Safranin O/Fast Green to visualize proteoglycan content and collagen
content, respectively, within the repair cartilage and the underlying subchondral bone.

6.2.9

Statistical Analysis
All statistical analyses were performed using GraphPad Prism 9 software, with

data reported as mean±standard deviation and significance for all performed analyses
determined at p<0.05. One-way ANOVAs were performed with Tukey's honestly
significant difference (HSD) post-hoc testing to compare functional outcomes between
porcine donors, cell viability across precultured composites (for different surgeries), and
functional outcomes for the experimental groups investigated in the porcine model.
Alternatively, Two-way ANOVAs were performed for the analysis of acellular and
precultured composites’ compressive moduli initially and 12 weeks after implantation, and
multiple comparisons were performed with α=0.05 and Tukey's HSD post-hoc test.
6.3

RESULTS AND DISCUSSION

6.3.1

pMSC Donor Screen for Chondrogenic Potential
To evaluate the therapeutic efficacy of MEW-NorHA hydrogel composites for the

repair of full-thickness cartilage defects, it was necessary to first validate that the
composites support the chondrogenesis of adult porcine MSCs toward the formation of
neocartilage. Importantly, adult pMSCs were selected as an allogenic cell source to
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mitigate any potential immune responses upon implantation into porcine models.35
Moreover, isolated pMSCs were age-matched to the host animals (12-14 mo.) to ensure
that they best represented the clinically-relevant scenario in which autologous cells are
sourced and used within implants.
Since donor variability is known to influence human MSC properties such as
proliferation and differentiation,36 pMSCs from three prospective porcine donors (Donors
1, 2, 3) were screened to identify a cell source with the requisite chondrogenic potential to
form neocartilage when cultured in chondrogenic media for 28 days (Figure 6.1a). Given
the age of the encapsulated adult pMSCs, it was expected that the mechanical properties
and relative amounts of cartilaginous ECM components in these composites would be
inferior to those observed in composites containing juvenile bovine MSCs (Chapter 5).
However, increases in the compressive moduli of pMSC-laden composites were still
observed over 28 days when compared to acellular composite controls (~100 kPa;
Chapter 5, Figure 10).
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Figure 6.1: In vitro screening of porcine MSC donors. a) (Left) Schematic of the MEWNorHA composites used to evaluate adult porcine mesenchymal stromal cells (pMSCs)
sourced from three porcine donors. (Right) Images of MEW-NorHA composites containing
encapsulated pMSCs during culture. b) (Left to right) Compressive modulus and biochemical
contents (i.e., DNA, glycosaminoglycan (GAG) and collagen (COL) contents) of composites
containing encapsulated adult porcine MSCs from 3 donors and cultured for 28 days in
chondrogenic media. n=4, One-way ANOVA, *p<0.05, ns = not significant.

Minimal differences were observed across the donors with respect to the
compressive moduli of composites cultured for 28 days (Figure 6.1b). However, The DNA
content of composites cultured with pMSCs from Donor 3 was significantly higher than the
DNA content of composites containing pMSCs from Donor 2 despite all the cell-laden
composites being fabricated with the same density of encapsulated cells, suggesting that
cells from Donor 3 may have an innately higher proliferative capacity. This data is
qualitatively corroborated by the observation of faster expansion times for Donor 3 cells
plated on tissue culture plastic (TCP) at a density of 6.67x103 cells/cm2 when compared
to other donors (data not shown). In addition, pMSCs isolated from Donor 3 and
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encapsulated in composites led to neotissue with significantly higher sulfated
glycosaminoglycan contents than composites containing pMSCs from Donor 1 or 2
(Figure 6.1b).
Evaluation of these composites via histology and immunohistochemistry also
demonstrated that composites containing cells from Donors 1 and 3 stained significantly
more intensely for sGAG and type I collagen (COL I) than composites containing cells
from Donor 2 (Figure 6.2). However, the morphology of the encapsulated pMSCs, the
relative distribution and organization of ECM, and the overall staining intensity was
qualitatively comparable across all donors (Figure 6.2). Based on all these results, Donor
3 was selected as the primary allogenic cell source for all of the cell-laden composites
fabricated and cultured for the animal study to maximize the chondrogenic potential and
efficacy of precultured composite implants.
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Figure 6.2: ECM staining of composites across porcine MSC donors. After 28 days of
culture in chondrogenic media, ECM within composites containing encapsulated MSCs from
three porcine donors is visualized via a) Alcian Blue staining (for sulfated glycosaminoglycans,
sGAG), b) type II collagen (COL II) immunohistochemistry, and c) type I collagen (COL I)
immunohistochemistry. a-c) Representative images (left) and quantification of staining
intensity (right) to characterize a) sGAG, b) COL II, and c) COL I distribution and organization
for 3 porcine donors. n=81 images, 9 sections, 3 composites; One-way ANOVA, ****p<0.0001,
ns = not significant.

6.3.2

Animal Study Design
After screening porcine donors, the ability of MEW-NorHA composites to facilitate

cartilage repair in vivo was evaluated in a porcine model of full-thickness cartilage damage
(Figure 6.3a).10 Cartilage defects were created along the femoral trochlea of Yucatan
minipigs to investigate the performance of implanted acellular and precultured (i.e.,
chondrogenic culture for 28 days in chondrogenic media) composites in comparison to
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empty defect controls or defects treated with microfracture. To mitigate the potential
influence of defect location on the performance of different experimental groups, treatment
location was randomized across the performed surgeries.

Figure 6.3: Overview of in vivo study design. a) Schematic of the animal model,
experimental groups, and study design employed to evaluate MEW-NorHA composites for
cartilage repair. Full-thickness cartilage defects are created along the trochlear groove of the
patellofemoral joint (right, hind stifle joint) for seven pigs, with empty and microfracture controls
and either acellular or precultured (chondrogenic media, Donor 3 pMSCs, 28 days) MEWNorHA composites. 12 weeks after implantation, the quality of repair cartilage within each of
these respective defects is evaluated via gross observation, arthroscopic imaging, mechanical
testing, microCT, and histology. To ensure that implants are retained within the created
cartilage defects, composites are fixed with either b) bioresorbable polylactic acid (PLA) pins
or c) fibrin glue sealant. b-c) Representative images of defects formed along the trochlear
groove (left) and composites fixed with either b) pins or c) fibrin glue (right).

Two distinct fixation methods were also investigated to identify how best to implant
MEW-NorHA composites within cartilage defects: 1) pinning of composites to the
underlying subchondral with bioresorbable PLDLLA (poly(l-lactide- co-d,l-lactide)) pins,
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which degrade on the order of months, and 2) fixation with fibrin glue (Figure 6.3b). While
the former fixation method has been previously shown to retain nanofibrous HA-based
scaffolds within full-thickness porcine defects, it is also associated with appreciable
subchondral bone remodeling. 16 Alternatively, past results suggest that subchondral bone
remodeling is attenuated with the use of fibrin glue,16 but that the retention of implants
within defects is not significantly improved when compared to press-fitting alone.17 Given
the previously reported advantages and limitations of these respective approaches, this
study aimed to identify the fixation method most appropriate for use with MEW-NorHA
composites.
Unilateral stifle joint surgeries were performed on a total of nine animals, such that
n≥4 defects were created for each of the respective experimental groups: empty defects
(n=5),

defects

treated

with

microfracture

(n=5),

pinned

acellular

composites

(‘Acellular+Pin’, n=6), pinned precultured composites (‘Precultured+Pin’, n=4), glued
acellular

composites

(‘Acellular+FG’,

n=4),

and

glued

precultured

composites

(‘Precultured+FG’, n=4). In two of the nine total animals, post-operative lateral patellar
luxation was observed approximately 3 weeks after the initially performed surgery,
compromising the animals’ ability to ambulate or bear load on the right stifle; therefore,
early euthanasia was elected. The observed patellar luxation in the first animal may likely
be attributed to recovery-related complications, while the second instance of patellar
luxation was accompanied by urticaria and incisional dehiscence consistent with a
previously reported case of suture hypersensitivity in a Yucatan minipig.37 For all other
animals, repair cartilage within defects was evaluated via arthroscopy, gross observation,
mechanical testing, microCT, and histology 12 weeks after the initial defect formation and
treatment (Figure 6.4).
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Figure 6.4: Overview of implant distributions for porcine surgeries. Representative
schematics detailing the location of each experimental group (empty defect, microfracture
therapy, acellular composite, precultured composite) along the operated trochlear groove for
each respective animal. The location of experimental groups is varied across surgeries to
account for any potential differences associated with defect location. Two animals experienced
operation-related complications and did not complete the 12-week time course. For surgeries
1 and 2, an additional fifth defect is created on the lateral distal portion of the trochlea, as initial
attempts to pin composites within the medial distal defects resulted in poor composite fixation.
Composites are fixed within created cartilage defects using PLA pins for surgeries 1-5 and
fibrin glue for surgeries 6 and 7.

Across all the surgeries in which precultured composites were implanted
(Surgeries 1-4, 6-7), the viability of implants was investigated via live/dead staining of
constructs after the first 7 days of culture in chondrogenic media (Figure 6.5). Importantly,
no differences in cell viability were observed across precultured composites prepared for
separate surgeries, and cell viability that is suitable for adult pMSCs was achieved across
all the implants (~80%).
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Figure 6.5: Cell viability of precultured composites for implantation in vivo. a)
Representative images and b) quantification of cell viability for precultured composite implants
stained 7 days after encapsulation for each of the respective performed animal surgeries to
ensure the viability of implanted constructs. n=3, 9 images, One-way ANOVA, ns=not
significant.

6.3.3

Evaluation of Repair Cartilage
To characterize the healing response within cartilage defects 12 weeks after

surgery, repair cartilage was first assessed via arthroscopy (Figure 6.6).29,38 Although the
appearance of defects varied across different animals, a number of features were
conserved within each of the treatment groups. For example, empty defects were
consistently filled and generally smooth but exhibited some fibrillation at the defect
interface. Similarly, defects that were treated with microfracture consistently exhibited a
smooth surface and complete defect filling, with intimate integration along the border of
the defect. Given the size of the created defects (~0.13 cm2), these observations are
consistent with the short-term repair outcomes seen clinically for defects <4 cm2 that are
treated with microfracture.39 Pinned and glued composites however exhibited
heterogeneous and incomplete defect filling, with apparent fissures along the defect
border in defects treated with pinned composite. Glued composites resulted in similarly
heterogeneous repair cartilage; however, in some instances, glued composites facilitated
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complete defect filling and the formation of smooth cartilage that integrated with the
surrounding tissue.

Figure 6.6: Arthroscopic observation of repair cartilage. Representative arthroscopy
images of repair cartilage corresponding to each of the respective experimental groups 12
weeks after surgeries (FG = fibrin glue).

Macroscopic gross imaging of the femoral trochlea corroborated the trends
observed via arthroscopy (Figure 6.7). Interestingly, 8 of the 10 defects investigated with
pinned composites contained a visible pinhead after explanting the femoral trochlea;
although it is expected that the pin would be retained within all defects after 12 weeks
based on their previously reported degradation behavior, a 75% success rate of implant
fixation was previously reported with the use of these pins in the same animal model.
However, retention of implants within the two defects where the pin may not be readily
seen may still have been achieved. Given the observation of pin failure in at least one
instance (i.e., lateral distal defect in Surgery 2), it is possible that the pin head may have
translocated away from the defect post-operatively. Alternatively, the formation of repair
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cartilage around and/or above the pin may be obscuring the presence of underlying pins.
For example, pinheads were observed in both lateral defects in Surgery 1, albeit further
way from the articular surface (i.e., deeper) than what was observed in other samples.

Figure 6.7: Gross observation of repair cartilage. Representative gross images of
explanted trochlea 12 weeks after composite implantation.

Despite the apparent presence of pins in most defects after 12 weeks, India Ink
staining of the opposing patellar surface did not reveal any damage or defects that may
have been caused by the pins (Figure 6.8). Similarly, India ink staining confirmed that the
patella remained undamaged by the use of fibrin glue for composite fixation.
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Figure 6.8: Gross observation of the opposing articulating surface. Representative
images of patella explants 12 weeks after composite implantation. Patella explants are stained
with India ink to reveal any potential damage caused by the presence of pins or glue on the
opposing articulating surface. No appreciable staining is observed on the surface of the patella
for joints that contained pinned or glued composites (left) when compared to positive controls
(i.e., contralateral patella explants that were damaged with a scalpel) (right).

Generally, macroscopic images show that the volume of the pin used to fix
composites qualitatively impeded the complete filling of defects containing acellular or
precultured composites (Figure 6.7). Moreover, the potential contraction of composites
upon formation of pilot holes or the application of the fixation guide (for the insertion of
pins through composites and into the subchondral bone) may have perturbed the
composite-native tissue interface, further influencing defect fill and repair cartilage
integration. The appearance of repair cartilage in defects treated with acellular and
233

precultured composites varied considerably. In some instances, damage to the
subchondral bone and adjacent cartilage was evident (e.g., Surgery 2), while in other
examples repair tissue adjacent to the pin was white and level with the adjacent tissue
(e.g. Surgery 4).30 Empty defects and defects treated with microfracture consistently filled
with white repair cartilage, but possessed fissures and fibrillated rough surfaces in most
instances (Figure 6.7).30
Improved defect fill and macroscopic appearance was observed for composites
fixed within defects using fibrin glue in lieu of pins; however, at least one defect appeared
to be entirely empty (Surgery 7, lateral proximal defect), while the appearance of repair
cartilage in defects containing glued acellular and precultured composites was variable
(Figure 6.7). Specifically, both groups exhibited instances where complete defect fill was
achieved and a homogenous, smooth cartilage surface was observed; in parallel, other
defects partially filled at smaller depths with more apparent fissures.30
MicroCT was performed on all the cartilage defects to qualitatively assess the
relative amounts of bone resorption associated with each of the respective treatment
groups (Figure 6.9). While some degree of bone resorption is qualitatively observed
across all experimental groups via microCT, including in empty defects alone as previously
reported,27 resorption is especially pronounced in defects treated with microfracture or
pinned composites. Importantly, subchondral bone remodeling may compromise the longterm stability of any repair cartilage formed in the overlaying defect, or alternatively give
rise to differential osteochondral loading, leading to the progression of OA.40
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Figure 6.9: MicroCT scans of cartilage defects and underlying subchondral bone.
Representative cross-sectional images 12 weeks after surgeries (FG=fibrin glue). Insets show
the top-down view for each defect. Control osteochondral samples are isolated from the most
distal portion of the trochlea for qualitative comparisons.

To gain insight into the composition of repair cartilage within each of the cartilage
defects, Safranin O/Fast Green staining was performed (Figure 6.10).41 All the
experimental groups resulted in variable repair tissue staining and morphology across
animals. Empty and microfracture groups however stained with Safranin O and Fast
Green consistently, suggesting the abundant presence of both proteoglycans and
collagen within defects. Importantly, integration of nascent tissue can be visualized with
the adjacent healthy tissue. Acellular and precultured composites that were pinned
however exhibited marginal Safranin O staining, even adjacent to the pin. When
composites were fixed within defects via application of fibrin glue, the best-performing
samples exhibited significant proteoglycan content and distribution, as evidenced by
Safranin O staining comparable to what was observed for control groups. To this end, the
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Safranin O staining intensity was higher in precultured composites than in acellular
composites, suggesting that the formation of nascent tissue prior to implantation via
chondrogenic preculture period may help to mediate repair cartilage maturation. However,
across all the defects that filled with significant proteoglycans, tissue morphology
consistent with fibrocartilage was observed.

Figure 6.10: Safranin O /Fast Green staining of repair cartilage. Representative crosssectional images showing the center of cartilage defects for each of the respective
experimental groups 12 weeks after surgeries (FG=fibrin glue). Control osteochondral samples
are isolated from the most distal portion of the trochlea for qualitative comparisons.

Finally, the functional properties of repair cartilage were evaluated via indentation
creep testing, which enables the in situ mechanical testing of tissues within defects to
elucidate the compressive modulus, tensile modulus, and permeability (Figure 6.11). The
measured average compressive modulus of repair cartilage across all the experimental
groups did not exceed 0.4 MPa, suggesting that repair cartilage possessed inferior
mechanical properties when compared to previously reported modulus values for native
cartilage.42 Indentation testing of healthy tissue controls isolated from the most distal
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region of the lateral trochlear groove (compressive modulus = 2.00

0.64 MPa) confirmed

that each treatment group led to only partial restoration of the defect’s biomechanical
function.

Figure 6.11: Indentation testing of repair cartilage. The compressive moduli (left), tensile
moduli (middle) and permeability (right) of explanted repair cartilage quantified via Hertzian
biphasic creep testing 12 weeks after surgeries (FG=fibrin glue). n 4, One-way ANOVA,
*p<0.05.

Statistical differences in compressive modulus were observed between defects
treated with microfracture and pinned precultured composites, and pinned composites
possessed higher compressive moduli than glued composites. However, the elevated
compressive moduli observed for pinned acellular and precultured composites may
potentially be due to the presence of the pin within the defect. Careful attention was given
to ensure that all indentation tests were performed on tissues adjacent and away from
pins toward to avoid any contribution of the pin to the mechanical properties. Since the
pins were also inserted into composites perpendicular to the cartilage surface, it is unlikely
that pins were inadvertently underlying tested regions of interest. An alternative source for
these observed differences in compressive modulus may be the recruitment of
endogenous cells during the formation of pilot holes into the subchondral bone, (i.e.,
combinations of composites with a single microfracture hole).
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In accordance with the tension-compression non-linearity observed in healthy
articular cartilage, the repair cartilage in all of the experimental groups exhibited tensile
moduli that were appreciably larger than their respective compressive moduli;43 however,
no significant trends were otherwise observed across groups. The permeability of repair
cartilage across experimental groups is expected to have an inverse relationship with the
compressive and tensile moduli, but this trend is only observed for the latter, further
highlighting the variability of the measured mechanical properties.
Despite the variability in healing response observed across all the experimental
groups, when comparing composites only with their baseline properties prior to
implantation, the compressive modulus of all implanted composites increased over time,
suggesting delivered and/or endogenous cells mediated the elaboration, maturation,
and/or remodeling of nascent repair tissue (Figure 6.12).
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Figure 6.12: Mechanical properties of composites before and after implantation. The
compressive moduli of acellular and precultured composites quantified via Hertzian biphasic
creep testing both prior to implantation in animals (for both fixation methods; FG=fibrin glue)
and 12 weeks after the initial surgeries. Increases in the mechanical properties of all
composites are observed 12 weeks after implantation. n≥4, Two-way ANOVA, *p<0.05.

6.4

CONCLUSIONS
Previously developed composites of MEW-NorHA were successfully translated to

adult porcine MSCs that exhibited viability, chondrogenesis, and cartilage formation during
culture. Further, fixation methods and the capacity of MEW-NorHA composites to facilitate
repair cartilage within full-thickness chondral defects were evaluated. Despite their ability
to form neocartilage in vitro with multiple porcine donors, composites with chondrogenic
preculture did not exhibit any marked improvements over the quality of cartilage formed
via control microfracture treatment. Arthroscopic and gross observation of defects
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demonstrated that significant variability exists across all the experimental groups, with the
most pronounced differences observed within composite groups. While the use of PLDLLA
pins appears to have ensured the retention of composites within defects, the size of the
pins relative to the defect size may have compromised the ability for repair tissue to
completely fill defects; moreover, the loading imparted by the pinning process itself could
have adversely impacted the outcomes of pinned composite groups by compromising the
mechanical properties of composites and or contracting the composites, causing them to
sink in defects and poorly integrate with peripheral tissue. In contrast, fixation of
composites with fibrin glue led to repair cartilage with improved gross appearance and
more complete defect filling.
With these results in mind, it is clear that further improvements in fixation, overall
cartilage properties, and the animal model selected are needed for a thorough assessment
of composites. While retention of samples with fibrin glue may be less reliable, the reduced
subchondral bone remodeling taken together with the improved ECM contents, as
evidenced by histology, suggests that future approaches for cartilage repair with MEWreinforced hydrogels should leverage fibrin glue over bioresorbable pins. To this end, the
composite design may be further improved towards increasing the prospects of this
approach. Namely, improved fixation and integration may be achieved through the
incorporation of tissue-adhesive hydrogels,44 while the chondrogenic potential of adult
pMSCs may be augmented via coculture with chondrocytes,

45

the presentation of

signaling cues that recapitulate the cell-cell interactions present during mesenchymal
condensation (i.e. N-cadherin mimetic peptide HAVDI), or the sustained delivery of growth
factor such as TGF-B3 in vivo.21,45,46 Lastly, the 4 mm defect selected in this model is quite
small (~0.13 cm2) and repaired well with both untreated and microfracture controls. To this
end, it is important to note that this defect size is within the indicated range that
240

microfracture would be clinically recommended.1 Therefore, the comparisons made
between microfracture surgery and composite implantation in this study likely do not
illustrate the composites’ potential advantages in repairing defects that would be otherwise
challenging to repair (i.e., larger defects approaching or greater than 4 cm2).
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CHAPTER 7: DIGITAL LIGHT PROCESSING OF MACROPOROUS AND
HYDROLYTICALLY DEGRADABLE NORHACA HYDROGELS FOR USE WITH
AUTOLOGOUS MATRIX-INDUCED CHONDROGENESIS
7.1

INTRODUCTION
Despite the multitude of biofabrication approaches implemented for the repair of

articular cartilage to date, including a large number of bioprinting strategies for the
fabrication of cell-laden implants,1 few if any have successfully translated into the clinic
and improved patient outcomes. Existing clinical repair strategies that employ the delivery
of cells to afflicted patients such as autologous chondrocyte implantation (ACI) and matrixassisted ACI (MACI) also suffer from several limitations. For example, therapies that
employ autologous cells from patients require multiple surgeries and significant time to
both isolate and expand cells in vitro to achieve sufficient cell numbers for therapeutic
benefit. Moreover, these autologous cells may exhibit attenuated chondrogenic potential
if isolated from either older patients and/or diseased tissues. Donor site morbidity has also
been previously reported for instances in which chondrocytes are isolated for ACI. Even
with the successful isolation and expansion of a cell source, additional challenges remain
such as ensuring the retention of viable cells and maintaining their chondrogenic
differentiation.
An alternative approach to these therapies and the cell-based approaches
explored in Chapters 4-6 is the use of acellular scaffolds as a medium to provide both
mechanical support and physiochemical cues to endogenous cells. Autologous matrixinduced chondrogenesis (AMIC) is clinically employed to treat isolated osteochondral
lesions (≤1.5 cm2 in size) via combining subchondral microfracture with the fixation of a
collagen membrane using fibrin glue.2,3 As a one-stage procedure, AMIC circumvents a
number of the highlighted challenges associated with MACI and other cell-based
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approaches, while achieving comparable patient outcomes in the short term (i.e., 2 years).
The inclusion of a collagen scaffold with microfracture has been shown to improve the
retention of recruited stromal cells, while also providing mechanical support to the blood
clot against shear forces generated within the joint.4 Moreover, it is believed that AMIC
addresses a number of the limitations associated with conventional microfracture alone,
including insufficient defect filling and limited formation of hyaline tissue.5 To this end, a
randomized control trial comparing patient outcomes for 47 patients treated with either
AMIC or microfracture showed that AMIC results in significantly improved cartilage repair,
with filled defects and functional tissue observed 5 years after treatment.6 While additional
studies are needed to characterize the performance of AMIC relative to other repair
strategies such as ACI and MACI,3 the general prospects for AMIC may be significantly
improved, especially in instances where cartilage defects are large,5 by enhancing the
ability of implanted scaffolds to promote and facilitate MSC chondrogenesis.
While collagen has been used in clinical AMIC procedures, there is interest in the
engineering of alternatives that may provide improved outcomes through their design. The
ideal scaffold for AMIC should exhibit a degradation rate that is matched to the rate of
neocartilage formation, such that tissue maturation and remodeling can occur over time
without impedance from the presence of the scaffold.7 However, the scaffold must also
persist long enough to ensure that recruited cells are able to deposit and engage with
nascent matrix at early timepoints.7,8 Additionally, scaffolds for AMIC must enable or
support the infiltration of endogenous cells from the bone marrow to ensure that ECM is
deposited throughout the entirety of the scaffold and integrates with the surrounding
tissue.9 To this end, macroporous constructs with high degree of interstitial pores are
required to facilitate the filling and distribution of marrow throughout the full thickness of
the scaffold and defect. It is also important that the scaffold possess suitable mechanical
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properties so that it may stabilize the initial blood clot formed during microfracture,
ensuring that cartilage defect remains entirely filled with recruited cells. Finally, scaffolds
engineered for AMIC should be amenable to growth factor delivery towards improving the
chondrogenic potential of cells. There have been a number of approaches to engineer
scaffolds that meet these properties, including with multipolymer electrospun scaffolds
(i.e., composed of PCL and HA),10 electrospun HA scaffolds,11 and a number of
commercial scaffolds;12 these include photocrosslinkable PEG hydrogels (ChonDux),
freeze-dried polyglycolic-HA scaffolds with loaded chemoattractant (Chondrotissue), and
autologous scaffolds that form upon mixing of patient’s whole blood with chitosan glycerol
phosphate (BSTCarGel).12 In addition, composite hydrogels with these properties were
recently bioprinted with chondroprogenitor cells into porous films towards the delivery of
paracrine signals to recruited MSCs in an adapted AMIC approach.13
In response to the challenges of cell-based approaches for cartilage repair and the
findings of Chapter 6, the aim of this study is to fabricate a novel acellular scaffold that
encompasses each of these design considerations for future investigation in the treatment
of cartilage defects via AMIC. NorHA macromers are engineered using an alternative
chemistry from that which was used in Chapters 4-6 to obtain NorHA with hydrolytically
labile pendant norbornene groups (NorHACA). Hydrolytically degradable step-growth
hydrogels with a range of mechanical properties and degradation behaviors are then
fabricated, and a computational model is developed to relate the stochastic degradation
of NorHACA crosslinks to macroscopic gel properties over time. It is expected that the
continued development of this model will assist with hydrogel characterization, and
eventually, help predict the degradation behavior of prospective NorHACA hydrogel
formulations for use in AMIC. Unlike the scaffolds currently employed clinically in AMIC,
the developed NorHACA hydrogels are processed via digital light processing (DLP), which
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permits precise control over the scaffold geometry towards achieving optimal infilling of
marrow (from subchondral microfracture) within the implant.
7.2

METHODS

7.2.1

Materials
Sodium hyaluronic acid was purchased from Lifecore Biomedical (Chaska, MN)

and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) was purchased from
Colorado Photopolymer Solutions (Boulder, CO). Unless otherwise specified, all other
reagents and materials were purchased from Sigma-Aldrich (St. Louis, MO).
7.2.2

NorHACA Synthesis, Hydrogel Fabrication, and Photorheology
HA modified with hydrolytically labile norbornene functional groups (NorHACA) was

synthesized via an esterification reaction with carbic anhydride. HA was dissolved in DI
water and titrated to pH~8.7 with 1 N NaOH. Carbic anhydride was then added dropwise
(20 molar equivalents relative to HA) throughout the first two hours of the reaction. pH was
maintained between 8.4 and 8.6 by continued addition of NaOH for the duration of the
reaction (3 to 3.5 hours). Thereafter, the reaction solution was stirred overnight at 4 °C,
and further titrated to a pH of 8.5 (so that the HA would react with any remaining carbic
anhydride that had not yet been hydrolyzed) the next day. The reaction solution was then
frozen and lyophilized. Multiple degrees of modification of HA with norbornene were
targeted by changing the concentration of HA and the reaction time. To quantify degree
of modification, samples were analyzed via 1H-NMR spectroscopy (Bruker Neo400 360
MHz; Figure 7.1).
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Figure 7.1: Overview of hydrolytically degradable NorHACA hydrogel formation. a)
Schematic of the synthesis and photocrosslinking of hydrogels from norbornene-modified
hyaluronic acid (HA). Sodium HA is reacted with carbic anhydride under basic conditions to
yield NorHACA, which is then photocrosslinked via a thiol-ene reaction in the presence of di1

thiol crosslinker (DTT, dithiothreitol) and LAP photoinitiator (0.05%). b) H-NMR spectra of
synthesized NorHACA macromer. To quantify the degree of norbornene modification, the vinyl
protons of norbornene (2H, ~5.9-6.4 ppm) are integrated relative to the methyl protons found
on the backbone of HA (3H, ~1.8-2.1 ppm). Norbornene modifications of (left) ~14% and
(right) ~40% of the disaccharide repeat units of HA were obtained.

Hydrogels were formed via thiol-ene crosslinking by dissolving NorHACA macromer
in PBS with LAP photoinitiator (0.05%) and DTT (XDTT=1.0), casting the hydrogel precursor
into molds (diameter~4.78mm), and curing with blue light (Exfo Omnicure S1500 lamp,
400−500 nm filter, I=10mW/cm2) for 5 min. To characterize reaction kinetics, the storage
(G’) and loss (G’’) moduli of NorHACA hydrogels were monitored during gelation using an
AR2000 stress-controlled rheometer (TA Instruments) fitted with a 20 mm diameter cone
and plate geometry, 59 min 42 s cone angle, and 27 μm gap. All time sweeps (0.5% strain,
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1 Hz) were performed in the presence of visible blue light (Exfo Omnicure S1500 lamp,
400−500 nm filter, I=10mW/cm2, t=5 min).
7.2.3

Compression Testing
The compressive moduli of hydrogels were determined via unconfined uniaxial

compressive testing (Q800, TA Instruments), with a loading rate of 0.2N/min and the
modulus calculated as the slope of generated stress-strain curves between 10% and 20%
strain. To determine the Poisson ratio (ν ) of hydrogels, the compression of samples (n=3,
5% NorHACA, 40%mod) to 30% strain was recorded (loading rate of 0.2 N/min). Images from
the beginning and the end of the loading ramps were then processed using Image J
software, and strains in the transverse direction for each experiment were measured to
determine

= 0.441±0.019. Therefore,

~0.44 was assumed for all the hydrogel

formulations investigated.
7.2.4

Characterization of NorHACA Hydrogel Bulk Degradation
Hydrogels were incubated in 1 mL of phosphate buffered saline (PBS) at 37°C

(n=3) until the complete degradation of the hydrogel (i.e., reverse gelation) was observed.
Throughout the incubation time course, the PBS was regularly replaced (at a minimum 23 times per week), and the supernatant collected (and stored frozen until future analysis)
to quantify the cumulative release of HA from the hydrogel. After reverse gelation was
observed, samples were incubated overnight at 37°C in hyaluronidase (1 mg/mL, 7503000 U/mg) solution to ensure the complete degradation of any residual entangled or
covalently linked macromers.
The release of HA from crosslinked hydrogels was quantified as previously
described via reaction of collected supernatant with carbazole to detect uronic acid (a
degradation product of HA), using a 96-well assay.14 In each well, samples containing
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released HA (50 μL) were mixed with 25 mM sodium tetraborate decahydrate (200 L) in
sulfuric acid and incubated at 100°C for 10 min. After cooling to room temperature,
samples were then reacted with 0.125% carbazole in ethanol at 100°C for 10 min. The
absorbance of samples at 550 nm was then quantified on a Tecan Infinite M200
spectrometer, with a four-parameter logistic regression used to fit generated 8-point
standard curves (concentrations ranging from 0-1 mg/mL HA).
The dry and wet masses of hydrogels were measured as previously described to
calculate the mass swelling ratio (Qm) of hydrogels in the relaxed state (i.e., immediately
after crosslinking), the equilibrium state (i.e., 24h after crosslinking), and at different time
points (t) over the course of their degradation.15 Qm was calculated using Equation 7.1:

where Mwet and Mdry are the wet and dry masses, respectively, of hydrogels.
Following wet weight measurements, compression testing was performed as
described in the preceding section to quantify the compressive modulus of NorHACA
hydrogels over the course of degradation.

7.2.5

Modeling of Hydrogel Degradation Behavior
A custom MATLAB script was developed using an object-oriented programming

approach to simulate the random degradation of crosslinks and subsequent release of
macromer chains from a network. This model is based on a previously described model
by Jahanmir and colleagues, who modeled the hydrolysis of high molecular weight dextran
hydrogels (40 kDa) crosslinked via thiol-Michael addition.16 Specifically, an array of
crosslinkable ‘nodes’ was first constructed based on input macromer properties and
hydrogel formulation, where each column (n) represents an individual polymer chain
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(n=1000 polymer chains simulated per each modeled network) and each row (m)
corresponds to a discrete norbornene group attached to the polymer chain backbone,
such that an index (xn,m) is assigned to every norbornene actively forming a crosslink within
the network.
Model inputs included the macromer concentration, macromer molecular weight,
repeat unit molecular weight, and the hydrogel volume, all of which inform the total number
of crosslinks incorporated into the simulated network. For example, assuming a
homogenous distribution of norbornene modifications and molecular weights across all
the polymer chains prior to crosslinking, as well as the formation of an ideal network (i.e.,
every norbornene reacts with another norbornene to form a functional crosslink), a 5wt%
NorHACA hydrogel with a 40% degree of modification yields an array composed of 1000
columns and 109 rows. Every index of the array is randomly coupled to another index,
representing the random formation of crosslinks between macromers. Since the network
architecture that arises from this process is unique for every iteration, multiple network
structures were generated and simulated (n=25).
Within each simulated network, the number of degraded crosslinks and released
polymer chains was monitored as a function of time. As a result, the mole number of
macromers retained between crosslinks and the average number of active functional
groups participating within crosslinks may be determined and thereafter related to
hydrogel properties of interest. Several simplifying assumptions were made to ensure that
this model framework could be applied to the NorHACA hydrogels.17 The reactivity of
norbornenes across all macromer backbones is assumed to be equal and to remain
constant independent of the extent of crosslinking. Similarly, the probability of any pendant
norbornene functional group undergoing hydrolysis is assumed to be the same across all
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norbornenes. Finally, no intermolecular or non-specific interactions are assumed to occur
between pendant norbornenes.
At any given time, a crosslink within the NorHACA network may exist in three states
(1-3): (1) entirely intact, such that the two esters attaching norbornenes to HA backbones
are both retained (2) partially intact, where one of the two esters attaching norbornenes to
HA backbones is hydrolytically cleaved, and (3) completely degraded, where both esters
attaching norbornenes to HA backbones are cleaved so that the crosslinker is released
from the network (Figure 7.2).

Figure 7.2: Overview of possible crosslink states within NorHACA hydrogels. Every
crosslink within the network exists in one of three possible states (shown from left to right):
intact, partially intact, or fully degraded. Each of these crosslink states have their own
respective probabilities of existing during the degradation of the hydrogel, which are defined
by the hydrolysis kinetics. When a norbornene (green) group is hydrolytically cleaved, the
parent macromer is disconnected from the DTT crosslinker (purple). For any given macromer,
when all the pendant norbornenes participating in crosslinks are cleaved, the parent macromer
is released from the continuous network. Macroscopically, a minimum average of two
crosslinks must be attached to each macromer backbone for a stable gel to persist. When this
condition is no longer met, the network undergoes reverse gelation and macromers are
released as uncrosslinked polymer chains. Thus, the number of active functional groups
participating in crosslinks per each macromer backbone (N) is directly related to the
degradation rate (k) and the degradation time (t). Importantly, N varies as a function of the
hydrogel formulation (i.e., macromer molecular weight and degree of modification) and the
effective crosslinking efficiency (η) during gelation (i.e., macromer concentration, XDTT, and
photocrosslinking parameters such as the photoinitiator concentration and molar absorptivity,
the light intensity, and the light exposure time).

Assuming that the hydrolysis of NorHACA hydrogels is a first order process that
abides by pseudo first order degradation kinetics (i.e., constant concentration of PBS,
constant pH, homogenous exposure of water to degradable ester bonds throughout the
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hydrogel network), the molar concentration of esters ([ester]) incorporated within the
network as functional crosslinks over time (t) can be described by Equation 7.2 as follows:

where k is the degradation rate constant. Solving this rate equation yields the
concentration profile of esters within functional crosslinks over the course of degradation
(Equation 7.3).

Moreover, the probability of an ester bond (within crosslinks) hydrolyzing (Pdeg) can be
described by Equation 7.4:

which describes the extent of ester hydrolysis degradation within the network. With this
probability defined, each of the respective crosslink states previously described may be
assigned probabilities in accordance with the law of conditional probability.
Since the probability of a single ester bond being intact can be described as (1Pdeg) the probability of any crosslink being fully intact ( ) is given by Equation 7.5:

Alternatively, the probability of any crosslink being partially intact ( ) is given by Equation
7.6:
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since there are two possible scenarios in which one ester bond within a crosslink is
cleaved and the other is intact.
Finally, the probability of any crosslink being fully degraded ( ) is given by Equation 7.7:

A first-order Erlang distribution is employed to model the random hydrolysis of
esters within NorHACA networks at discrete simulation time steps (0.05 days), since a
similar approach has been previously used to model the surface degradation of
polymers.18 Every crosslink node is assigned a random variable, ϵ, that is equally
distributed and exists in between 0 and 1.16 An exponential distribution of node lifetimes
(in accordance with the probability of a single ester bond undergoing hydrolysis) is then
established by setting ϵ equal to P

(Equation 7.8).

This expression may then be solved explicitly to relate the randomly assigned variables to
an arbitrary node lifetime (Equation 7.9).

During simulation timesteps, the lifetime of individual crosslinks corresponding to the nth
polymer and the mth norbornene along the backbone (t

,

) is compared to the simulation

time. When the latter value is larger than the randomly assigned lifetime, the crosslink
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node is considered hydrolyzed; this is reflected by the variable

,

, which is assigned to

every index within the network and is defined by Equations 7.10 and 7.11 as follows:

While non-idealities such as the reaction of DTT crosslinkers with only one norbornene,
unreacted norbornenes, and cyclization of norbornenes (i.e., reactions between pendant
norbornenes on the same macromer, also known as ‘back biting’) are known to occur
during the crosslinking of long chain step-growth hydrogels, ideal networks do not account
for this. Therefore, empirical swelling data from hydrogels in the relaxed and equilibrium
swollen state was used to characterize the number of functional groups that effectively
participate in crosslinks.
To account for non-idealities that occur during the crosslinking of norbornenes, or
‘nodes’ within the simulated network, the effective crosslinking efficiency,

, was

determined using Equation 7.12:

where ν

,

and

,!"#$!%

are the mole numbers of macromer chains in between

crosslinks for an idealized network and for actual hydrogel samples. While

,&' !%

may be

theoretically calculated based on the molar concentration of macromer and the degree of
norbornene modification used,

,!"#$!%

was determined via the well-characterized Bray

Merrill Equation,19 which relates the polymer volume fraction within the hydrogel to the
mole number of macromer chains in between crosslinks, and as a result, the crosslink
density (() ).

Specifically, the crosslink density of any hydrogel may be defined by

Equation 7.13:
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where *+

%,,

is the initial hydrogel volume in the relaxed state, * is the molar volume of

the solvent (i.e., V =18 mL/mol for water), ν

,.

is the polymer volume fraction in the

equilibrium swollen state, χ is the Flory polymer−solvent interaction parameter (0 ~0.473
for HA and water),20 and ν
To solve for

,1

,!"#$!%

is the polymer volume fraction in the relaxed state.

in Equation 7.13, empirical mass swelling ratios (Qm) are first

used to determine the polymer fractions ν

where ̅

,.

and ν

,1

using Equation 7.14:

is the specific volume of water ( ̅ =1 mL/g) and ̅ is the specific volume of

hyaluronic acid ( ̅ =0.547 mL/g for HA in water at 37°C).21
Once a value for

,!"#$!%

was quantified,

was calculated using Equation 12 and

used to determine the maximum possible number of crosslinks within the true network in
the equilibrium swollen state (t=1 day). The network architecture was initialized to reflect
this, yielding an updated array of crosslink nodes.
The final requirement for the simulation to proceed is the selection of the rate
constant k to determine the rate at which random ester hydrolysis events occur.
Importantly, this rate constant may be determined via theoretical relationships to the
degradation time.
To identify the point of reverse gelation, Macosko and Miller previously developed
a recursive model that describes the evolution of network architecture during crosslinking,
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such that the transition of macromer molecular weight from finite (when macromers exist
as soluble species) to infinite (when macromers are covalently crosslinked into a
continuous network) can be elucidated.22,23 The reverse of this transition period is
considered the reverse gelation point, or the extent of hydrolysis at which bulk degradation
of a continuous hydrogel is complete. The law of conditional probability was applied to
describe changes in hydrogel molecular weight over time towards identifying the reverse
gelation time.
For step-growth reactions in which stoichiometric mixtures of reagents are used
(as is the case for all the NorHACA hydrogels investigated; i.e., XDTT=1.0), gelation is
observed when an average of at least two crosslinks are attached to every macromer
backbone.24 At the gel point, the extent of reaction is predicted by the Carothers Equation
(Equation 7.15):

where Xc is the critical extent of crosslinking at which gelation occurs and N is the average
number of active functional groups participating in crosslinks on the NorHACA macromer
backbone.24 Importantly, N can be determined using model inputs for the hydrogel
formulation (Equation 7.16):

where MW67 is the molecular weight of the unmodified HA macromer (~88 kDa),
89'&:!"";!,&' is the molecular weight of the disaccharide repeat unit (~378.3 g/mol), and
DM is the degree of norbornene modification.
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At the critical time at which the gel point occurs (tc), the critical extent of crosslinking
X=t > ) may be described as the probability of ester bonds being intact.24 Since this
probability is defined by Equation 7.5, the degradation time of a hydrogel with N active
functional groups contributing to crosslinks is given by Equation 7.17:

Substitution of X=t > ) (Equation 7.15) and

' + =?" @

(Equation 7.4) into Equation 7.17 and

solving for the rate constant reveals the relationship between k, t > and N (Equations 7.18
- 7.21):

This approach may be implemented to determine input rate constants from
empirically observed degradation times and swelling behavior. Alternatively, rate
constants may be determined via model recursion to predict the time at which reverse
gelation occurs for distinct hydrogel formulations. Simulations were performed with the
number of intact crosslinks and released macromer chains recorded at each time step.
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The mole number of macromers retained between crosslinks (

,!"#$!% )

and the average

number of active functional groups participating within crosslinks (N) were calculated from
these model outputs, such that mass swelling ratios could then be predicted using
Equations 7.13 and 7.14.
The compressive modulus was also predicted (A

, ')

as previously described

using calculated crosslink densities at discrete simulation times and the Poisson’s ratio
(ν =0.44 for all hydrogels investigated) of the hydrogel (Equation 7.22):25

where R is the universal gas constant (R=8.3145 m3 Pa mol-1 K-1) and T is the temperature
(T=310.15 K).

7.2.6

Preparation of Copolymer Hydrogels
Non-degradable NorHA was synthesized as previously described via BOP

coupling of HA and 5-norbornene-2-methylamine.26 NorHACA macromer and nondegradable NorHA were then dissolved in PBS along with LAP photoinitiator (0.05%) and
DTT (XDTT=1.0), cast into molds (diameter~4.78mm), and crosslinked via irradiation with
blue light (Exfo Omnicure S1500 lamp, 400−500 nm filter, I=10mW/cm2) for 5 min.
7.2.7

Digital Light Processing of Hydrogels
NorHACA hydrogels (5% NorHACA, 40% modification, 0.5% LAP, XDTT~1.0) were

printed on a Lumen Alpha Prototype Projector (Volumetric Inc., Houston, TX) with a 405
nm LED light source (I=15 mW/cm2), 100 m step size, and a print speed of 30 mm/min.
Variable concentrations of tartrazine photoabsorber (TTz, 0.5-1 mM) and light exposure
times (4-10 s) were initially investigated to identify the requisite resin formulation and
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printing conditions required for the fabrication of stable constructs with internal negative
features. Ultimately, 1 mM TTz and 6 s exposure time were selected used to print 2D
patterns, as well as 3D bulk and macroporous structures. Porous constructs printed for
the characterization of bulk degradation were washed post-printing with PBS containing
1% LAP and 15 mM DTT, and then stabilized with post-print curing (Exfo Omnicure S1500
lamp, 400−500 nm filter, I=10mW/cm2, and t=5 min, with constructs flipped after 2.5 min
of curing). Visualization of 2D printed constructs was achieved via swelling of constructs
in rhodamine-labeled dextran (which is then pseudo-colored green), while the visualization
of 3D printed constructs was achieved via the presence of TTz.
7.2.8

Statistical Analysis
All data are reported as mean±standard deviation and were analyzed using

GraphPad Prism 9 software. One-way ANOVAs were performed with Tukey's honestly
significant difference (HSD) post-hoc testing and significance determined at p<0.05 to
compare the compressive modulus of casted and 3D printed NorHACA hydrogels.
7.3

RESULTS AND DISCUSSION

7.3.1

Rational Design of Degradable Hydrogels for AMIC
To create a scaffold that can be implemented in the AMIC approach for cartilage

repair, it is of interest to target degradation times that match the rate of neocartilage
formation by endogenous cells. Although candidate degradable hydrogels have been
previously engineered with protease-sensitive crosslinkers,27 enzymatic degradation is
typically dependent on the local environment and varies dynamically with both local
enzyme concentration and cellular behaviors.28 Conversely, hydrolytically degradable
hydrogels may be engineered with degradation timescales that are defined a priori by the
selection of the hydrogel chemistry and network structure. Additionally, the crosslinking
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method used to form scaffolds for AMIC should be well controlled to ensure that the
resultant mechanical properties, crosslink density, and mesh size are defined, since each
of these properties will influence both the overall hydrogel degradation behavior and
cellular infiltration into the hydrogel network overtime.15,29
HA macromers with hydrolytically sensitive functional groups have been previously
synthesized, including methacrylated-HA with incorporated caprolactone or lactic acid
units between the HA backbone and methacrylate groups.30,31 However, these macromers
are all crosslinked via free radical crosslinking, which leads to heterogenous network
architectures and variable mesh sizes. In contrast, macromers that undergoes step-growth
crosslinking may offer more precise control over network structure and hydrolysis.
Although hydrolytically degradable crosslinkers could be employed to achieve the
degradation of step-growth hydrogels crosslinked via thiol-ene reaction, there are very few
thiol-modified crosslinkers that possess the requisite hydrolytically sensitive bonds,
miscibility in aqueous conditions, and size (i.e., small molecule) desired for this system.
Thus, alternative methods were needed. Generally, biopolymers may be modified with
norbornenes via esterification or amidation reactions with molecules containing
norbornenes and terminal carboxylic acid or amine groups;32 however, recent studies have
also shown that modification of polymers (e.g., gelatin, carboxymethyl cellulose, PEG)
with norbornene may also be achieved via reaction with carbic anhydride. 33–36 In contrast
to traditional norbornene synthesis routes, the use of carbic anhydride results in the
conjugation of norbornenes with an additional attached carboxylic acid group; the
presence of this carboxylic acid group significantly increases the overall hydrophilicity of
the pendant norbornene, enabling the hydrolysis of ester bonds found between the
norbornene and the macromer backbone.

264

To this end, NorHACA macromer with hydrolytically labile norbornene groups was
synthesized via esterification of HA with carbic anhydride (Figure 7.3a). Hydrogels were
then formed via thiol-ene photocrosslinking with blue light, and the resultant mechanical
properties were readily achieved via changes to the macromer concentration or the degree
of norbornene modification (Figure 7.3b). Across a range of hydrogel formulations,
NorHACA undergoes rapid crosslinking, as evidenced by photorheological time sweeps,
which also illustrate changes in storage moduli with variations in crosslink density (Figure
7.3c).

Figure 7.3: Characterization of NorHACA hydrogel mechanical properties. a) Compressive
moduli of NorHACA hydrogels across changes in NorHACA concentration (1, 3, 5%) and extent
of norbornene modification (14, 40% mod) (n=5). b) Photorheological time sweeps (1Hz, 0.5%
strain) showing increases in the storage (G’) and loss (G’’) moduli during the gelation of 14%
modified (left, orange) and 40% modified (right, purple) NorHACA hydrogels of varying
macromer concentrations (1, 3, 5%) with exposure to visible light (400-500 nm, light on at
t=120 seconds). Two-way ANOVA, *p<0.05, **p<0.01, ****p<0.0001.

7.3.2

Characterization and Modeling of Bulk Degradation in NorHACA Hydrogels
The ability for NorHACA hydrogels incubated in PBS to degrade via ester hydrolysis

was validated qualitatively via observation of reverse gelation. Quantitative release
assays, swelling measurements, and compression testing were also performed to
elucidate the temporal evolution of the network with degradation (Figure 7.4). Across all
of the investigated NorHACA hydrogel formulations, the sustained release of HA polymer
chains was observed, consistent with a bulk mode of degradation.29 The swelling ratios
265

and compressive moduli of all the investigated NorHACA formulations also exponentially
increased and decreased, respectively, consistent with the first order process of ester
hydrolysis. However, relative differences existed between hydrogel formulations, as the
rate at which hydrolysis occurred was mediated not only by the pendant group chemistry,
but also the overall network architecture. Increases in the macromer concentration or the
degree of modification resulted in corresponding increases in the hydrogel crosslink
density as expected, which was proportional to the compressive modulus and inversely
proportional to the swelling ratio.29 With increasing crosslink density, the total number of
crosslinks required to hydrolyze prior to reverse gelation also increased; therefore,
increases in the macromer concentration and the degree of modification also resulted in
prolonged reverse gelation times. Generally, NorHACA hydrogels degraded after 3-12 days
of incubation in PBS at 37 °C.

Figure 7.4: Characterization of NorHACA hydrogel degradation. HA release (left), swelling
ratio (middle), and compressive moduli (right) of hydrogels across changes in NorHACA
concentration (1, 3, 5wt%) at either a) 14% modification or b) 40% modification upon
incubation in PBS at 37°C until complete degradation (i.e., reverse gelation) is observed (n=3).

Modeling can be useful to better understand synthesized networks towards their
use in biomedical applications. For example, a multiscale computational model was
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developed to characterize the transition of cell-laden, enzymatically degradable hydrogels
into neocartilage.37 Motivated by this, the work herein described aims to use computational
modeling to inform the design of NorHACA hydrogels. Specifically, a kinetics-based model
was combined with Monte Caro simulations of NorHACA hydrogel degradation to relate
changes in hydrogel mesh size over time to macroscopic gel properties.16 In doing so, the
rate of NorHACA hydrogel degradation might be precisely defined via alterations to the
hydrogel formulation to match desired rates.
Several theoretical models have been previously developed to describe the bulk
degradation of hydrogels crosslinked via free radical crosslinking,24,38,39 step growth
crosslinking,

25,40,41

and even mixed modes of crosslinking (i.e., concurrent radical and

step growth crosslinking).42 However, many of the models that characterize the
degradation of step-growth hydrogels involve hydrogels composed of small molecule
monomers and/or multi-arm macromers with a fixed number of functional groups, resulting
in relatively simple network structures.40 In contrast, the step-growth crosslinking of long
NorHACA macromers, which may exhibit a distribution of molecular weights or degrees of
modification, results in random network architectures with variable mesh sizes throughout
the hydrogel.
To recapitulate the randomness observed during crosslinking, a statistical-cokinetic model was developed and combined with Monte Carlo simulations.16 Through this
generalizable approach, probability functions were employed to capture the random and
differential hydrolysis of crosslinks. Moreover, the averaging of these random and discrete
events at the microscale provides insights into the overall mesh size of the hydrogel over
time. As a result, the crosslink density and macroscopic properties such as mass swelling
ratios and compressive moduli may be predicted (Figure 7.5). Model simulations were
performed across randomly generated network architectures using the inputs shown in
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Table 7.1, including theoretical rate constants that were determined recursively based on
the hydrogel composition and empirically observed swelling behavior (Figure 7.4). The
model generated swelling and compressive modulus profiles comparable to those
obtained empirically, demonstrating its potential use in the future as a predictive tool for
NorHACA hydrogel design. However, the degradation timescales predicted by the model
using these input rate constants were generally shorter than those observed empirically
for NorHACA hydrogels. This may be due to the additional contributions of polymer chain
entanglement and intermolecular interactions to the overall hydrogel stability, both of
which are not currently captured by the modeI (which only accounts for covalent crosslinks
within the network). Importantly, the model may be further adapted to account for these
phenomena so that eventually only swelling data at early time points is needed to
accurately predict degradation timescales, and as a result, swelling and mechanical
properties as a function of time.
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Figure 7.5: Modeling the degradation behavior of NorHACA hydrogels via Monte Carlo
simulations. a) Overview of the modeling approach employed to characterize NorHACA
hydrogel degradation. Empirical mass swelling data collected immediately after hydrogel
formation (i.e., in the relaxed state; B ,, ,ν ,1 ) and 24 h afterwards (i.e., in the equilibrium
swollen state; B ,: , ,: ) is used to determine the effective crosslinking (η) achieved between
pendant norbornene groups. The moles of norbornene incorporated into crosslinks is then
calculated (CD,EF?GEH) and used to create an initial network architecture composed solely of intact
nodes, recapitulating the covalent network of the hydrogel in the equilibrium swollen state.
Simulations are then performed to model the stochastic transition of intact nodes to expired
nodes, representing the hydrolysis of pendant norbornene groups and the disruption of
hydrogel crosslinks (for each hydrogel formulation, n=25 simulations of unique networks,1000
polymer chains per network). Throughout each simulation, the remaining moles of
norbornenes contributing to crosslinks (CD,EF?GEH) are monitored and related to the hydrogel
crosslink density ((x) to predict mass swelling ratios and compressive moduli over time. The
degradation kinetics (i.e., degradation rate constant, k) for each simulation are determined via
a recursion that optimizes generated predictions for mass swelling ratios and compressive
moduli. b) Model predictions for the swelling behavior and mechanical properties of 14%
modified NorHACA hydrogels (1,3,5%) during degradation, with comparisons to empirical data
shown (n=3). c) Model predictions for the swelling behavior and mechanical properties of 40%
modified NorHACA hydrogels (1,3,5%) during degradation, with comparisons to empirical data
shown (n=3).

269

Table 7.1: Model inputs for network initialization prior to Monte Carlo simulation.

While NorHACA hydrogels exhibit promise as degradable scaffolds for AMIC, longer
degradation timescales may be needed for clinical translation. To this end, the degradation
of hydrolytically sensitive biopolymers has been previously modulated via the
incorporation of additional macromers to form copolymers.30,31 For example, nondegradable macromers have been previously combined with hydrolytically degradable
macromers to achieve prolonged degradation times;30 alternatively, macromers that are
sensitive to enzymatic degradation have also been introduced to endow hydrogels with
dual modes of degradation.31
The degradation behavior of NorHACA hydrogels is further tuned via combinations
of non-degradable NorHA macromer with NorHACA macromer to yield copolymers (Figure
7.6). The incorporation of small amounts of non-degradable NorHA into hydrogels results
in prolonged degradation behavior in comparison to pure NorHACA hydrogels alone
(Figure 7.6a). However, at some critical concentration, the addition of NorHA macromer
into copolymers results in the formation of a network that transiently degrades overtime
but does not undergo reverse gelation (Figure 7.6b).
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Figure 7.6: Degradation behavior of NorHACA:NorHA hydrogels. To modulate the
degradation behavior of NorHACA hydrogels without changing the degree of norbornene
modification or the macromer concentration, NorHACA macromer is mixed with a nondegradable, hydrolytically stable NorHA macromer. a) Macromer mixtures (Copolymer 1=
4.75% NorHACA:0.25% NorHA; Copolymer 2= 4.5% NorHACA:0.5% NorHA) extend
degradation timescales, as evidenced by prolonged HA release (left) and swelling behavior
(middle), and higher compressive moduli (right) over time (n=3). b) The incorporation of
excessive amounts of stable NorHA into macromer mixtures (Copolymer 3= 4% NorHACA:1%
NorHA) results in hydrogels that do not degrade after 30 days and that exhibit plateaus in both
swelling ratios and compressive moduli, similar to non-degradable controls (0.5% NorHA
alone). After 30 days, Copolymer 3 and control hydrogels are degraded via treatment with
hyaluronidase (n=3). In these studies, 40% modification NorHACA and 30% modification
NorHA are used.

Interestingly, the statistical-co-kinetic model that was developed enables the
prediction of swelling ratios and compressive moduli for copolymers that undergo reverse
gelation (Figure 7.7), capturing the unique features observed in these systems and not in
pure NorHACA hydrogels. To this end, potential copolymer formulations may eventually be
screened to obtain hydrogels with extended degradation timescales or complex, nonlinear release profiles.
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Figure 7.7: Modeling the degradation behavior of NorHACA:NorHA hydrogels. The model
is adapted to accommodate the incorporation of non-degradable norbornene crosslinks such that
the a) mass swelling ratios and b) compressive moduli of mixed macromer formulations can be
characterized over simulation time. Model predictions for the a) swelling behavior and b)
mechanical properties of Copolymers 1 and 2 during degradation, with comparisons to empirical
data shown (n=3).

7.3.3

Digital Light Processing of NorHACA Hydrogels
Digital light processing (DLP) is a powerful biofabrication approach that enables

the formation of hydrogel constructs with complex internal features and print resolutions
superior to those accessible via extrusion printing (Figure 7.8a).43,44 To this end, a number
of studies have investigated the use of DLP for cartilage tissue engineering.45–48 Increased
attention has also been focused on the development of hydrolytically degradable resins
for DLP.49
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Figure 7.8: Overview of digital light processing (DLP) and considerations for printability.
a) In DLP, non-viscous resin is contained within a vat and is brought into contact with a buildplate (black). Light is projected through an underlying lens (into a 2D light pattern of interest,
which is achieved via digital micromirror devices) to cure the resin onto the build-plate (1).
Thereafter, the build-plate rises, allowing uncured resin (orange) to flow underneath the cured
resin (yellow), which is attached to the build-plate (2). The replenished resin may then be cured
with projected and patterned light, so that it integrates with the preceding layer of resin (3),
and the cycle proceeds to achieve layer-by-layer fabrication of photosensitive constructs (4).
If the resin does not flow underneath the build-plate (2,4) in between successive curing steps
(1,3), then the printed construct will contain defects and/or be incomplete. Therefore, the resin
viscosity cannot be too high, or else the resin will not regularly interface with the build-plate.
Important consideration must also be given to the build-plate retraction height/speed and the
wait time whenever the build-plate is retracted. b) Schematic detailing the importance of cure
depth (Cd) in DLP. The printing parameters, curing conditions, and resin formulation must be
balanced to achieve desired print resolution, especially toward the fabrication of constructs
with negative features. If the cure depth is too low, failure between successive layers of
material might occur during the printing process. However, if the cure depth is too high,
negative features such as pores, which are critical for tissue engineering applications, may be
inadvertently cured.
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In one study, DLP was used to fabricate a scaffold that could be press fit into a
focal cartilage defect and then infilled with an injectable, photocrosslinkable cell-laden
hydrogel to create a composite scaffold that slowly degrades over time and facilitates
cartilage repair in situ.50 Similarly, PEGDA structures with a range of possible mechanical
properties were previously printed via DLP into macroporous structures, which were then
combined with cell-instructive, soft hydrogels. Specifically, MSC-laden hydrogels (PEGnorbornene) containing ECM molecules (chondroitin sulfate) and tethered growth factors
or peptide sequences (i.e., RGD) were infilled into these structures to achieve the requisite
microenvironments required for cartilage formation. The composite system was evaluated
in ex vivo porcine osteochondral plugs and subsequently employed to create a biphasic
scaffold for OC tissue engineering.51
It is expected that DLP may be similarly leveraged to form degradable
macroporous scaffolds for implementation in AMIC, where infilling of the scaffold with
marrow occurs. However, to process NorHACA hydrogels via DLP, permissible printing
conditions need to first be identified (Figure 7.8b).
An adapted form of the Beer-Lambert Law is commonly used to describe the light
attenuation that occurs as light is projected through a resin during DLP. For a given resin
formulation, the Jacobs Equation (Equation 7.23) relates the thickness of a single cured
layer (i.e., the cure depth, C to the penetration depth of projected light (D ) and the energy
dosage A applied for photo crosslinking:43,52

where EL is the critical energy dosage required for resin crosslinking (i.e., gelation only
occurs when E M EL ). When the light intensity used for printing is constant, t L describes
the critical exposure time required for gelation. Ideally, the relative amount of macromer
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photocrosslinking at the layer-layer interface (in between successive z-steps during
printing) should be just slightly higher than what is required for the gel point to ensure that
successful integration between printed layers is achieved. By tuning printing parameters
such as the light intensity and exposure time (E), layers of different thickness can be
targeted.
The cure depth of a resin is significantly influenced by the crosslinking kinetics,
which is dictated by the rate of radical species generation and consumption and the
irradiation conditions (e.g., the photoinitiator concentration and molar absorptivity, the
applied energy dosage) .53 Therefore, the incorporation of photoabsorbers into resins is
often exploited to increase the A" such that the light penetration depth for a given energy
dosage is decreased, increasing the achievable print resolution (i.e., smaller cure depths).
46,54

NorHACA resin was supplemented with variable amounts of tartrazine
photoabsorber (TTz, 0.5 mM-1mM) and photocrosslinked with a range of energy dosages
to elucidate how the cure depth varies with curing conditions. Logarithmic-linear plots of
cure depth versus energy dosage, which are also known as working curves, were used to
identify the D (slope of working curve) and A" (x-intercept of working curve) of resin
formulations (Figure 7.9a).
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Figure 7.9: DLP of NorHACA hydrogels for tissue engineering applications. a) Working
curves to determine the requisite curing conditions (i.e., light intensity, exposure time) and
resin formulation required to achieve desired cure depths (Cd) for DLP. NorHACA resin (40%
modification, 5wt%) containing 0.5% LAP, DTT (XDTT=1.0), and variable concentrations of
tartrazine photoabsorber (TTz, 0.5, 0.75, 1mM) is exposed to a range of different energy
2
dosages (E, mJ/cm ) to identify the penetration depth (Dp) of light through each resin
formulation, as well as the critical energy dosage (EC) required for the conversion of liquid
NorHACA resin into a hydrogel. b) The compressive moduli of casted NorHACA hydrogels and
printed NorHACA hydrogels with variable concentrations of TTz (0.75, 1mM) and light exposure
times (4,6,8,10s). NorHACA resin containing 1 mM TTz is selected with an exposure time of 6
seconds since it exhibits good printability while conserving sufficient mechanical integrity. c)
Representative images of NorHACA hydrogels printed into a range of porous, 2D geometries
with features ranging from ~100-500μm. d) Representative images of NorHACA hydrogels
printed into complex 3D geometries, including a model femoral condyle (left) and a gyroid
structure (right), which possesses macroporous features that are visible when submerged in
PBS (far right).
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Increasing the concentration of TTz within the NorHACA resin led to decreases in the light
penetration depth and critical exposure times, effectively increasing the possible resolution
of stable features (Table 7.2).
Table 7.2: DLP working curve fit parameters for NorHACA resin.

The compressive modulus of printed NorHACA discs however were lower than
casted hydrogel controls across permissible printing conditions (Figure 7.9b) since
complete crosslinking of layers is avoided to ensure that successive layers of resin
crosslink with one another. A final TTz concentration of 1 mM and an exposure time of 6
s was selected to fabricate a range of complex, 2D porous structures, highlighting the
printability of NorHACA resins (Figure 7.9c). Impressively, NorHACA resin could also be
processed into complex 3D structures, including a model femoral condyle and a gyroid
with macroporous porosity (Figure 7.9d).
To demonstrate that NorHACA resin can be 3D printed into degradable scaffolds,
porous discs were fabricated and incubated in PBS at 37°C to monitor hydrogel
degradation over time (Figure 7.10a). After 10 days, reverse gelation was observed in all
the printed constructs. Although the compressive modulus and the swelling ratio of these
constructs were lower than casted hydrogels composed of the same macromer
concentration and degree of modification (Figure 7.4), a comparable HA release profile,
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swelling profile, and drop in mechanical properties was observed, indicating that NorHACA
scaffolds may be processed via DLP towards their use in AMIC (Figure 7.10b-d).

Figure 7.10: Degradation behavior of porous NorHACA hydrogels fabricated via DLP. a)
NorHACA hydrogels (40% modification, 5wt%) are printed via DLP to yield porous cylinders
(green) and then incubated in PBS at 37°C until complete degradation (i.e., reverse gelation)
is observed. b) The relative amounts of HA released during the incubation, c) the mass
swelling ratio, and d) the compressive moduli of printed hydrogels during degradation (n=3).

Several ECM biopolymers have been modified via reaction with carbic anhydride
to develop inks or resins for biofabrication. For example, collagen has been previously
reacted with carbic anhydride to achieve a bioink that could be processed via extrusion
printing while conserving its helical conformation.55 In addition, Rizzo and colleagues
synthesized norbornene-modified gelatin via reaction of free amines with carbic anhydride
for the rapid volumetric printing of cellularized tissue constructs.56 However, it is believed
that this study encompasses the first use of carbic anhydride to obtain a norbornene278

modified ECM resin toward use for DLP. The amenability of NorHACA hydrogels to DLP
was demonstrated through the characterization of working curves and representative
prints of both bulk and porous structures. In addition, the degradability of NorHACA
constructs fabricated via DLP is confirmed, suggesting that these scaffolds may be further
designed for use in AMIC.
7.4

CONCLUSIONS
As a first step towards the design of macroporous hydrogel scaffolds for AMIC in

cartilage repair, a new hydrolytically degradable hydrogel was synthesized, characterized,
modeled, and processed with DLP. Specifically, NorHACA hydrogels were fabricated with
compressive modulus ranging from ~2-70 kPa and degradation times ranging between
three days and two weeks. Importantly, the hydrogel’s mechanical properties and
degradation behavior were readily modulated through the selection of different macromer
concentrations and degrees of modification. Moreover, the use of copolymers composed
of both degradable and non-degradable macromers extends the degradation times of
hydrogels to nearly 3 weeks. A statistical-co-kinetics model was also developed to
describe changes in network mesh size and macroscopic hydrogel properties as a function
of crosslink hydrolysis.
Ongoing work is focused on investigating the degradation behavior of NorHACA
hydrogels with high degrees of modification, which are expected to exhibit different
degradation timescales than the formulations herein characterized. Early results suggest
that reactions of HA with carbic anhydride can yield fully modified NorHACA macromers
(i.e., ~100% norbornene modification). As a result, the crosslink density may be
significantly increased, potentially increasing hydrogel degradation times. In addition, high
modification NorHACA macromer may be combined with non-degradable NorHA to form
additional copolymer formulations with prolonged degradation times. However, important
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consideration must be given to the potential for high degrees of norbornene modification
to attenuate the innate bioactivity of HA, such as its ability to interact with MSCs via cellsurface receptors (e.g. CD44).57 Each of these respective approaches will be explored
towards achieving degradation timescales that better match the required time need for
neocartilage to form (i.e., ~ 1 month, as evidenced by the in vitro studies performed in
Chapters 4-6 with MSC-laden hydrogels).
The developed model may also be further adapted to predict mass loss profiles for
hydrogel formulations of interest,

24,25,38,39,42

which may be related to the generated HA

release profiles obtained by uronic acid assay. However, while past theoretical models
assume that the rate of diffusion of degradation products is significantly faster than the
rate of degradation,24 this assumption is likely invalid in the case of NorHACA hydrogels,
where the use of high molecular weight macromers leads to chain entanglement and
perturbations to the polymer chain dynamics.

Additional features may also be

incorporated into the model to account for complex non-idealities such as intermolecular
interactions between functional groups and restricted mobilities due to diffusion limitations
that arise with crosslinking.58 It is expected that with these alterations, initial swelling data
collected at short time scales (i.e., days) for any arbitrary hydrogel formulation may be
used to fit optimized rate constants using the model, permitting predictions of mass
swelling ratios, compressive modulus, and mass loss profiles at long time scales (i.e.,
weeks to months). Moreover, the incorporation of these model features will improve the
model’s ability to accurately predict degradation timescales observed in NorHACA
hydrogels.
Lastly, growth factors such as TGF-B3 may eventually be incorporated into printed
NorHACA scaffolds, allowing for sustained delivery to MSCs after microfracture to improve
chondrogenesis and ECM formation.59,60 Importantly, the developed model framework in
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this study may be adapted to model the kinetics of TGF-B3 release from the gel,61 and a
three-dimensional stochastic model may be used to account for random variations in
payload diffusivity due to network architecture and heterogenous mesh sizes if needed.62
7.5
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CHAPTER 8: CONCLUSIONS, LIMITATIONS, AND FUTURE DIRECTIONS
8.1

OVERVIEW
The overarching goal of the work described in this dissertation was to employ

light-based biofabrication technologies to engineer hydrogels composed of hyaluronic
acid for the repair of articular focal defects. Specifically, extrusion bioprinting, meltelectrowriting, and digital light processing were leveraged to design three complex and
distinct scaffolds, each of which aimed to improve upon the limitations of scaffolds
currently employed in the clinic for the treatment of cartilage defects. (e.g., collagen
scaffolds). The design and fabrication of these respective scaffolds was informed by the
fundamental theories of photocrosslinking described in Chapter 3, such that HA hydrogel
properties were controlled through understanding of thiol-ene reaction behavior and the
applied biofabrication technology. Norbornene-modified hyaluronic acid (NorHA) was
used in the development of each of these scaffolds, since the use of step-growth
hydrogels permits the fabrication of hydrogels with well-defined crosslink densities and
predictable reaction behavior.
First, a novel in situ crosslinking technique for the 3D printing of living MSCs in
HA hydrogels was characterized to demonstrate the ability to create large-scale
neocartilage constructs with anatomical features. Many implants that are clinically
employed in the repair of articular focal defects fail due to poor integration with the
surrounding tissue, whereas this bioprinting technique enabled the formation of implants
with patient-specific geometries to improve defect filling. Thereafter, the influence of HA
hydrogel crosslink density on encapsulated MSC chondrogenesis and ECM production
was investigated to identify HA hydrogel formulations that best support the formation of
cartilage. MSC-laden hydrogels that are soft and loosely crosslinked are shown to form
dense neocartilage in vitro, but their low initial mechanical properties preclude their use
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in vivo. To address this, polycaprolactone (PCL)-based microfiber meshes were
fabricated via melt electrowriting to mechanically reinforce soft hydrogels without
compromising their chondrogenic potential. Importantly, composites of PCL meshes and
HA hydrogels resulted in the formation of cartilage with mechanical properties
approaching those of native tissues. Therefore, composites were evaluated for their
ability to repair focal defect lesions in a porcine model of cartilage damage, and their
performance was compared to microfracture. Implanted composites supported the
formation of repair cartilage in some animals, suggesting that this repair approach may
potentially be employed with additional refinement. Finally, novel HA hydrogels with
tunable degradability were synthesized and 3D printed via digital light processing for use
as scaffolds in autologous matrix induced chondrogenesis (AMIC), a clinical procedure
that combines microfracture surgery with scaffolds containing cellular signals to improve
the quality of tissue formed by recruited MSCs. The ability to fabricate macroporous
implants amenable to infilling with marrow during AMIC is shown, and a computational
model is developed to characterize how the hydrogel formulation may be tuned to match
the rates of implant degradation and neotissue formation.

8.2

SPECIFIC AIM 1

Employ an in situ crosslinking bioprinting technique to fabricate MSC-laden HA
constructs for the formation of cartilage.

Conclusions
Extrusion bioprinting is a promising approach for the repair of cartilage tissue
after damage due to injury or disease; however, the design of 3D printed scaffolds has
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been limited by the availability of bioinks with requisite printability, cytocompatibility, and
bioactivity.1 In Aim 1, an approach termed in situ crosslinking was developed and
characterized to permit the printing of non-viscous, photocrosslinkable bioinks via the
direct-curing of the bioink with light through a photopermeable capillary prior to
deposition. NorHA macromer was used as a representative bioink to demonstrate how
thiol-ene crosslinking kinetics and the printing parameters (e.g., capillary length, flow
rate, light intensity) could be tuned to identify printing conditions that were optimal for the
ink. The printing process was cytocompatible, with high cell viability and homogenous
distribution of mesenchymal stromal cells (MSCs) observed throughout printed
constructs. Over 56 days of culture in chondrogenic media, printed constructs increased
in compressive moduli, biochemical content (i.e., sulfated glycosaminoglycans,
collagen), and histological staining of matrix associated with cartilage tissue. This
generalizable printing approach may be used towards the repair of focal defects in
articular cartilage or broadly towards widespread biomedical applications across a range
of photocrosslinkable bioinks that can now be printed.

Limitations and Future Directions
Although the developed in situ crosslinking technique was used to successfully
print large tissue constructs with centimeter-scale dimensions, large filament diameters
were required to do so; otherwise, the required print times would have been prohibitively
long, and the viability of cells would have been compromised. In addition, prolonged print
times could potentially lead to cell settling prior to the in situ crosslinking of filaments in
the print head, which would lead to the heterogeneous printing of cells within a construct.
In most cases, the developed photorheological models were able to identify
appropriate printing conditions for a given ink formulation; however, the permissible
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printing regime for some bioinks is inherently narrow, limiting the relative flexibility of
certain printing setups. To this end, even small perturbations to the steady state flow of
bioink during printing may lead to extents of crosslinking within the photopermable
capillary that either impede the continuous extrusion of filaments or result in
heterogeneously crosslinked filaments. Future studies may therefore explore the use of
photoabsorbers to modulate crosslinking kinetics in a manner similar to their use in
DLP.2
Conversely, printed filaments must also undergo sufficient crosslinking to achieve
stable filaments. While NorHA hydrogel formulations with compressive modulus of ~6
kPa were consistently and reliably printed with the in situ crosslinking technique, softer
hydrogel formulations (compressive modulus of ~2 kPa) that were identified in Aim 2 as
better alternatives for the formation of neocartilage could not be easily printed.
8.3

SPECIFIC AIM 2

Fabricate composites of soft hydrogels with supporting melt electrowritten
polycaprolactone and evaluate their potential for neocartilage formation.

Conclusions
NorHA hydrogels were shown to support MSC chondrogenesis and neocartilage
formation in vitro in Aim 1. However, in Aim 2 a range of hydrogel formulations were
investigated to elucidate the influence of NorHA crosslink density on the formation of
repair cartilage. In keeping with previously reported findings, it was shown that NorHA
hydrogel networks with lower crosslink densities are generally more amenable to the
deposition and distribution of nascent matrix by encapsulated MSCs.3,4 However, the low
initial mechanics of these hydrogels rendered them ill-suited for implantation into a
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cartilage defect, where complex and dynamic loading forces are present. Therefore,
melt-electrowriting was employed as a method to mechanically reinforce soft NorHA
hydrogels. MEW-NorHA composites were engineered with high compressive properties,
which significantly increased with the encapsulation and chondrogenic culture of MSCs.
Moreover, MSC-laden MEW-NorHA composites demonstrated the capacity to integrate
with native cartilage tissue ex vivo.

Limitations and Future Directions
While previous examples of MEW-reinforced hydrogels involve the molding of
MEW meshes within hydrogels,5 MEW-NorHA composites were fabricated via infilling of
hydrogel precursor into the PCL mesh, allowing for the potential fabrication of
composites with irregular geometries or topographies. For instance, this may be of
interest in potential applications where composites are prepared intraoperatively (with or
without cells) during the surgical repair of cartilage, as the MEW mesh may be
processed into a shape of interest (i.e., a patient-specific defect shape) and hydrogel
precursor may then be crosslinked in situ within the mesh. However, the decision to
process composites in this manner necessitates the use of excess amounts of
macromer and cells (relative to the amount needed to form a casted composite of the
same volume). For example, in this study ~100 L of macromer suspension containing
MSCs was used to fill a single MEW mesh (~15 L), which is important to consider if
these composites are to be scaled toward the repair of large cartilage defects (4 cm2).
Further, the addition of hydrogel precursor into the MEW mesh does not always yield a
perfectly homogenous construct, as the presence of misaligned MEW fibers may give
rise to imperfections in hydrogel filling. In instances where this occurs, additional
macromer and cells are required.
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Fiber misalignment within fabricated MEW meshes is typically observed as the
fiber density and/or mesh thickness is increased (e.g., 200 m interfiber spacing in boxstructure meshes, and heights greater than 1mm).6 However, thicker MEW meshes with
precisely patterned architectures could yield composites with even higher compressive
properties, and more importantly, enable improved integration and/or filling of full
thickness defects in instances where the defect thickness is greater than 1 mm.
Conventional MEW systems employ a fixed voltage and collector distance, such
that over time as the height of the mesh increases, excessive charge accumulates within
deposited fibers, resulting in mesh distortion and inaccurate fiber deposition.6 However,
if the electrostatic force is maintained throughout the print, the accumulation of this
excess charge may be circumvented, allowing for the fabrication of thick MEW scaffolds
(e.g., 7 mm).7 Thus, future improvements to MEW hardware may facilitate the generation
of dynamic electric fields through the digital control of the applied voltage and the
collector distance, allowing for the fabrication of meshes with improved fiber alignment at
higher thicknesses.6
Although not investigated in these studies, past examples of MEW-reinforced
hydrogels have also demonstrated poor mechanical properties under dynamic loading
conditions.8 Towards eventually employing these composites for the repair of focal
defects at load bearing sites, alternate MEW structures and combinations therein should
be explored with NorHA hydrogels to elucidate if the mechanical properties can be
further improved.89 Alternatively, combinations of MEW meshes and interpenetrating
network hydrogels, which typically possess mechanical properties that significantly
supersede their single hydrogel network counterparts, may be explored if tough IPNs
with suitable chondrogenic potential can be achieved.10
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8.4

SPECIFIC AIM 3

Evaluate implantation of MEW-NorHA composites to facilitate cartilage repair in a
porcine model of articular cartilage damage

Conclusions
In Aim 3, MEW-NorHA composites were investigated in a porcine model of
cartilage damage to evaluate their ability to promote cartilage repair in vivo. In some
animals, composites successfully facilitated the formation of repair cartilage over 3
months. However, observed outcomes were highly variable and dependent on the
method used for composite fixation. Qualitative assessment of defects via arthroscopic,
gross, and histology images three months after performed surgeries suggests that fibrin
glue was better suited than resorbable pins for the fixation of MEW-NorHA composites in
small defects, as the resorbable pins used accounted for a significant fraction of the total
defect area. Safranin O/Fast Green staining also revealed that the repair cartilage
formed in defects was not hyaline-like, suggesting that defects may have filled with
tissue resembling fibrocartilage. These results were corroborated by indentation testing.
While implanted composites exhibited significant increases in compressive modulus
after implantation, repair cartilage across all the experimental groups was inferior to
healthy cartilage controls.

Limitations and Future Directions
While large animal models are necessary to evaluate the efficacy of novel
cartilage repair strategies,11 careful consideration must be given to the selection of
appropriate models and timepoints. As discussed in Chapter 6, the composites’ true
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ability to facilitate cartilage repair in focal lesions cannot yet be fully assessed given the
significant variability that was observed across outcomes. In addition, appreciable defect
fill and tissue repair was observed in both defects treated with microfracture and empty
defect controls. These outcomes suggest that the cartilage defect size employed may
have been too small to reliably compare the performance of composites and
microfracture; alternatively, longer time points may have better illustrated any differences
between these repair strategies. Moreover, both of the fixation methods investigated in
this study demonstrated varied results, highlighting the demand for improved fixation
techniques.12–14
Future studies may employ hydrogels with tissue adhesiveness towards ensuring
successful composite retention and integration with the surrounding tissue.15 For
example, HA has previously been modified with gallol moieties via EDC-coupling for use
as a tissue adhesive biomaterial ink.16 A similar approach could be readily employed to
adorn NorHA with adhesive moieties. Towards improving the quality of neocartilage
formed in composites prior to implantation, the chondrogenic potential of adult pMSCs
may be improved via coculture with chondrocytes or the presentation of N-cadherin
mimetic peptides (HAVDI) during culture.17,18

8.5

SPECIFIC AIM 4

Engineer hydrolytically degradable, thiol-ene step growth hydrogels amenable to
digital light processing (DLP) for cartilage repair applications.

Conclusions
In Aim 4, hydrolytically degradable NorHACA was synthesized for use as a DLP
resin toward the development of scaffolds for autologous matrix induced chondrogenesis
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(AMIC). Importantly NorHACA hydrogels were engineered with tunable mechanical
properties and a range of degradation behaviors, allowing for the rational design of a
hydrogel that can promote cartilage formation endogenously (via combination with
microfracture). A computational model was also developed using Monte Carlo
simulations and gelation theory to simulate the stochastic process of crosslink hydrolysis
in NorHACA hydrogels. As a result, empirical hydrogel degradation behavior could be
predicted, establishing a framework that may be potentially used to predict and screen
the degradation behavior of various NorHACA hydrogel formulations. Finally, NorHACA
hydrogels were successfully processed via DLP to construct macroporous, degradable
scaffolds with user-defined geometries. Ultimately, the development of this new, modular
hydrogel system may inform the next generation of degradable and cell-instructive
scaffolds used in AMIC.

Limitations and Future Directions
NorHACA hydrogel formulations investigated in this aim exhibit relatively rapid
degradation times; while this could be beneficial for the rapid release and transient
exposure of MSCs to TGF-B3,19 generally much longer degradation time scales are
required to ensure the mechanical integrity of blood clots formed in AMIC is retained
long enough for the formation of neotissue to begin. To this point, the in vitro culture of
MSC-laden hydrogels in Specific Aims 1-3 suggests that cells require on the order of 1
month to form stable, continuous ECM toward the formation of neocartilage. Ongoing
work is focused on the characterization of high modification NorHACA and copolymer
formulations incorporating non-degradable NorHA macromer. It is expected that these
alternatives may yield hydrogels that degrade over significantly longer timescales (more
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than two weeks) than what has been observed for either 14% modified or 40% modified
NorHACA (less than two weeks).
The engineered NorHACA hydrogels exhibit rapid swelling with the hydrolysis of
crosslinks, such that the initial print resolution of hydrogels fabricated via DLP is quickly
lost; this is especially true for macroporous constructs (as opposed to bulk hydrogel
constructs) in which the surface area for mass contact is significantly increased.
Interestingly, the developed copolymers composed of degradable and nondegradable macromers exhibited prolonged degradation times and attenuated swelling
over time when compared to NorHACA hydrogels alone. Future work will investigate the
DLP of these copolymers to determine if they may achieve the requisite balance of
printability, degradability, and swelling required to ensure successful integration with
bone marrow during AMIC.
If both increased degrees of modification and/or the use of copolymers results in
degradation times that are still too short, modification of the second carboxylic acid
group on the pendant norbornene group may be explored to impede hydrolysis, either
through changes to the functional group’s hydrophobicity or overall steric hindrance.
The developed Monte Carlo model may be improved to account for several nonidealities, which better approximate the true nature of hydrogel crosslinking and
degradation over time. These include relative changes to norbornene reactivities and
rates of ester hydrolysis due to intermolecular interactions and diffusion limitations within
the crosslinked network.20 In addition, random distributions of polymer chain lengths and
degrees of medication will be incorporated into the model to better capture the stochastic
nature of NorHACA macromer synthesis prior to hydrogel formation. Since the goal for
this model is to ultimately provide predictive capabilities toward screening prospective
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NorHACA formulations for AMIC, future work should validate the predictive capabilities of
the model for polymer species with long degradation times.

8.6

OVERALL SUMMARY
This dissertation work provides an instructional overview of how biomaterials,

biofabrication techniques, and tissue engineering may be combined to inform and develop
future strategies for cartilage repair, and more broadly, for regenerative medicine. The use
of NorHA hydrogels for cell-based therapies was systematically investigated through a
series of in vitro, ex vivo, and in vivo studies, providing insights on how engineered
biomaterials may be used to elicit therapeutic outcomes. In addition, new biomaterials
were synthesized and characterized with the goal of instructing cells behaviors toward
guiding the formation of new tissues.
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